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Abstract 
Study 1: This study investigated the effects of high intensity interval running (HIIR) and diet 
on the activation of signalling pathways involved in mitochondrial biogenesis.  HIIR did not 
increase AMPK or p38MAPK phosphorylation.  Therefore, it was unclear whether feeding 
carbohydrate (CHO) during recovery from this acute bout of high intensity exercise would 
blunt the activation of these pathways during a subsequent bout of HIIR.  An increase in 
ACCβ phosphorylation was found after HIIR and was not blunted by CHO feeding during a 
subsequent bout of HIIR. 
Study 2: This study compared the changes in mitochondrial biogenesis and endurance 
performance in response to two weeks of HIIR or endurance running (ER) in Gaelic games 
players.  Compared to 6 sessions of ER, HIIR induced a similar improvement in endurance 
performance and a more pronounced increase in mitochondrial biogenesis.   
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Chapter 1  
Introduction 
Skeletal muscle is a very versatile tissue as is evident by its ability to adapt to distinct 
patterns of contractile activity 1,2.  Exercise represents a stimulus capable of inducing both 
acute and chronic cellular adaptations in skeletal muscle 3.  Chronic adaptations are likely to 
be induced by cumulative bouts of contractile activity leading to an increase in gene and 
protein expression, and ultimately distinct phenotypic changes 4,5.   
Endurance training (ET), which is characterized by prolonged bouts of exercise at 
submaximal intensities, elicits metabolic and morphological responses that promote a more 
oxidative phenotype 4,6.  These adaptations are intricately linked to mitochondrial 
biogenesis 5,7.  Over the past decade our understanding of the molecular events involved in 
this process has advanced greatly.  Signalling pathways activated in response to 
perturbations’ in myocellular calcium (Ca2+) concentrations and metabolic rates, changes in 
muscle force tension and hormone signalling have culminated in inducing changes in gene 
and protein expression in the hours after exercise 8.  
High intensity interval activity refers to repeated session of brief exercise bouts 
performed at maximal effort (≥ 90%   2max).  Depending on the training intensity, a single 
session can last from a few seconds (s) to several minutes (min), with multiple bouts 
separated by passive or active recovery periods.  Recent evidence suggests that acute or 
chronic low volume high intensity interval exercise can induce metabolic adaptations that 
are similar to endurance training 9–13.  Studies employing high intensity interval training 
(HIIT) have consistently found an increase in muscle oxidative capacity, indicated by an 
 24 
increase in mitochondrial enzymes such as citrate synthase (CS), cytochrome c oxidase  and 
3 hydroylacyl CoA dehydrogenase (β-HAD) 10,12,14,15.  The ability of HIIT to elicit rapid changes 
in skeletal muscle oxidative capacity is related to its ability to recruit both type 1 and type II 
fibers.   
From a cellular perspective a key regulator of oxidative enzyme expression in a 
number of cell types, including skeletal muscle is the peroxisome proliferator-activated 
receptor (PPAR) γ coactivator 1α (PGC-1α) 16.  PGC-1α is a transcriptional co-activator which 
through the activation of both nuclear and mitochondrial transcription factors up-regulates 
mitochondrial biogenesis 17,18.  Several signalling pathways have also been linked to exercise 
induced activation of PGC-1α and mitochondrial biogenesis, including adenosine 
monophsophate activated protein kinase (AMPK) 19, p38 mitogen activated protein kinase 
(p38MAPK) 20 and calcium-calmodulin dependant protein kinase (CaMK) 21.  A number of 
HIIT studies have found an increase in PGC-1α, AMPK, p38MAPK, and CaMK with a 
subsequent increase in oxidative enzyme activity, and in some studies enhanced 
performance in endurance exercise sessions 11,12,15,22,23.  The majority of the studies which 
show an increase in mitochondrial biogenesis after HIIT have used cycling protocols and 
recreationally active and/or sedentary subjects 11,12,15,22.   
The effects of HIIT on mitochondrial biogenesis may be influenced by certain 
nutrient-gene interactions 24–26.  When exercise is undertaken in the presence of low muscle 
glycogen content, the transcription of a number of genes involved in mitochondrial 
biogenesis are up-regulated 27,28.  Some of these transcription factors have glycogen binding 
domains, and when muscle glycogen is low, these factors are discharged to associate with 
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different proteins, subsequently inducing training adaptations 26.  However, a recent study 
found that activation of a number of signalling proteins, which play a key role in the activity 
of several transcription factors may also be sensitive to nutrients and their activation 
enhanced by CHO ingestion 25.   
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Study Aims 
The following series of studies will i) investigate the activation of signalling pathways 
induced by high intensity interval running ii) assess whether CHO feeding blunts the 
activation of these signalling pathways iii) determine the effect of 6 sessions of high 
intensity training or endurance training on skeletal muscle mitochondrial biogenesis.  
Objectives 
1. To investigate the effects of an acute bout of HIIR on the activation of AMPK and 
p38MAPK signalling pathways 
2.  To compare the effect of feeding either a solution high in CHO or a nonenergetic 
placebo solution on the activation of HIIR induced signalling molecules 
3. To compare the effects of 6 sessions of either HIIR with ER on proposed mediators of 
mitochondrial biogenesis 
4. To determine whether 6 sessions of either HIIR or ER can enhance performance 
Hypotheses 
1. A bout of high intensity interval running will activate AMPK and p38MAPK signalling 
pathways 
2. Feeding a high CHO diet prior to a HIIR session will blunt the activation of the 
signalling molecules 
3. 6 sessions of both HIIR and ER will induce similar exercise induced skeletal muscle 
adaptations 
4. Performance will be enhanced in both groups after HIIR and ER 
 27 
Chapter 2  
Review of Literature 
Mitochondria 
Mitochondria play a central role in cellular energy metabolism, providing the 
majority of the energy for skeletal muscles under aerobic conditions.  An increase in 
mitochondrial volume referred to as mitochondrial biogenesis 29 enhances the capacity of 
the muscle cell to generate ATP via oxidative phosphorylation 30,31.  In 1967, Hollozsy et al., 
(1967) 30 reported an increase in skeletal muscle mitochondrial number and oxidative 
capacity in response to endurance training in rats.  The increase in mitochondria, were 
associated with an improvement in endurance exercise performance.  The introduction of 
the needle biopsy technique in the late 1960s, allowed researchers to investigate the 
changes in mitochondrial structure and function in human skeletal muscle in response to 
acute and chronic exercise.  Mitochondrial density, enzyme number and activity was 
subsequently found to significantly increase in men and women following ET ranging from 8 
to 20 weeks 32–36.  Mitochondrial density varies depending on the energy requirements of 
the cell. Tissues with a high capacity to perform aerobic metabolic functions such as the 
kidney and skeletal muscle have a larger number of mitochondria 37.  Intermyofibrillar 
mitochondria are thought to have a higher activity per unit of mass than sacrolemma 
mitochondrial and play a major role in maintaining the adenosine monophosphate (ATP) 
supply during contractile activity 38.   
 28 
Mitochondrial Function 
Mitochondria are oval shaped organelle, about 2 μm in length and 0.5 μm in 
diameter and exist as both an individual capsule shaped organelle or an interconnected 
network, much like the sarcoplasmic reticulum 39.  Mitochondria in skeletal and cardiac 
muscle are located in the sarcolemma, immediately beneath the cell membrane and deeper 
within the muscle in the intermyofibrillar space.  Sarcolemmal mitochondria account for 5-
40% of the total mitochondrial volume depending upon muscle fiber type 38.  Dynamic in 
nature, mitochondria continuously engage in both fusion and fission 40.  Fusion is the 
process by which mitochondria combine with other mitochondria, while fission is the 
process by which mitochondria, derived from pre-existing mitochondria, split.  The balance 
of fusion and fission is likely a major determinant of mitochondrial morphology 40.  
Mitochondria are composed of an outer and inner phospholipid layer, an 
intermembrane space and an internal soluble matrix (Figure 2.1).  The outer membrane is a 
relatively simple phospholipid bilayer, containing protein structures called porins.  These 
voltage-dependent anion channels are the most abundant proteins in the mitochondrial 
outer membrane and are permeable to molecules <10 Kd.  ions, nutrient molecules, ATP, 
adenosine monophosphate (ADP), nicotinamide adenine (NAD) and Coenzyme A can pass 
through the outer membrane with ease 40.   
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The inner mitochondrial membrane is a highly complex structure and is the site of 
oxidative phosphorylation.  It includes all of the complexes of the electron transport chain 
(ETC), the ATP synthase complex, and transport proteins.  The membrane is folded into a 
series of internal ridges known as cristae which increases the surface area for ATP 
production and contains the proteins responsible for replication of mitochondrial 
deoxyribonucleic acid (DNA) 37.  The movement of molecules and ions across the inner 
mitochondrial membrane require specific membrane transporters.  This separation of the 
matrix from the cytosolic environment by the inner membrane is a central feature in the 
conversion of free energy derived from oxidizable substrates.  The mitochondrial matrix 
contains a range of enzymes, which form parts of major metabolic pathways such as CHO, 
lipid and amino acid oxidation and urea and haem biosynthesis 41.   
Mitochondrial Evolution 
Mitochondria appear to have originated from an ancient bacterium that was 
captured by a primitive eukaryotic cell 42.  Within the cytoplasm of the eukaryotic cell, both 
the bacterium and the primitive eukaryotic cell developed a symbiotic relationship 42.  The 
two cells enjoying this relationship evolved into mitochondria and eukaryotic cells.  
Figure 2.1 Structure of the mitochondria 
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Similarities in the results of DNA analysis of the genomes of mitochondria and the genomes 
of the bacterium Rickettsia Prowazekki support this theory 42.  Both Rickettsia Prowazekki 
and mitochondria rely on eukaryotic cells in order to reproduce.  The size and structure of 
ribosomes found within mitochondria are similar to ribosomal sequences found in bacteria.  
The fact that mature mitochondria are derived from pre-existing mitochondria by fission, 
which is similar to binary fission, the method by which bacteria multiply suggests that 
mitochondria and bacteria share a common ancestor.  Indeed, mitochondrial ribosomes and 
transfer ribonucleic acid (RNA) molecules are similar to those of bacteria. 
Mitochondrial Biogenesis 
Skeletal muscle is a very pliable tissue and repeated exercise sessions elicit specific 
morphological and metabolic adaptations referred to as mitochondrial biogenesis. These 
adaptations result in an increase in mitochondrial content per gram of tissue and/or a 
change in mitochondrial composition with an alteration in the protein content.  Exercise-
induced mitochondrial biogenesis is a complex process that involves specific signalling 
processes which are initiated by rapid changes in Ca2+ flux, ATP turnover and the increase in 
oxygen (O2) consumption 
18.  Various signalling cascades initiate replication of DNA, and its 
transcription.  This involves the transcription of a primary RNA transcript which is 
subsequently spliced to messenger RNA (mRNA) (Figure 2.2).  Skeletal muscle contraction 
generates transient increases in the quantity of mRNA 43–45.  This increase in mRNA induces 
an increase in protein synthesis leading to a change in the steady state level of specific 
proteins and a new functional threshold.  The increase in transcriptional activity and the 
subsequent protein synthesis is thought to be due to the cumulative effects of multiple 
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exercise bouts.  However, recent studies have found that a single bout of exercise can 
induce changes in the transcription of genes, leading to an increase in oxidative muscle 
phenotype with improved resistance to fatigue 46. 
 
 
Figure 2.2 Gene expression in eukaryotes 
Control of Mitochondrial Biogenesis 
The complex process of mitochondrial biogenesis is under the control of several 
transcriptional co-activators and transcription factors, which are also regulated by exercise 
and include PGC-1α and the peroxisome proliferator-activated receptor (PPAR) family.  PGC-
1α acts as a ‘master regulator’ of mitochondrial biogenesis in skeletal muscle, via the co-
activation of a number of mitochondrial transcription factors (Figure 2.3) 17,47. 
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Peroxisome proliferator-activated receptor gamma co-activator (PGC-1α) activates transcription factors (NFs) 
leading to transcription of nuclear- encoded proteins and of the mitochondrial transcription factor A (Tfam). 
Tfam activates transcription and replication of the mitochondrial genome. Nuclear-encoded proteins are 
imported into mitochondria through the outer- (TOM) or inner (TIM) membrane transport machinery. Nuclear- 
and mitochondria-encoded subunits of the respiratory chain are then assembled. Mitochondrial fission 
through the related protein 1 (DRP1) for the outer membrane and OPA1 for the inner membrane of 
mitochondria allow mitochondrial division while mitofusins (Mfn) control mitochondrial fusion. Processes of 
fusion and fission lead to proper organization of the mitochondrial network. OXPHOS: oxidative 
phosphorylation.  
 Molecular Mechanisms Regulating Mitochondrial Biogenesis 
Signal transduction refers to the activation of a cell surface receptor via intra or 
extracellular stresses and signalling molecules.  Many of the signal transduction pathways 
are transduced to cytosolic or nuclear targets by the action of kinase or phosphatase 
enzymes on key regulatory pathways 48.  Skeletal muscle contraction activates signalling 
pathways by altering a range of primary messengers including calcium flux, ATP turnover, 
cellular stress, redox potential, O2 tension and reactive oxygen species production (Figure 
2.4).  Many of these signalling pathways have been found to be involved in the regulation of 
Figure 2.3 Mitochondrial biogenesis induced by contractile activity 
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mitochondrial biogenesis 4,49–51.  It is well established that acute and chronic exercise is a 
significant stimulus for the regulation of multiple metabolic and transcriptional processes in 
skeletal muscle 8.  These adaptive responses are mediated by specific genes that are up-
regulated by complex regulatory pathways.  Different homeostatic perturbations, such as 
those related to metabolic flux, skeletal muscle loading, hormonal and neuronal alterations 
are sensed by specific sensory molecules that activate specific signalling cascades.  These 
cascades ultimately control muscle fate via the regulation of gene expression.   
 
 
 
 
 
 
 
 
 
 
Different homeostatic perturbations, such as those related to metabolic flux, loading, hormonal and neuronal 
alterations, are converted by specific sensory molecules into the activation of signalling cascades. These 
ultimately control muscle fate via the regulation of gene expression. Consequently, gene expression represents 
an important layer of control for the processing of physiological information towards 
Adenosine Monophosphate Activated Protein Kinase-Mediated Signalling (AMPK) 
Adenosine monophosphate activated protein kinase (AMPK) is a member of the 
sucrose non-fermentor kinase family that functions as an intracellular fuel sensor (Figure 
Figure 2.4 The complex stimulus of exercise in recruited muscle 
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2.5) 52.  It is a heterotrimeric serine/threonine protein comprising an alpha (α) (63 kDa), beta 
(β) (38 kDa) and gamma (γ) (38 kDa) subunits.  The α subunit is the catalytic subunit and 
requires phosphorylation for activation.  The β and γ subunits are regulatory, although they 
have been found to interact with the active subunit in liver.  Two isoforms of the α and β 
subunits have been identified and 3 isoforms of the γ subunits making a total of 12 possible 
heterotrimeric AMPK combinations 53.   
 
 
 
 
AMPK monitors cellular energy status in response to cellular energy deprivation by 
increasing ATP production while simultaneously decreasing the cellular energy-consuming 
anabolic processes 54.  It is activated in response to an increase in AMP.  A 5-fold increase in 
the adenosine diphosphate (ADP) to ATP ratio during muscle contraction results in a 25-fold 
increase in the AMP (adenosine monophosphate) to ATP ratio indicating that the cellular 
concentrations of AMP change much more dramatically than ATP or ADP 53. 
Activated AMPK inhibits cellular growth and fatty acid and sterol biosynthetic 
pathways and stimulates catabolic pathways 55,56.  The effects of AMPK are mediated 
primarily by direct substrate phosphorylation that controls enzymatic activity and the 
transcriptional complexes regulating these processes 57. 
Figure 2.5 The structure of adenosine monophosphate activated protein kinase 
(AMPK) 
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Acute exercise 58–61 and electrical stimulation 62 increase phosphorylation of AMPK 
and its enzymatic activity.  AMP moderately activates AMPK by binding to the cystathionine 
β-synthase (CBS) domain of the γ subunit 63.  Binding to the CBS domain results in a 
conformational change in the enzymes structure making AMPK a better substrate for up-
stream kinase(s) such as LKB1 (liver kinase B1) or calcium calmodulin dependant kinase 
kinase (CaMKK) 57.  Binding of LKBI and CaMKK phosphorylates the α-subunit on Thr172 
making it a poorer substrate for inactivating phosphatases 64.  This enhances AMPK activity 
more than 100-fold 65 (Figure 2.6).  The effects of AMP binding on AMPK are antagonized by 
high ATP concentrations, therefore [ATP]/[AMP] is thought to be the best predictor of AMPK 
activity 54.  
 
 
 
 
 
 
 
 
AMPK is activated by phosphorylation of Thr
172
 catalysed by LKB1:STRAD:MO25 complex in response to 
increase in the AMP/ATP ratio and by CaMKK in response to elevated Ca
2+
 levels.  SIRT 1 activation leads to 
deacetylation of Lys48 and possibly other key lysine residues in LKB1.  This activated LKB1s kinase activity, 
which in turn phosphorylates AMPK. Thr
172
 is dephosphorylated by PP2C protein phosphatase switching active 
AMPK to the inactive form.  
  
Figure 2.6 Regulation of AMPK activation in response to exercise 
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AMPK Upstream Protein Kinases 
LKB1, CaMKK and more recently SIRT1 (silent mating type information regulation 2 
homolog) a NAD+-dependent histone/protein deacetylase have been identified as important 
up-steam kinases for AMPK in muscle and most other cells.  The compound aminoimidazole-
4-carboxymide-1-β-D-ribfuranoside (AICAR) is an analog of AMP that is capable of 
stimulating AMPK.  The effects of AICAR administration in combination with electrical 
stimulation has been investigated in mice lacking the LKB1 gene 66,67.  These studies found 
that α1 AMPK activity was only partially activated and α2 AMPK phosphorylation was absent 
following both in situ 68,69 and ex vivo 67 stimulation.  More recent studies have indicated 
that LKB1 activity is not increased during exercise but is continually activated in the muscle 
cell in the resting state, allowing AMPK to be continually phosphorylated and 
dephosphorylated in a futile cycle 68,70.   
 SIRT1, has been shown to activate AMPK in rat liver cells in vivo under conditions of 
calorie restriction 71. The deacetylation of LKB1 by SIRT1 is associated with its movement 
into the cytoplasm, where it binds to and is activated by STRAD.  Studies have found that 
this mechanism activates AMPK in human embryonic kidney cells 72. Although studies have 
found an increase in SIRT1 gene expression after an acute bout of prolonged exercise in rat 
skeletal muscle 73, this has yet to be linked to the activation of LKB1. In human skeletal 
muscle, it has been found that exercise induced up-regulation of SIRT1 plays a role in 
mitochondrial biogenesis 74,75. However, the mechanism by which SIRT1 induces these 
adaptations and whether it is associated with the activation of AMPK has yet to be 
elucidated.  
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Exercise Activation and regulation of AMPK 
Activation of total AMPK in muscle during exercise contraction was first 
demonstrated in rats 76.  A Six-fold increase in AMPK activity was found in response to 5 min 
of exercise at treadmill velocity > 20 m.min-1. The increase in kinase activity was relatively 
transient and returned to baseline within 90 min after the cessation of exercise. 
It was later shown in human skeletal muscle that the AMPK activation was mediated 
by activation of both the α1 and α2 AMPK containing trimers.  The degree to which the two α 
sub-units were activated was found to be related to both exercise intensity and duration 
66,77,78.   
Muscle glycogen is thought to partly regulate the activity of AMPK during exercise.  
At rest, AMPK activity is increased in the presence of low muscle glycogen levels compared 
to normal.  AMPK activity has been found to significantly increase after 20 min of exercise at 
80%   2peak in humans when exercise is undertaken in the presence of low muscle 
glycogen levels 79.  In contrast, Wadley et al., (2006) 80 compared the effect of absolute 
versus relative exercise intensity on AMPK signaling and substrate metabolism under 
normoxic and hypoxic conditions in untrained men.  A higher AMPK activation was found 
during 30 min of cycling at the same absolute workload under normoxic (51%   2max) than 
hypoxic (11.5% O2) (72%   2max) conditions despite the fact that pre-exercise glycogen 
levels were similar at the start of exercise and the rates of muscle glycogen utilisation were 
similar in both conditions 80.  There was no significant difference between AMPK α1 or α2 at 
the same absolute exercise intensities (51% Normoxia vs. 72% Hypoxia) despite significantly 
different levels of muscle glycogen utilisation.  The effect of muscle glycogen concentration 
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on AMPK activity is dependent on the glycogen binding domain on the β-subunit and varies 
according to the degree of glycogen branching 81.  
The Activation of AMPK by High Intensity Interval Training 
Recent findings indicate that both the α1 and the α2 AMPK subunits are stimulated by 
intense interval exercise 23,82.  Chen et al., (2000) 82 found an increase in both α1 and α2 
AMPK phosphorylation of approximately two to three fold respectively, in untrained men 
(n=7) and women (n=4) following a 30 s supramaiximal cycle exercise bout.   In a more 
recent study Gibala et al., (2009)23  also found a significant increase in both α1 and α2 AMPK 
phosphorylation in six untrained men following a single session of HIIT involving 4 x 30 s 
bouts of cycling at maximal effort, with 4 min of active recovery between exercise bout.  
Clark et al., (2004) 83 found an increase in AMPK phosphorylation at Thr172 on both the 
AMPK α1 and α2 subunits in endurance trained cyclists in response to seven HIIT sessions 
involving cycling over a 3 wk period.  Each session consisted of a 20 min warm-up at 65% 
  2peak followed by 8 x 5 min work bouts at 85%   2peak with 60 s of active recovery. 
To date, relatively few studies examining the effect of high intensity interval exercise 
(HIIE) on AMPK activity have used a running protocol.  Bartlette et al., (2012) 84 found a 1.9 
fold increase in AMPK phosphorylation compared to resting levels in 10 recreationally active 
men following a single session of HIIE involving 6 x 3 min bouts of treadmill running at 90% 
  2max interspersed with 3 min of active recovery at 50%   2max.  Participants ran for 7 
min at 70% VO2max before and after the interval session.  Serpiello et al., (2011) 
85 only 
found moderate changes in AMPK phosphorylation following a single session of HIIE and 12 
sessions of HIIE undertaken 3 times per week for 4 weeks in recreationally active men (n=7) 
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and women (n=3).  The training program consisted of 3 sets of 5 x 4 s maximal sprints 
interspersed with 20 s of passive recovery and 4.5 min of a recovery period between sets.  It 
is possible that the duration of the sprint exercise may not have been of sufficient duration 
to induce a significant increase in AMPK activation. 
Recent studies have found that only 3 heterotrimeric AMPK complexes (α1/β2/γ1, 
α2/β2/γ1, α2/β2/γ3) are expressed in human skeletal muscle and each is activated differently 
during exercise 86.  The α2/β2/γ3 AMPK subunit was found to be  activated during short 
intense exercise  20 min in duration 86, while the α2/β2/γ1 is activated following ≥ 60 min of 
moderate intensity exercise 87.  Interestingly, increases in the activity of the α2/β2/γ3 
complex is correlated with an increase in acetyl-CoA carboxylase (ACCβ) phosphorylation, 
suggesting that this complex may play a role in the regulation of fatty acid oxidation 86,87.  An 
increase in ACCβ phosphorylation in response to both endurance and high intensity exercise  
may therefore indicate the activation of the AMPK α2/β2/γ3 isomer 
23,88.  In contrast, the 
α2/β2/γ1 complex is linked to the activation of AS160 (Rab GAPase-activating protein), a 
molecule that has been associated with the regulation of glucose uptake 89.  
Metabolic Effects of AMPK in Skeletal Muscle During Exercise 
Although AMPK is a pleiotropic signalling molecule that is involved in the regulation 
of glycogen metabolism, fatty acid oxidation and protein synthesis, it plays a major role in 
skeletal muscle metabolism by activating signaling cascade that stimulates glucose uptake in 
contracting muscles 90,91 (Figure 2.7).  Muscle glucose uptake is increased in perfused rat 
skeletal muscle in response to chemical activation of AMPK by AICAR 90.   
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Glucose uptake requires the translocation of the glucose transporter 4 (GLUT4) 
transporters to the plasma membrane.  This process is mediated by the intracellular 
signalling molecule, AS160 that is activated by AMPK.  92  In contrast, phosphorylation of 
glycogen synthase by AMPK activation decreased the rate of glycogen synthesis by reducing 
the activity of glycogen synthase (GS) 93.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These including stimulation of glucose (1) and fatty acid uptake (2), fatty acid oxidation (3), mitochondrial 
biogenesis (4), inhibition of glycogen synthesis (5) and inhibition of TOR, hypertrophy (6).  Question marks 
indicate that the direct target for AMPK responsible for the observed downstream effect is not known. The 
effect on fatty acid uptake has to date only been observed in cardiac muscle.  
 The transport of long chain fatty acids (LCFA) into the resting or exercising muscle is 
essential for the oxidation of free fatty acids (FFA) and subsequent ATP production.  The 
mechanism by which AMPK regulates FFA oxidation is primarily at the level of LCFA entry 
Figure 2.7 Metabolic changes known to be induced by AMPK in skeletal muscle 
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into the mitochondria via phosphorylation of the biotin dependant enzyme, ACCβ at Ser218.  
AMPK deactivates ACCβ and potentially activates malonly-CoA decarboxylase (MCD) activity 
which decreases the formation of malonly CoA, 94, a potent inhibitor of carnitine palmitoyl 
transferase-1 (CPT-1) (Figure 2.7).  The interaction of AMPK with ACCβ does not necessarily 
alter the carboxylase activity but desensitizes ACCβ to allosteric activation by citrate 77 and 
sensitizes ACCβ to inhibition by palmitoyl-CoA 95. Therefore, a reduction in ACCβ activity will 
decrease the formation of malonly-CoA, relieving the inhibition of FA entry into the 
mitochondria and enhance FFA oxidation 96.   
AMPK Signalling and Mitochondrial Biogenesis 
In addition to the regulation of acute metabolic function, the protein targets of 
AMPK are also involved in regulating exercise induced alterations in skeletal muscle, 
including mitochondrial biogenesis.  Administration of AICAR to rats for 4 weeks results in a 
2.5-fold increase in AMPK activity, with subsequent increases in skeletal muscle 
mitochondrial enzymes including, hexokinase (HK), CS, and succinate dehydrogenase (SDH), 
and an increase in cytochrome c and GLUT 4 activity 97.  Incubation of the epitrochlearis 
muscle with AICAR for 18 h increases GLUT4 protein by 50%, indicating that AMPK activation 
by AICAR is independent of systemic factors 98.  Fryer et al., (2002) 99 found that AMPK 
activation improves glucose uptake and induces the translation of GLUT4 mRNA, along with 
an increase in the expression of HK by over expressing a constituently-active AMPK gene in 
skeletal muscle.   
 The mechanism by which AMPK induces protein expression and mitochondrial 
biogenesis, depends on the activation of several transcription factors, and co-activators 
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(Figure 2.8).  It appears that AMPK mediated mitochondrial biogenesis involves the 
posttranslational modification of the transcriptional co-activator, PGC-1α and subsequent 
expression of the downstream transcription factors, nuclear transcription factor 1 (NTF-1) 
and nuclear transcription factor 2 (NTF-2), mitochondrial Tfam (transcription factor A) and 
peroxisome proliferator activated receptor alpha (PPARα).  Bergeron et al., (2001) 100 found 
AMPK activation in rats in response to a 9 week dietary intervention which included the 
guanidine derivate, β-guanadinopropionic acid (β-GPA) promoted skeletal muscle 
mitochondrial biogenesis through PGC-1α and NRFs.  AMPK increases GLUT4 via the PGC-1α 
pathway.  Michael et al., (2001) 101 found increases in GLUT4 protein and the transcriptional 
activity of myocyte-specific enhancer factor (MEF) isoforms.  These are GLUT4 transcription 
factors that are activated in response to adenovirus mediated over expression of PGC-1α in 
both animal and cultured muscle cell lines.   
  
 43 
 
 
 
 
 
 
 
AMPK mediates mitochondrial biogenesis through PGC-1α, NRF 1, NRF 2, Tfam, MEF and PPARα.  
 Exercise also activates AMPK and promotes mitochondrial biogenesis via the PCG-
1α pathway.  Terada et al., (2002) 102 found an increase in AMPK activation and PGC1α 
mRNA expression following 6 h of low intensity swimming.  An increase in AMPK activation 
and PGC-1α has also been found after low frequency (10 Hz) electrically stimulating isolated 
rat muscle to mimic endurance training 62.  However, AMPK may not be essential in inducing 
mitochondrial biogenesis.  In a recent study PGC-1α mRNA expression increased despite a 
60% reduction in AMPK signalling at rest and during exercise in α2 AMPK knockout mice  
103.  
The significant decrease in AMPK activation may be explained by the absence of a functional 
copy of the α2 AMPK isoform.  In a subsequent study, they found no reduction in the 
training-induced increases in HK, GLUT4, cytochrome c oxidase complex IV subunit 1, 3 β-
HAD, or CS protein in response to exercise in α2 AMPK knockout mice 
104.  
In summary, AMPK plays an important role as an energy sensor in skeletal muscle 
cells and helps to maintain a state of intracellular homeostasis.  Activation of AMPK 
Figure 2.8 AMPK mediates mitochondrial biogenesis 
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enhances the muscle cells ability to produce energy by up-regulating a number of oxidative 
enzymes.  There is evidence linking exercise induced increases in AMPK to mitochondrial 
biogenesis.  However, many other signalling pathways exist such as, MAP kinase, protein 
kinase C (PKC), CaMK and calcineurin are activated in response to exercise and may overlap 
with the actions of AMPK. 
Calcium Dependent Signaling Pathways and Mitochondrial Biogenesis 
The increase in cytosolic Ca2+ triggered by contractile activity has also been shown to 
play a role in mitochondrial biogenesis 85,88,105.  Raising cytosolic Ca2+ in myotubes increases 
gene expression of GLUT4 98, NRF-1, -2 and PGC-1α 105.  Calcium dependant pathways such 
as CaMKs, have been implicated as signalling molecules in the response to exercise.  Two of 
these multifunctional kinases, CaMKII and CaMKIV are thought to play an important role in 
affecting muscle phenotype.    
Recent studies have shown an increase in activated CaMK II protein signaling in 
response to both repeated sprint exercise (10 min running at 50% of   2peak followed by 
3.5 min at 100%   2peak) and endurance exercise (2 h cycling at 80%   2max) 
85,88.  There 
was also an increased phosphorylation and subsequent removal of the histone deacetylase 
(HDAC 5) protein in response to exercise, which allows for its export from the nucleus, 
removing the inhibition on MEF2 and ultimately allowing PGC-1α transcription to progress 
106 (Figure 2.9).  Activation of CRE binding protein (CREB) via phosphorylation is also up-
regulated by protein kinases such as CaMKII 107. 
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Signalling through calcineurin occurs through downstream substrates, the nuclear factor of activated T cells 
(NFAT) and myocyte enhancer factor (MEF2).  Acute exercise leads to phosphorylation of the class II histone 
deacetylases (HDACs) by Ca
2+
–calmodulin-dependent protein kinase IV (CaMKIV) and thus contributes to 
activation of the MEF2 transcriptional activity 
In summary, there is strong evidence that contractile mediated activation of CaMKII 
may play a role in mitochondrial biogenesis in human skeletal muscle, and that its activity is 
influenced by exercise intensity.   
Mitogen activated protein kinases (MAPK) 
Mitogen activated protein kinases (MAPK) transduce extracellular signals that lead to 
a variety of cellular responses including proliferation, differentiation, apoptosis and 
adaptation to environmental stress 108.  Skeletal muscle MAPK can be divided into four 
subfamilies; extracellular signal related kinase (ERK) 1/2, p38MAPK, c-Jun NH2-terminal 
kinases (JNK), and the extracellular signal-related kinase 5 (ERK5).  The MAPK’s are activated 
through phosphorylation of specific upstream kinases, which are in turn activated by a 
diverse range of upstream MAPK kinase kinases (MAP3K) in response to external stimuli 
such as exercise (Figure 2.10) 20,109–111.   
Figure 2.9 The role of calcineurin signalling in PGC-1α up-regulation 
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Growth factors, cytokines, hypoxia, changes in intracellular calcium, glycogen 
depletion and mechanical stress, have all been found to stimulate MAPK.  MAPK signalling 
pathways may also play a role in converting mechanical/biochemical stimuli elicited by 
skeletal muscle contraction into subsequent molecular responses 112,113 and may also been 
implicated in the regulation of gene transcription in numerous cell types.  
 
 
 
 
 
 
 
Structure and Activation of p38 MAPK 
The p38MAPK, is a stress activated protein kinase.  It can be activated by 
environmental stressors, including osmotic gradient change, heat shock, stretch and 
inflammatory cytokines.  In humans, there are 4 isoforms of p38MAPK; p38α, β, γ and δ.  
The isoforms can be categorised by their Thr-Gly-Tyr (TGY) dual phosphorylation motif.  The 
isoforms have > 60% overall sequence homology and > 90% identity within the kinase 
domains.  Despite this high degree of homology, the isoforms have distinguishable 
differences in tissue expression, upstream activations and downstream effectors.   
Figure 2.10 Putative exercise-mediated mitogen activated protein kinase (MAPK) 
signalling cascades in skeletal muscle 
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The isoform that predominates in skeletal muscle is p38γ.  This isoform is 
phosphorylated and activated by many external stimuli through MAP3K-MAPK kinase kinase 
(MKK) pathway (Figure 2.10).  The protein is rapidly activated by MKK-dependant dual 
phosphorylation on threonine and tyrosine residues at the sequence Thr-Gly-Tyr, located 
within the regulatory loop between subunits VII and VIII.  This phosphorylation induces a 
conformational change in the protein allowing ATP and substrate binding.  MKK3 and MKK6 
can phosphorylate p38MAPK within minutes after exposure to an externally activated 
stimuli.  The fate of the cell is dependent on the duration of phosphorylation, with sustained 
phosphorylation associated with apoptosis and transient phosphorylation associated with 
growth factor induced survival.  Crosstalk between different signalling pathways also 
influences the kinetics of p38MAPK signalling and its effects on the cell.  This crosstalk 
makes it difficult to interpret studies examining p38MAPK as the signalling pathways can be 
activated simultaneously, and as of yet there is a lack of specificity between the pathways.  
For example, p38MAPK shares common kinase substrates with ERK1/2, including MAPKAP 
K-2 and -3, MSK1 and 2 and CREB.   
 Phosphorylated p38MAPK can activate a wide range of substrates that include 
transcription factors, protein kinases and nuclear proteins.  Exercise induced increases in 
p38MAPK activation have been found to phosphorylate substrates involved in CHO and fat 
metabolism and mediate the regulation of PGC-1α-dependent gene transcription in skeletal 
muscle 114 (Figure 2.11).  
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Exercise Induced p38 AMPK Activation  
 Cycle exercise 115 and marathon running 113,116 result in phosphorylation of 
p38MAPK.  In an early study Widegren et al., (1998) 115 found an increase in p38MAPK 
phosphorylation in  healthy men and women after 1 h of single leg cycle exercise at 70% 
  2max.  There was evidence of phosphorylation 30 min and 60 min after exercise.  
Interestingly, increased activation p38MAPK was found in both the exercised and non-
exercised leg indicating that p38MAPK may be influenced by both local and systemic factors. 
A 4 fold increase in p38MAPK has also been found in trained men with a   2max of 60 
ml.kg-1.min-1 after running a marathon 113.   
Mei Yu et al., (2003) 117 found that activation of p38MAPK was greater in untrained 
than trained men following 8 x 5 min bouts of cycling at approximately 85%   2peak with 
60 s recovery between work bouts.  Since both groups exercised at the same relative 
exercise intensity the findings suggest that trained men may require a greater exercise 
stimulus to activate p38MAPK than untrained men.  Eccentric but not concentric contraction 
activates p38MAPK 118.  Also an acute bout of high intensity cycling and running increases 
p38MAPK phosphorylation in both active and sedentary men 13,23,25,119 84 .  
The Role of p38 MAPK in Mitochondrial Biogenesis (gene regulation) 
Studies in myocyctes have found that p38MAPK directly phosphorylates and 
activates PGC-1α 112.  It also stimulates down-stream transcription factors of PGC-1α, such 
as activating transcription factor (ATF-2) and MEF2 112,120.  Phosphorylating PGC-1α at three 
sites by p38MAPK stabilises the protein by disrupting its association with repressor protein 
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p160 myb binding protein (p160mbp) and thereby activating its transcriptional activity 121 
(Figure 2.11).  
 
 
 
 
 
 
 
p38 MAPK activation leads to the phosphorylation of transcriptional co-activator PGC-1α, thereby relieving it 
from the inhibitory action of p160
MBP
 and activating target gene expression. It can also directly phosphorylate 
PGC- α activating transcription factors AKT-2 and MEF2. 
A single bout of running or motor nerve stimulation induces a transient increase in 
PGC-1α mRNA in mouse plantaris muscle, mediated by activation of the p38MAPK pathway 
112.  The p38-mediated increase in PGC-1α activity was enhanced by the increased 
expression of the downstream transcription factor ATF-2.  This is a nuclear cyclic AMP 
response element (CRE) motif binding transcription factor, which can be bound and 
activated by ATF-2, which in turn binds to the response element binding site on the PGC-1α 
promoter site inducing transcription 112.   The p38MAPK/ATF-2 pathway is critical for 
contractile induced increase in PGC-1α mRNA 112,122.  Similar increases in p38MAPK 
phosphorylation has recently been found in human skeletal muscle after an acute bout of 
Figure 2.11 Exercise induced activation of p38MAPK and subsequent gene expression 
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endurance exercise at 40% or 80%   2peak 
88. However, an increase in ATF-2 
phosphorylation only occurred in response to endurance exercise at 80%   2peak indicating 
that the activation of ATF-2 during HIT may be stimulated by other factors.  The p38MAPK 
pathway may also be regulated during contractile activity by increasing the cytosolic Ca2+ 
concentration, leading to the expression of PGC-1α  123,124.  
Incubation of human skeletal muscle with caffeine increases cytosolic Ca2+ 
concentration, but is insufficient to cause the same activation of CaMK or p38MAPK and 
subsequent mitochondrial biogenesis as contractile activity 125.  The increases in PCG-1α and 
mitochondrial biogenesis seem to be dependent on CaMKII and p38MAPK activities via ATF-
2 binding.  Inhibition of CaMKII or p38MAPK prevents the calcium induced increase in 
p38MAPK phosphorylation, ATF-2 activation and subsequent mitochondrial biogenesis 21. It 
is possible that p38MAPK is downstream from CaMKII in a signalling pathway and that 
increasing [Ca2+] in the cytosol induces an increase in PGC-1α mRNA and mitochondrial 
biogenesis in muscle through the activation of this pathway, CaMKII to p38MAPK inducing 
AFT-2 activation.  
Gibala et al., (2009) 23 found a significant increase in phosphorylation of AMPK and 
p38MAPK immediately after an acute session of intense intermittent cycle exercise involving 
4 x 30 s maximal cycling with 4 min of active recovery between bouts.  PGC-1α mRNA was 
significantly increased approximately twofold above rest after 3 h of recovery.  However, a 
significant change in the phosphorylation state of CaMKII was not found suggesting that 
p38MAPK activation after repeated sprint exercise is mediated by pathways other than 
CaMKII.  MAPK kinase 3 and 6 are classical activators of p38 MAPK in response to numerous 
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stress stimuli.  AMPK may also be an activator of MKK3 and p38MAPK 126.  Signalling through 
AMPK and p38MAPK to PGC-1α may explain in part the metabolic remodelling induced by 
low-volume intense interval exercise, including mitochondrial biogenesis and an increased 
capacity for glucose and fatty acid oxidation.   
Genetic and Molecular Responses to Exercise 
Contractile activity induces adaptations in muscle phenotype at both the metabolic 
and physiological level.  The changes in muscle phenotype are a result of alterations in the 
protein content of the cell that may be controlled at a transcriptional, translational and/or a 
post-translational level.  Exercise induced adaptations result in qualitative alterations in 
protein content that are controlled by an increase in mRNA levels.  These exercise induced 
alterations in muscle are related to either an increase in the transcriptional rate of the 
specific gene or enhanced RNA stabilisation of specific transcripts.  
Gene Transcription 
Gene transcription is the process of creating a complementary RNA copy of a DNA 
sequence and is the first step in gene expression.  Methylated histones create a highly 
compact structure containing DNA that is inaccessible to initiators of transcription.  Histones 
and DNA are exposed to transcriptional regulators following post-translational modification 
of the histone octomer to form a nucleosome core.  Histone demethylation and 
phosphorylation promotes further chromatin remodeling.  For example, histone acetylation 
by histone acetyl transferase (HAT) provides the molecular basis for initiation of gene 
transcription 127. 
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Transcription Factors and Co-Regulators 
In skeletal muscle and other metabolic tissues, transcription factors and co-regulator 
proteins have the ability to target and alter the expression of key metabolic enzymes and 
mitochondrial proteins, and coordinate the process of mitochondrial biogenesis.  The most 
commonly researched of these proteins, which can be described as metabolic regulators in 
skeletal muscle include, PGC-1α, PPARs, NRF-1, NRF-2, estrogen related recptor α (ERRα), 
forkhead box protein O1 (FOXO1), MEF2 and nuclear receptor interacting protein 1 
(RIP140).  These transcription factors and co-regulators co-ordinate the expression of genes 
involved in CHO metabolism (HKII, pyruvate dehydrogenase kinase 4 (PDK4), GLUT4), lipid 
metabolism (CPT-1, medium chain acyl CoA dehydrogenase (MCAD), lipoprotein lipase 
(LPL)), oxidative phosphorylation (cytochrome c, COXIV) and mitochondrial biogenesis 
(Tfam). 
Mitochondrial Transcription Factor A (Tfam) 
Tfam coordinates both mitochondrial and nuclear gene transcription and therefore 
induces mitochondrial biogenesis in skeletal muscle 49.  Following Tfam mRNA translation, 
the newly synthesised protein translocates to the mitochondria and activates mitochondrial 
DNA replication and transcription 128 (Figure 2.3).  Studies have found that Tfam 
heterozygous knockout mice have reduced mitochondrial transcription and increased 
respiratory chain dysfunction 129.  The transcriptional regulation of Tfam is not yet well 
understood but it seems that NRF-1 is essential in activating transcriptional activity 130.  
Tfam has been found to increase in response to aging in human muscle.  It is believed that 
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the age related increase in Tfam is to maintain mitochondrial DNA (mtDNA) stability 131.  
Certain forms of contractile activity have been found to induce Tfam expression in humans 
by binding to its promoter region 132.  An acute bout of HIIE involving 7 x 30 s bouts of 
cycling at maximal intensity resulted in a 1.5 fold increase in Tfam mRNA in endurance 
trained male cyclists 133.  In contrast, Tfam mRNA was not altered following high volume 
interval exercise involving 3 x 20 min at 87%   2peak  
133.  It is possible that high exercise 
intensity may be required to increase the expression of the Tfam gene in endurance trained 
athletes.   
Four weeks of one legged knee extensor training resulted in a 3.4 fold increase in 
Tfam mRNA following an acute 3 h  bout of two legged knee extensor exercise 134.  In 
contrast, Norrbom et al., (2004) 135 found no increase in Tfam at 6 h following 45 min of 
knee extensor exercise.  
A single exercise session involving 10 x 4 min bouts of cycling at 90%   2max with 2 
min passive recovery between each high intensity exercise bout, increased Tfam mRNA by 
54% 15.  The exercise session was repeated on 6 occasions during the following 2 weeks and 
Tfam mRNA remained elevated immediately following each session.  The Tfam protein 
content was unchanged whereas mtDNA was increased during the 2 week training program.  
The increase in mtDNA during the training, suggests that activation of existing Tfam may 
contribute to mitochondrial biogenesis after training.  Electrical stimulation of the tibialis 
anterior and the extensor digitorum longus muscles in rats (10 Hz, 3 h/day) for 2 weeks 
increased Tfam mRNA levels by 55% after 4 days, along with an increased the import of 
Tfam into the mitochondria.  136.  The increase in mitochondrial Tfam was accompanied with 
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an increase in COX subunit III mRNA and an increase in COX enzyme activity after 7 days of 
stimulation.  A recent study found a 37% increase in Tfam protein content after 2 weeks of 
HIIT involving 8-12 x 60 s at 100% peak power output with 75 s passive recovery between 
bouts of exercise 74.  There was also a 29% increase in COX maximal activity and a 35% and 
38% increase in protein content of COX subunits, II and IV, respectively.  These findings 
support the role of Tfam in co-ordinating the expression of mitochondrial proteins and 
subsequent mitochondrial biogenesis.  
The Discovery of Peroxisome Proliferator Activated Receptor Gamma (PPAR-γ) co-
activator (PGC) 1α  
PGC-1α was discovered during research on the science of adaptive thermogenesis, a 
physiological process through which energy is dissipated as heat in response to 
environmental stressors such as cold and over-feeding.  It has long been known that 
peroxisome proliferator activated receptor gamma (PPAR-γ) is essential for tissue 
differentiation such as the conversion of white adipose tissue (WAT) to brown adipose 
tissue (BAT).  The primary physiological function WAT and BAT is energy storage and energy 
dissipation in the form of heat, respectively.  Early studies indicated that PPAR-γ activation 
was required, but not sufficient to activate brown tissue adipose differentiation.  This lead 
to the discovery of PGC-1α as a co-activator of PPAR-γ, as PGC-1α binds to PPAR-γ, co-
activating the transcription of genes involved in BAT differentiation.  In this process PGC-1α 
was instrumental in stimulating mitochondrial biogenesis, increasing fatty acid oxidation 
and uncoupling oxidative phosphorylation in skeletal muscle and BAT via adaptive 
thermogenesis.  
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Expression of PGC-1α in skeletal muscle 
The expression of PGC-1α mRNA is prominent in tissues with high energy demands, 
such as the heart and skeletal muscle 137,138.  In rat skeletal muscle PGC-1α content is related 
to mitochondrial content 139.  In contrast, Norrbom et al., (2004)  found no difference in 
human skeletal muscle PGC-1α mRNA levels between type 1 and type 2 muscle fibres 135.  
Others have found PGC-1α protein expression markedly increased in type IIb muscle fibers 
compared to type IIa 140.  
Structure of PGC-1α 
The PGC-1α family contains homologues, PGC-1β and PGC-1 related co-activator 
(PGC), along with PGC-1α.  PGC-1α contains approximately 795 amino acids with a 
molecular mass of 92 kDa.  The N-terminal domain contains regions for interacting with 
transcription factors 141 and the C-terminal domain has an RNA-binding motif (Figure 2.12).   
 
 
 
 
 
 
 
Protein complexes associated with PGC-1α. PGC-1α binds to the AT and TRAP/DRIP/Mediator complexes at the 
amino and carboxyl termini, respectively. SIRT1 and p160 bind to the repression domain, which also contains 
three p38 MAP kinase phosphorylation sites. LXXLL and LLXXL denote nuclear receptor by PGC-1α and β of 
mitochondrial genes encoded by the two binding sites. 
Figure 2.12 The structure of PGC-1α 
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Interaction of PGC-1α with Transcription Factors 
PGC-1α is not directly involved in the modification of histones, but instead mediates 
interactions between transcription factors and RNA polymerases 142.  There is a 
conformational change in PGC-1α, when it docks with and co-activates a transcription 
factor.  This  increases its binding with HAT proteins including steroid receptor coactivator 
(SRC-1) and CBP/p300, allowing for histone acetylation, subsequent chromatin remodeling 
and access to transcription factors that increase gene transcription 142.  The additional 
docking of a thyroid receptor associated protein (TRAP) complex at the C terminus is also 
required for complete transcriptional activation by recruiting RNA polymerase II 143.  Both of 
these mechanisms are required for PGC-1α to exert transcriptional control on targeted 
genes. 
PGC-1α Gene Expression and Contractile Activity 
MEF2 is a transcription factor with response elements on a variety of genes involved 
in muscle remodelling 144.  Contractile activity induces the expression of MEF2 and CREB 
(cAMP-response element binding protein), mediated by AMPK and CaMK (Figure 2.13).   
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Figure 2.13 The suggested coupling between exercise factors potentially involved in inducing 
PGC-1α gene expression. Adopted from Egan 2008 
Acute myofibrillar contraction results in the phosphorylation (p) and activation of AMPK, CaMKII and p38 
MAPK through molecular sensing of increased ATP turnover, increased calcium release from the sarcoplasmic 
reticulum, and mechanical stress, respectively. AMPK and CaMKII phosphorylate class IIa HDACs, leading to 
their nuclear exclusion and relieving the inhibitory effect of HDACs on MEF2 transcriptional activity at the 
MEF2 binding sequence on the PGC-1α promoter. AMPK and CaMKII also phosphorylate and activate CREB, 
resulting in an activating effect on the CRE sequence of the PGC-1α promoter. p38 MAPK phosphorylates and 
activates ATF-2, that in turn acts on the same CRE site resulting in transcriptional activation. These combined 
effects on the MEF2 and CRE sequences result in increased PGC-1α promoter activity and increased PGC-1α 
gene transcription. HDAC, Histone deacetylases 
Enhanced expression of MEF2 leads to improved binding to the promoter region of 
the PGC-1α gene, increasing PGC-1α expression.  PGC-1α can then co-activate MEF2 
providing a positive feed-forward signal that rapidly induces PGC-1α expression in an 
autoregulatory loop 107 (Figure 2.13).  MEF2 binds to PGC-1α on at least two binding sites 
and alters its expression through MEF2 interaction with HDAC5 145.  Recent studies 146,147 in 
mice, have found that MEF2 and CRE sequence elements on the promoter region play an 
essential role in PGC-1α induced activity, as inhibition of both sequences in mutant mice 
completely abolished PGC-1α activity.  PGC-1α induces the expression of ERRα, a nuclear 
receptor which activates the expression of NRF-1, NRF-2 and ERRα itself 148 (Figure 2.14).   
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Co-activation of MEF2 by PGC-1α provides a positive feed-forward signal to rapidly induce PGC-1α expression 
following muscle contraction. PGC-1α induces the expression of ERRα, which activates the expression of NRF-
1, NRF-2, and ERRα itself.  These molecular events lead to the stimulation of nuclear-encoded mitochondrial 
genes. PGC-1α also simultaneously regulates the expression of slow-twitch muscle fiber genes through co-
activation of MEF2. 
NRF-1 and -2 have been identified as transcription factors which induce the 
expression a number of mitochondrial genes encoded by the cell nucleus, including β-ATP 
synthase, cytochrome c, COX subunit IV and mitochondrial Tfam.  Co-activation of NRF-1 
and -2 facilitates the transcription of the nuclear encoded Tfam.  Once the Tfam mRNA is 
translated, the newly synthesised protein translocates to the mitochondria and activates 
mitochondrial DNA replication and transcription 128.  This pathway coordinates both 
mitochondrial and nuclear gene transcription and therefore induces mitochondrial 
biogenesis in skeletal muscle.  
Another mechanism which regulates PGC-1α expression in muscle after exercise 
involves the activation of p38MAPK (Figure 2.11).  P38MAPK can activate both MEF2 and 
Figure 2.14 Regulation of PGC-1α expression in skeletal muscle and 
mechanisms by which PGC-1α stimulates mitochondrial gene 
expression 
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AFT-2.  In rats, a short bout of exhaustive swimming increases the phosphorylation of 
p38MAPK and ATF-2 in parallel with PGC-1α translocation to the nucleus 122.  These events 
coincided with an increase in CS and cytochrome c mRNA, which precede an increase in 
PGC-1α protein.  Although limited to rats, this study demonstrated the role p38MAPK in 
PGC-1α activation, and its translocation to the nucleus.  Egan et al., (2010) 88 recently found 
that 2 h of cycling at 80%   2 max increased both p38MAPK and AKT-2 phosphorylation, 
and PGC-1α mRNA expression. 
The Regulation of PGC-1α activity 
The activity of PGC1-α is tightly controlled by transcriptional and posttranslational 
mechanisms.  The signalling protein p38MAPK phosphorylates and activates PGC-1α in 
response to cytokine stimulation in the muscle 110.   Phosphorylation of PGC-1α by p38MAPK 
enhances PGC-1α activity in two ways.  Firstly, it increases the stability and half-life of the 
PGC-1α protein, along with disrupting the interaction between PGC-1α and p160MBP, a 
repressor protein, which inhibits its activity in myoblasts (Figure 2.15).   
AMPK regulated PGC-1α expression through direct and indirect mechanisms.  AMPK 
directly phosphorylates PGC-1α which mediates an increase in PGC-1α protein 47.  AMPK is 
linked indirectly to the activation of PGC-1α via the direct phosphorylation of HDAC5 
resulting in its exportation from the nucleus (Figure 2.15).  The exportation of HDAC5 .from 
the nucleus facilitates the expression of PGC-1α through the recruitment of HAT containing 
proteins.  In this way AMPK not only enhances mitochondrial biogenesis by inducing PGC-1α 
expression but also by activating the protein.   
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Class II HDAC regulation of MEF2 activity. MEF2 is a transcription factor and is kept in an inactive state via 
binding to the Class II HDACs.  Phosphorylation of HDAC by a kinase, such as AMPK induce their nuclear export, 
removing the inhibition on MEF2 and subsequently inducing the expression of PGC-1α.  Phosphorylation of 
PGC-1 α by p38 AMPK disrupting the interaction between PGC-1α and p160Mbp, a repressor protein, which 
inhibits its activity in myoblasts.  
 The acetylation status of PGC-1α protein is the most prominent modification in 
terms of controlling its activity and physiological output 149,150 (Figure 2.16).  SIRT1 induces 
deacetylation of PCG-1α 150.  SIRT1 activity is up-regulated by nutrient deprivation and 
fasting conditions.  SIRT1 is a NAD+ dependent enzyme that is regulated by fluctuations in 
the levels of NAD+ and/or NAD+/NADH ratio.  In muscle and hepatic cells, SIRT1 has been 
shown to deacetylate and thereby activate PGC-1α and induce transcription of target genes 
150.  In a recent study involving nutrient deprived muscle cell lines, up-regulation of SIRT1 
enhanced gene expression of mitochondrial and oxidative genes and enhanced fat oxidation 
151.  Interestingly AMPK phosphorylation and activation of PGC-1α at Thr177 and Ser538 ,47 is 
suggested to prime PGC-1α  for deacetylation by SIRT1  150.
 
Figure 2.15 The regulation of PGC-1α activity via AMPK and p38AMPK 
phosphorylation 
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SIRT1-mediated deacetylation activates PGC-1α, while acetylation by GCN5 inhibits PGC-1α-directed gene 
expression. SIRT1, sirtuin 2 ortholog 1; Ac, acetyl group; GCN-5,  
Studies examining the putative role of the SIRT1 protein in the induction of 
mitochondrial biogenesis in whole muscle after exercise is less clear.  In rats, 14 d of both 
high intensity (30 m.min-1, 18.5% incline, 60 min.d-1) and low intensity (20 m.min-1, 18.5% 
incline, 90 min.d-1) exercise increased SIRT1 and PGC-1α proteins, HK activity, GLUT4 
protein, mitochondrial proteins and enzyme activities, and  in the soleus muscle 152.  
However, SIRT1 protein concentration in rat skeletal muscle decreased after 7 days of 
chronic electrical stimulation and in response to chronic administration of AICAR despite 
increased mitochondrial content 153, suggesting that an increase in SIRT1 protein may not be 
essential for exercise induced mitochondrial biogenesis.  Dumke et al., (2009) 154 found an 
increase in SIRT1 mRNA in trained men after 3 h of cycling at 57% PPO  whereas, 6 weeks of 
HIIT (1 h of 10 x 4 min intervals at 90%   2peak separated by 2 min passive recovery, 3 d 
per week) decreased SIRT1 protein content in men 155.  This study also found an increase in 
maximal activities of mitochondrial enzymes in skeletal muscle and PGC-1α protein, along 
with whole muscle SIRT1 activity.  However, the decrease in SIRT1 protein content is not 
consistent with its role as a major regulator of PGC-1α induced mitochondrial biogenesis.  
Figure 2.16 Control of PGC-1 activity via acetylation and deacetylation 
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Further research is needed to determine the role of SIRT1 in PGC-1α induced mitochondrial 
biogenesis.  
In summary, the expression of PGC-1α is controlled by a variety of transcriptional 
and posttranslational modifications allowing for a system that responds to a number of 
cellular stimuli.  This helps to ensure that PGC-1α co-activates the transcription of the 
precise protein(s) required to satisfy the energy needs of the cell.  
Metabolic Effects of PGC-1α 
PGC-1α and Lipid Metabolism 
PPARα is co-activated by PGC-1α which subsequently regulates fatty acid uptake and 
oxidation, via the transcriptional control of several nuclear genes encoding mitochondrial β-
oxidation enzymes, including MCAD and muscle CPT-1 156 (Figure 2.17).  The transcription 
factor ERRα is also known to play a central role in integrating PGC-1α and lipid metabolism.  
It directly activates the expression of the PPARα gene in cardiac myocytes, skeletal 
myotubes and primary mouse fibroblasts (Huss 2004).  It also binds to the promoter region 
of the gene encoding MCAD which catalyses the first step in β-oxidation and therefore 
directly regulates fatty acid oxidation 158.  
A recent study by Benton et al., (2008) 139 demonstrated a role of PGC-1α in fatty 
acid metabolism in rat models.  A modest over expression of PGC-1α in rat muscle cells 
resulted in an increase in fatty acid transporters FAT/CD36 and an increase in palmitate 
oxidation.  
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PGC-1α and Glucose Uptake  
GLUT4 is the key glucose transport protein in skeletal muscle.  It is well established 
that exercise induced PGC-1α stimulates an oxidative phenotype which contains an 
increased high concentration of GLUT4, making it plausible that PCG-1α may induce the 
expression of the GLUT4 protein.  An over expression of PGC-1α in myotubes results in an 
increased GLUT4 expression 101.  In contrast, an over expression of PGC-1α in transgenic 
mice failed to induce an increase in GLUT4 expression 159.  This resulted in a  decrease in 
insulin stimulated muscle glucose uptake 160.  It is important to note that although 
transgenic animal models are useful to study the function of certain genes, they may not 
however, be appropriate for investigating the effect of PGC-1α GLUT4 expression and insulin 
sensitivity.  
Figure 2.17 Schematic overview of selected metabolic proteins regulated by PGC-1 
α in skeletal muscle* 
*Proteins in red are induced by PGC1- α, whereas the protein in blue is reduced 
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The effects of GLUT4 gene expression are thought to be partially mediated through 
PGC-1α binding to and activating MEF2 101.  Removal of HDAC repression on MEF2 via HDAC 
phosphorylation allows MEF2 to act on its binding site in the promoter region of the GLUT4 
gene and recruit PGC-1α to enhance the transcription process. A single bout of exercise 
reduces HDAC5 association with MEF2 161, possibly through phosphorylation of HDAC5 by 
exercise-induced kinases. In addition, acute exercise increases MEF2/PGC-1α association, 
which may indicate an exercise-induced enhancement in MEF2 transcriptional function, 
thereby potentially leading to increased PGC-1α and GLUT4 expression by the mechanisms 
previously described. 
Cellular glucose concentration is not only controlled at the level of entry into the cell 
via GLUT-4, but also at the level of entry of pyruvate into the citric acid cycle.  The pyruvate 
dehydrogenase complex (PDC), catalyses the irreversible decarboxylation of pyruvate to 
acetyl CoA.  Pyruvate dehydrogenase kinase 4 phosphorylates and deactivates PDC resulting 
in a glucose sparing effect and enhancing fatty acid oxidation (Figure 2.18).  Activators of 
PPARα, induces the expression of PDK4, although the mechanism is not clearly understood 
162.  In myotubes co-activation of ERRα by PGC-1α occurs independently of PPARα activation 
of the mouse PDK4 gene promoter 163.  These studies indicate that muscle genes activated 
by PGC-1α enhance fatty acid oxidation which may serve to replenish muscle glycogen 
concentrations by decreasing glucose utilisation during recovery from exercise.
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PCG-1α mediated up-regulation of PDK4 leads to an increase in fat oxidation in skeletal muscle. ERRα, estrogen 
related receptor α, PDC pyruvate dehydrogenase complex, TCA tricarboxylic acid  
In summary, the up-regulation of mitochondrial fatty acid oxidation induced via PGC-
1α in conjunction with enhanced glucose uptake and storage, suggests a critical role for 
PGC-1α in fuel selection in resting muscle. 
PGC-1α and Substrate Regulation 
An increase in energy expenditure induced by contractile activity alters the substrate 
environment within the muscle and appears to modulate alterations in PGC-1α expression.  
In 9 physically active untrained men, Pilegaard et al., (2005) 164 found that 5 d of reduced 
CHO intake increased PGC-1α mRNA for 24 h after a 75 min exercise bout of cycling at 75% 
  2max .  Other studies have also found that changes in muscle glycogen after exercise are 
related to the changes in PGC-1α protein 165.  If PGC-1α is influenced by glycogen and CH  
availability it makes sense that PGC-1α may also modulate the usage of CH  within the 
muscle.  Overexpression of PGC-1α in mice has been shown to increase the basal rates of 
Figure 2.18 PGC-1α mediated up-regulation of pyruvate dehydrogenase kinase (PDK) 4 
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glucose transport with subsequent increases in intracellular glycogen concentration 166 and 
also prevented muscle glycogen depletion during exercise.  The effects of PGC-1α on 
glycogen metabolism were attributed to an increase in glucose transport, reduced glycolytic 
flux, and downregulation of glycogen phosphorylase.  Palmitoylcarnitine oxidation also 
increased indicating that the increase in lipid oxidation may have also contributed to the 
changes in CHO metabolism 166. In contrast, muscle glycogen repletion rates post-exercise 
were reduced in PGC-1α-deficient animals. 
Since PGC-1α has a substantial effect of lipid metabolism, it may be possible that 
fatty acid availability may also alter the expression of PGC-1α.  Watt et al., (2004) 167 found 
an increase in PGC-1α mRNA in the presence of reduced circulating levels of  fatty acids.  
However, others failed to find a relation between FFA and exercise-induced PGC-1α mRNA 
expression 168. More recent studies have found that intramuscular fatty acids or their 
metabolites and not circulating fatty acids may mediate the changes in PGC-1α expression in 
skeletal muscle 169,170 
The Role of PGC-1α in Skeletal Muscle Mitochondrial Biogenesis 
Contractile activity activates PGC-1α, which induces the expression of a large 
number of nuclear and mitochondrial genes, thereby activating the coordinated expression 
of mitochondrial proteins, including increased respiratory chain subunit expression, 
mitochondrial density and mitochondrial enzyme activity 124,165,171.  The role PGC-1α plays in 
inducing mitochondrial biogenesis was first demonstrated by expressing PGC-1α in 
myotubes 17 and in mouse skeletal muscle 172.  This resulted in an increase in the expression 
of genes involved in oxidation phosphorylation such as cytochrome c and COX IV.  Ectopic 
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expression of PGC-1α in myotubes stimulates GLUT4 expression and mitochondrial 
oxidation. Transgenic expression of PGC-1α in fast twitch skeletal muscle fibers markedly 
increased myoglobin protein expression, which was accompanied by the transformation of 
the muscle fibers to the metabolic characteristics of slow twitch muscle fibers 172.  In 
contrast, PGC-1α deficient mice have been shown to have reduced mRNA content of genes 
encoding mitochondrial oxidative proteins and are prone to contraction induced fatigue 
172,173.   
The regulation of mitochondrial biogenesis through PGC-1α, NRF-1 and ERRα and 
was described in an above section.  In addition to the stimulatory effect of NRFs on Tfam 
expression, these transcription factors also bind to target sequences on nuclear- and 
mitochondrial-encoded mitochondrial genes, including cytochrome c and COXIV 174.  
Similarly, ERRα in association with NRF-2 has been shown to be related to PGC-1α-induced 
mitochondrial biogenesis 175,176.  ERRα was shown to be essential for PGC-1α-mediated 
mitochondrial biogenesis and function upstream of NRF-1 action in the program of oxidative 
phosphorylation gene expression 176.  This implies that ERRα binding sites are present in the 
promoters of genes such as cytochrome c and β-ATP synthase 174. 
Exercise as a Stimulus for PGC-1α 
PGC-1α’s involvement in mediating exercise induced mitochondrial biogenesis is 
supported by both acute endurance exercise 3,134,168,177 and several weeks of endurance 
training 134,140,178.  Pilegaard et al., (2003) 134 were the first to demonstrate the effects of 
both acute exercise and prolonged exercise training on PGC-1α transcription in human 
skeletal muscle.  After 4 weeks of one legged knee extensor exercise training, PGC-1α mRNA 
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was increased in the trained leg at rest and after exercise (3 h of two-legged knee extensor 
exercise).  It is interesting to note that PGC-1α mRNA was increased to a greater extent in 
the trained leg despite the fact that the relative work intensity for the acute bout of exercise 
was much lower for the trained than the untrained leg.  This suggests that the mechanism(s) 
regulating the exercise-induced activation of the PGC-1α gene in muscle may become more 
sensitive to acute exercise with endurance training 179.  
Cycling for 2 h at 50% PPO has been found to result in a 4.8 fold increase in PGC-1α 
mRNA immediately after exercise and a 12 fold increase 1 h post-exercise respectively, in 7 
untrained men 168.  The muscle levels of PGC-1α mRNA returned to basal levels 4 h post 
exercise.  In contrast, Tunstall et al., (2002) 180 failed to find an increases in the expression of 
PGC-1α gene in untrained men and women following 9 d of endurance exercise for 1 h a day 
at an intensity corresponding to 63%   2max. It is possible that the expression of PGC-1α 
mRNA may require a stimulus from muscle contraction lasting more than 1 h.  It is also 
possible that the accumulative effect of a number of consecutive bouts of acute endurance 
exercise may be required to increase the expression of PGC-1α mRNA.  Russell et al., (2003) 
140 found a 2.2 fold increase in PGC-1α mRNA and a 2.8 fold increase in protein 
concentration in response to 6 weeks of combined interval (1-3 min of 5-6 intervals  70-
80%   2max) and submaximal exercise training (40 min running   60%   2max) in 
untrained men.  Differences in the acute and chronic responses of PGC-1α mRNA are 
probably due to the acute and chronic changes in cellular homeostasis with the constant 
stress of exercise training gradually stimulating a new increased steady state level of PGC-1α 
gene expression.  
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High Intensity Interval Exercise as a Stimulus for Mitochondrial Biogenesis 
The majority of early studies that have examined the effect of acute and chronic 
exercise training on PGC-1α induced mitochondrial biogenesis have involved primarily 
steady state submaximal endurance exercise  135,165,168.  Recently, evidence is accumulating 
which indicates that both acute and chronic low volume HIIE can also induce mitochondrial 
biogenesis.  Gibala et al., (2009) 23 found a twofold increase in PGC-1α mRNA content in 
human skeletal muscle, 3 h after a single bout of HIIT in college aged men.  The exercise 
session involved 4 x 30 s of maximal cycling with a 4 min active recovery period between 
each exercise bout.  Using a similar study design Burgomaster et al., (2008) 11 reported a 
similar increase in PGC-1α protein in response to 6 weeks of high intensity cycle training (3 
d.week-1) and 6 weeks of endurance training involving 40-60 min of cycling at 65%   2peak, 
5 days per week in untrained men.  The similar increase in PGC-1α protein occurred despite 
the fact that the total training time and energy expenditure was 66 % lower (1.5 h vs. 4.5 h) 
and 90% (225 versus 2250kj week-1) lower in the high intensity training group than the 
endurance training group.   Earlier studies by both  Burgomaster et al., (2005)  12 and Gibala 
et al.,(2006) 22 also found an increase in maximal activity and/or protein content of 
mitochondrial enzymes in response to HIIT.  Acute and chronic HII studies involving running 
have also found an increase in PGC-1α mRNA and protein content 24,84,85.  Interestingly in 
one of these studies a mere 12 min of HIIR over a 4 week period resulted in a 33% increase 
in PGC-1α content 85. 
The relation between an elevation in mRNA abundance and a subsequent increase in 
PGC-1α protein content after acute or chronic exercise training is unclear.  Animal studies 
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have reported a 50% increase in PGC-1α protein content at various time points up to 18 h 
following an acute bout of either prolonged swimming or running 112,122,181–183.  A recent 
study by Gibala et al., (2009) 23 found a twofold increase in PGC-1α mRNA content in human 
skeletal muscle, 3 h after a single bout of HIIE in college age men.  The exercise session 
involved 4 x 30 s of maximal cycling with a 4 min active recovery period between each 
interval.  
Results from human studies that have measured PGC-1α protein content following 
acute and chronic exercise are equivocal.  Despite an acute increase in PGC-1α mRNA, 
Gibala et al., (2009) 23 found that PGC-1α protein content remained unchanged in response 
to 4 x 30 s bouts of maximal cycling with a 4 min active recovery period.  Psilander et al., 
(2010) 133 compared the effect of two different acute bouts of interval training separated by 
7 d on PGC-1α mRNA and PGC-1α protein content in 10 trained endurance cyclists.  The first 
session involved 7 x 30 s bouts of cycling at 120 W with 4 min of active recovery between 
each high intensity cycle.  During the second laboratory visit participants performed 3 x 20 
min bouts of cycling at approximately 87%   2 peak.  Although, there was a significant 
increase in PGC-1α mRNA following both exercise sessions, PGC-1α protein content did not 
significantly change 133.  Similar findings were reported by Watt et al., (2004) 167 in 
recreationally active men during and 3 h following a 3 h bout of moderate intensity cycling 
at 60%   2max.   
In contrast, a recent study by De Filippis et al., (2008) 184 found that PGC-1α protein 
content was increased by 20% and 40% when measured at 30 min and 300 min after an 
acute bout of exercise involving 4 x 10 min of combined moderate and high intensity cycling 
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separated by 2 min of active recovery with no resistance.  Using college age men, 
Burgomaster et al., (2008) 11 also found an increase in PGC-1α protein content following 6 
weeks of either low-volume HIIT or ET involving cycling.  Furthermore, Mathai et al., (2008) 
165 found that a 23% increase in PGC-1α protein immediately following a single exhaustive 
bout of endurance training at 65%   2 max.  PGC-1α protein content remained elevated at 2 
h of recovery, while PGC-1α mRNA had returned to resting levels.  
PGC-1α mRNA and PGC-1α protein expression were measured 4 and 24 h following 
the 1st, 3rd, 5th and 7th  HIIT exercise bouts  in untrained men 15.  Exercise sessions involved 
10 x 4 min bouts of cycling at 90%   2max with 2 min passive recovery between each high 
intensity exercise bout. There was a significant increase in PGC-1α protein expression 24 h 
after the first session.  PGC-1α protein expression continued to increase, attaining a plateau 
by the 5-7th training session.  PGC-1α mRNA increased significantly 4 h after the first session.  
However, in contrast to the PGC-1α protein expression, PGC-1α mRNA expression was 
attenuated as training progressed despite a continual increase in training power output.  
These findings indicate that transcriptional responses to exercise sessions may be blunted 
with training and that presence of an increase in PGC-1α mRNA, more than one exercise 
session or the attainment of a specific exercise intensity is required to increase PGC-1α 
protein.  
The rapid up-regulation of PGC-1α mRNA and subsequent protein synthesis during 
recovery from exercise is consistent with its role in the regulation of exercise-induced gene 
expression.  A number of studies have shown that mitochondrial biogenesis progresses in 
the absence of an increase in PGC-1α protein content 185.  It is possible therefore, that an 
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increase in PGC-1α protein may not be necessary to mediate alterations in gene expression 
in response to an acute bout of exercise and exercise training. 122,185.  
The Mechanism of PGC-1α in Mitochondrial Biogenesis 
Until recently it was assumed that the exercise induced stimulation of mitochondrial 
biogenesis was mediated by an increase in PGC-1α protein. 102,186  There is now evidence 
that the initial phase of the adaptive increase in mitochondrial biogenesis induced by 
exercise is mediated by the activation of PGC-1α rather than by an increase in PGC-1α 
protein expression.  Wright et al., (2007b) 187 found that the increase in protein content of 
several mitochondrial enzymes immediately after 6 h of swimming in rat preceded an 
increase in PGC-1α protein.  However, the increase in PGC-1α protein content was preceded 
by rapid translocation of PGC-1α into the nucleus followed by NRF-1 and -2 binding to DNA 
and increased CS mRNA.  In contrast, Hargreaves et al., (2004) 161 did not find an increase in 
nuclear PGC-1α protein immediately following 1 h of cycling at 70%   O2max.  They did 
however, find indices of increased nuclear PGC-1α activity (co-activation of the transcription 
factor MEF-2) with no change in total PGC-1α protein content.  Little et al., (2010) 188 found 
a 25% and 54% increase in nuclear PGC-1α and protein content PGC-1α after a single bout of 
high intensity training after a 90 min bout of moderate intensity endurance training, 
respectively.  In a more recent study Little et al., (2011) 13 found that HIIT increases nuclear 
PGC-1α which coincided with increased mRNA expression of several mitochondrial genes.  
Collectively, these findings suggest that activation of PGC-1α in response to acute 
exercise mediates the early stages of mitochondrial biogenesis and that increases in PGC-1α 
protein expression may serve to enhance the transcriptional response to subsequent 
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exercise challenges or sustain the greater mitochondrial volume already achieved through 
training 134.  The role of augmenting nuclear PGC 1α contents via nuclear translocation from 
the cytoplasmic pool remains equivocal in humans.  
Nutrient Interactions on Exercise Induced Skeletal Muscle Adaptations 
Carbohydrate availability is vital for performance during both prolonged submaximal 
exercise (>90 min) and during intermittent high intensity exercise.  The benefits of 
consuming a diet high in CHO to optimise pre-exercise glycogen stores has long been known 
to prolong time to fatigue during prolonged submaximal exercise 189–193.  Based on 
observations that training with low glycogen levels can increase training induced gains in 
skeletal muscle oxidative capacity and performance 194,195, it is now being suggested that 
athletes should train with low CHO stores but restore fuel availability for competition ("train 
low, compete high"). 
Hansen et al., (2005) 196 found that training low and competing high significantly 
improved performance (Figure 2.19).  In this study, 7 untrained men participated in a 10 
week knee extensor ‘kicking’ training program.  One leg trained twice every second day 
while the other leg trained daily.  A diet high in CHO (8g.kg-1.day) was consumed throughout 
the study, ensuring that one leg performed each exercise session in a glycogen replete state, 
whereas the leg that trained twice daily completed the second exercise session glycogen 
depleted.  There was a significant increase in resting muscle glycogen and CS activity at the 
end of the 10 week training period in the leg that trained twice a day compared with the leg 
that trained once daily.  There was also a 2-fold greater increase in time to fatigue in the 
‘train low’ leg in comparison to the leg that trained in a glycogen replete state.  
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At least 48 h after the last performance test, a blood and muscle biopsy (grey arrows) were obtained during 
rest and an overnight fast.  After the first set of performance tests participants trained both legs for 10 wks., 
followed by a second post-training set of performance tests. The training consisted of a 14 x 5 day cycle.  
During one 14-day period, one leg (low) was trained for 5 days by the participants performing 2 bouts of 
dynamic knee extensor exercise, each bout lasting 1 hr and separated by 2 h rest. Alternatively the other leg 
(high) was trained every day for 5
.
d per week, by participants performing 1 bout of dynamic knee extensor 
exercise for 1 h. Numbers in the boxes demote the number of days. The filled circles demote exercise, while 
the unfilled are rest.  
A study by Yeo et al., (2008) 197 also found skeletal muscle adaptations and 
improvements in performance responses to twice daily training sessions in 14 endurance 
trained cyclists over a 3 week training period.  Participants performed 6 exercise sessions 
per week divided into three sessions of cycling for 100 min at 70%   2peak, and three 
sessions of 8 x 5 min at maximal sustained power with 1 min recovery between sets (Figure 
2.20).  Participants were randomly selected into one group that performed one exercise 
session per day for 6 days (high group) and a second group (low group) that trained twice 
every second day.  Each interval session was preceded by 60 min of cycling at 70%   2max.  
Before and after the 3 week training period each participant completed a 60 min time trial 
to measure performance improvements.  There were significant increases in resting muscle 
glycogen concentrations, rates of whole body fat oxidation during steady state exercise and 
an increase in CS and β-HAD activities in the low group only.  However, despite these clear 
metabolic enhancements, which should in theory confer performance improvements, there 
was a similar improvement in performance (10%) in both training groups.   
Figure 2.19 Schematic representation of Hansen et al., (2005) 196 
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The unfilled circles denote aerobic training (AT)- high daily training. The unfilled circles represent high 
intensity interval training (HIIT). R= rest.    
The mechanisms responsible for these training adaptations under restricted CHO 
intake remain unclear.  Initially, it was found that low glycogen concentrations during 
exercise stimulated the rate of transcription of a number of genes involved in metabolic 
adaptations 26,198. Several of these transcription factors contain glycogen binding domains 
which are released and targeted toward different proteins when muscle glycogen levels are 
low.  Exercising with low muscle glycogen also enhances the activation of intracellular 
signalling pathways, such as AMPK and p38MAPK which control the expression of gene 
transcription and subsequent mitochondrial biogenesis.  
AMPK is an important metabolic regulator that decreases anabolic and increases 
catabolic processes to maintain cellular homeostasis 199.  When muscle glycogen is low at 
rest, AMPK activity is increased, and its activation is significantly enhanced during exercise 
Figure 2.20 Overview of study design, Yeo et al., (2008) 197 
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compared to when glycogen levels are high 79,200.  The rate of muscle glycogen utilisation 
during exercise does not affect AMPK activation when pre-exercise glycogen levels are 
normal 80. 
Exogenous CHO availability has been found to influence metabolic regulation in 
skeletal muscle and impact gene expression 201,202.  CHO ingestion both before and during 
exercise blunts training induced adaptations 203,204.  High glucose availability suppresses 
AMPK activation in rat skeletal muscle in vitro 201.  In humans however, pre-exercise CHO 
feeding did not augment AMPK phosphorylation 203.  In this cross-over study nine 
recreationally active men participated in a 2 h constant load cycle exercise at 75%   2peak.  
Participants exercised in either a fasted or fed state (150g of CHO before and 1 g. kg-1. bw-1 
h-1 during exercise).  Although exercise induced AMPK phosphorylation was slightly 
decreased in the group that exercised under high CHO availability, it was not statistically 
significant.  These findings were confirmed in a more recent study in which 9 recreationally 
active men completed 2 separate bouts of cycle exercise at 65%   2peak for 120 min.  
Participants ingested either an 8% CHO solution or an artificially sweetened placebo during 
exercise.  Despite the fact that CHO supplementation significantly increased blood glucose 
levels there was a similar increase in AMPK phosphorylation in both groups 202.   
One of the mechanism by which CHO ingestion during exercise is thought to reduce 
AMPK activity is via an increase in AMP.  In contracting skeletal muscle AMP/ATP ratio is a 
major regulator of AMPK activity during exercise, with a reduction in AMP decreasing the 
activity of AMPK.  However, in the study by Lee-young et al., (2006) 202 there was a 
disconnect between the changes in skeletal muscle AMP and AMPK activity.  AMP and 
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AMP/ATP ratio increased during both trials, with the decrease in both analytes significantly 
lower in the CHO than the placebo group.  These differences did not translate into a 
decrease in AMPK activity.  McConell et al., (2005) 205 also found that AMPK activity was not 
increased during prolonged exercise at 65%   2peak despite a 4-8 fold increase in the 
concentration of AMP during exercise.  The activation of AMPK requires a substantial 
increase in AMP and therefore a relatively small reduction in AMP may not translate into a 
reduction in AMPK activity 206.  Even though there was a decrease in AMP during exercise in 
the CHO fed group there was still a 12-fold increase in AMP which may help to explain why 
AMPK activity was not reduced by CHO availably.  
Morton et al., (2009) 24 simultaneously examined the effects of decreased muscle 
glycogen concentrations and the influence of exogenous glucose availability on training 
adaptations in 23 recreationally active men.  Participants undertook a 6 week training 
program that consisted of 4 high-intensity running sessions at a fixed intensity (Figure 2.21).  
They were divided into 3 groups and undertook the exercise sessions under either high CHO 
availability (single day training sessions), train low (2 training sessions per day, with the 
second session completed under glycogen depleted conditions) or train low + glucose (train 
twice per day with glucose intake before and during the second exercise session) conditions.  
Improvements in performance were similar in all groups with 10% and 18% improvements 
in   2max and distance run during the Yo-Yo intermittent test respectively.  However, the 
group that trained with both low glycogen and low exogenous glucose availability had 
significantly greater increases in the activity of SDH.  It is possible an increase in AMPK 
and/or p38AMPK due to a reduced CHO availability may have been partly responsible for 
the increase in SDH.  Both of these signalling molecules can phosphorylate and activate PGC-
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1α, which could allow for the increased expression of mitochondrial proteins, although this 
study provides no definite insight into this mechanism.  Cochran et al., (2010) 25 found no 
significant effect of reduced CHO availability on AMPK phosphorylation after a bout of HIT, 
suggesting that this pathway is not involved in nutrient enhanced metabolic adaptations 
after an acute bout of exercise training. 
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B, signifies blood and biopsy sampling. Subjects trained 4 x d
.
wk, either twice a day on Tuesday (Tu) and 
Thursday (Th) (Low+ Glu and Low + Pla groups) or once daily on Monday (M), Tu, Th and Friday (F) (Norm 
groups). Three days after the last training session, participants performed an additional exercise session (CE2) 
to assess the effects on the physiological and metabolic cost of the exercise bout. Dark circles represent, non-
supplemented exercise session, grey, CHO supplemented exercise session and open, placebo-supplemented 
during training. 
The MAPK pathways may also play a role in the interaction of signaling pathways 
with nutrients to enhance metabolic adaptations after exercise.  The p38MAPK protein is 
activated by cellular stress which couples cellular disturbances to various adaptive 
responses in skeletal muscle 108.  Chan et al., (2007) 207 found a decrease in skeletal muscle 
p38MAPK phosphorylation after 60 min of cycle exercise at 70%   2peak in the presence of 
reduced glycogen content and reduced CHO availability.  In contrast, Yeo et al., (2010) 208 
found that reduced glycogen content was not related to an enhanced p38MAPK activity.   
Cochran et al., (2010) 25 investigated the effects of manipulating CHO intake during 
recovery from HIIT exercise on the skeletal muscle adaptations to a subsequent bout of 
exercise.  Ten recreationally active men participated in two identical sessions of HIT 
involving 5 x 4 min of cycling at 90-95% heart rate reserve with 2 min of active recovery 
separated by 3 h of rest (Figure 2.22).  During the recovery period participants consumed 
Figure 2.21 Overview of study design from Morton et al., 2009 24 
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either 1.2 g.kg-1 h-1 (HI-HI) or a sweetened placebo (HI-LO).  There was 4-fold increase in 
p38MAPK phosphorylation after the first HIT session, which returned to normal prior to the 
second session in both groups.  However, after the second session p38MAPK was 50% 
higher in HI-LO than the HI-HI.  Since resting glycogen and glycogen depletion was similar 
between groups, it is possible that exogenous CHO availability altered the metabolic 
response to HIIT.  ATP and PCr levels were also reportedly lower after the second exercise 
session in the HI-LO in comparison to the HI-HI group, which may also have contributed to 
the increase in p38MAPK activity.  Exercising with reduced CHO availability increases FFA, 
and therefore the possible effects of FFA on inducing metabolic adaptations in response to 
exercise must to taken into account.  There was a 2-fold increase in FFA in the CHO 
restricted condition before the second exercise session compared to the high CHO-
supplemented group, which may have influenced the increase in p38MAPK phosphorylation 
in the HI-LO.  However, there is evidence that p38MAPK phosphorylation is increased when 
FFA levels are suppressed during prolonged exercise in humans 167. 
 
 
 
 
 
 
 
Figure 2.22 Overview of study design, Cochran et al., 2010 25 
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Performance Enhancements Conferred by Nutrient Interactions 
Studies have reported an increase in mRNA expression of genes related to fatty acid 
oxidation when training is undertaken in a fasted state compared to a CHO-fed state.  
However, there was no difference in performance 24,197.  De Block et al., (2008) 209 also 
demonstrated the effects of CHO feeding on skeletal muscle adaptations to endurance 
training.  Twenty recreationally active men participated in a 6 week training study consisting 
of cycling 1-2 h 3 d.wk-1 at 75%   2peak.  Participants were divided into two groups and 
trained in either a fasted or fed state.  Substrate utilisation was analysed during a 2 h bout 
of moderate exercise before and after the training period.  Although training in a fasted 
state increased fatty acid binding protein (FABPm), fatty acid oxidation was not increased, 
compared to the fed state.  Changes in peak   2 were similar in the fed and fasted state.  
In another study nine recreationally active men undertook a 10 week one legged-
knee extensor endurance training study in which they trained their respective legs 2 h per 
day, on alternative days, 5 days per week 210.  Participants trained one leg while consuming 
a glucose drink, and the other while consuming a placebo drink.  There were similar 
increases in muscle glycogen concentration, CS and β-HAD activities in both groups.  Time to 
fatigue and power output during the endurance test increased equally in both legs after the 
training period.  
Summary 
Significant progress has been made over the past decade to elucidate the regulation 
of exercise induced mitochondrial biogenesis, with a substantial body of evidence describing 
a subset of transcriptional factors and transcriptional co-regulators which are involved in 
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this process.  Skeletal muscle contraction activates various signalling pathways involving 
protein kinases, transcription factors and transcriptional co-regulators which transduce 
physiological stimuli into transcriptional adaptations.  PGC-1α is a key metabolic controller 
which regulates gene expression by a sequential and dynamic recruitment of different sets 
of proteins making a functional multiprotein complex that transcribes specific genes.  PGC-
1α is activated by multiple signalling pathways, although AMPK and p38MAPK seem to be 
the more dominant activators induced by exercise 23.  Exercise training results in an increase 
in PGC-1α and a subsequent increase in mitochondrial content, enhanced fatty acid 
oxidation, increased resting muscle glycogen content and enhanced exercise performance.  
PGC-1α is also indirectly involved in regulating the expression of mtDNA transcription 
through the increased expression of Tfam.  An increase in PGC-1α protein content may 
therefore indicate the co-coordinated metabolic expression of both nuclear and 
mitochondrial genome in response to exercise.  An increase in Tfam protein content may 
further cooborate exercise induced mitochondrial gene expression. 
Complexes of the ETC are comprised of multiple subunits which are encoded by both 
nuclear and mitochondrial genome.  Tfam and PGC-1α have been found to induce the 
expression of mtDNA and nuclear DNA which encodes these respiratory proteins 13,18,136 .  
An increase in these subunits would therefore indicate the co-ordinated expression of both 
nuclear and mitochondrial gene expression.  
An increase in PGC-1α in response to exercise has also been consistently associated 
with a subsequent increase in mitochondrial enzyme (CS and/or β-HAD) 11,12,22 activity 
indicative of mitochondrial biogenesis.  
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HIIT is a unique model for studying the molecular mechanisms that regulate and 
control mitochondrial biogenesis.  Recent studies have demonstrated the ability of a single 
HII cycle exercise session to induce similar phenotypic changes that resemble those elicited 
by endurance training.  This research study explores whether HII running can induce the 
same signalling cascades which activate mitochondrial biogenesis as HII cycle and whether 
nutrient interactions may blunt these pathways.   
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Chapter 3  
               STUDY 1 
Introduction 
Recent studies have found that HIIT stimulates an increase in mitochondrial volume, 
known as mitochondrial biogenesis.  The molecular events that promote these metabolic 
adaptations in the muscle cell involve a complex cascade involving the activation of specific 
signalling pathways which regulate exercise induced gene expression and protein synthesis 
(Figure 3.1).  Two integral components of the signalling pathways in skeletal muscle are 
AMPK and p38MAPK, which have been implicated as potential mediators in this adaptation 
process (Figure 2.13).  Both of these protein kinases are responsive to cellular stress in the 
skeletal muscle.  AMPK acts to maintain cellular energy homeostasis 57, while p38AMPK 
couples cellular disturbances to adaptive or maladaptive responses in the muscle 20.  In a 
recent study, Gibala et al., 23 found an increase in phosphorylation of AMPK (subunits α1 
and α2) and p38MAPK (p>0.05) immediately after an acute session involving 4 x 30 s bouts 
of maximal cycling with 4 min of passive recovery between bouts.  In addition, PGC-1α 
mRNA, the master regulator of mitochondrial biogenesis was increased approximately 
twofold above rest after 3 h of recovery (p>0.05).  The majority of studies that demonstrate 
an enhanced activation of both AMPK and p38MAPK after HIIT have involved cycle 
ergometry.   
Recent studies indicate that an increase in both endogenous CHO (muscle glycogen) 
and exogenous CHO (glucose supplementation) before and during exercise blunts the 
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activation of both AMPK and p38MAPK 24,25.  Morton et al., (2009) 24 simultaneously 
examined the effects of decreased muscle glycogen concentrations and the influence of 
exogenous glucose availability on training adaptations and found a significant increase in 
  2max and the distance completed during an intermittent run test.  However, the group 
that trained with both low glycogen and low exogenous glucose availability had a greater 
increase in SDH activity, indicating training induced mitochondrial biogenesis.  The signalling 
pathways were not investigated in this study.  
Signalling pathways and nutrient interactions after HIIE have been examined in only 
one study that involved cycling.  No studies have investigated the activation of signalling 
pathways in response to CHO feeding or low muscle glycogen content in weight bearing 
exercise such as running which involves a greater muscle mass involvement than running.  
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Study Aim 
To investigate the effects of high intensity interval running (HIIR) and diet on the 
activation of signalling pathways involved in mitochondrial biogenesis. 
Study Objectives 
1. To examine the effects of an acute bout of HIIR on the AMPK, p38MAPK and ACCβ 
signalling pathways 
1.1 To compare the effect of feeding CHO or placebo during recovery from an 
acute bout of HIIR on the AMPK, p38MAPK and ACCβ signalling pathways in 
response to a  subsequent bout of HIIR 
2. To compare the effect of feeding CHO or placebo during recovery from an acute bout 
of HIIR on a subsequent bout of HIIR.   
Study Hypothesis 
1. An acute bout of HIIR will significantly activate the AMPK, p38MAPK and ACCβ 
signalling pathways 
1.1 Compared to placebo, feeding a CHO solution during recovery following an 
acute bout of HIIR will blunt the activation of AMPK, p38MAPK and ACCβ 
activity during a  subsequent bout of HIIR 
2. Compared to placebo, feeding a CHO solution during recovery following an acute 
bout of HIIR will result in a significant increase in performance during a subsequent 
bout of HIIR 
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Methods 
Participants 
Eighteen club level Gaelic football players (mean ± SD; age 25.83 ± 5.40 yr; BMI 24.55  
± 1.40 kg.m2;   O2max 55.14 ± 4.90 ml·min
-1.kg-1) participated in the study.  Participants were 
fully informed of the experimental procedures and possible discomforts associated with the 
study before giving their written informed consent to participate.  The study was approved 
by the Research Ethics Committee at Dublin City University (DCUREC 148).  
Overview of Study Design 
The study design is outlined in figure 3.1.  Participants made two visits to the High 
Performance Laboratory in the School of Health and Human Performance in DCU.  The first 
visit was used to measure   O2max. During the second visit, participants performed two 
identical exercise trials separated by a 3 h recovery period (experimental trials).  After the 
first exercise trial participants were randomized to a CHO or placebo (P) group, in which 
they were fed either a CHO or a placebo solution and a low CHO lunch during the first 2 h of 
the 3 h recovery period. A muscle biopsy and blood sample was taken before and after each 
exercise trial.   
 
 
 
 
 
 
Figure 3.1 Study 1 research design 
 88 
Experimental Trial 
The two experimental trials were identical except for the nutritional manipulation.  
The experimental protocol is outlined in figure 3.2.  Participants arrived in the laboratory 2 h 
after consuming a standardised breakfast (617 kcal; 60% CHO, 30% fat, 10% protein).  They 
were instructed to refrain from caffeine for 12 h, and alcohol and physical activity beyond 
activities of daily living for 24 h before the experimental trials. 
 
 
Resting muscle and blood samples were obtained, after which participants 
completed a 20 min warm-up on a treadmill at an intensity corresponding to 70-80% 
  O2max (endurance run (ER)) followed by a 4 min passive recovery period.  This was 
followed by a HIIR protocol.  A second muscle and blood sample was obtained immediately 
following the bout of HIIR.   
Figure 3.2 Study 1 Experimental protocol 
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Participants then rested for 3 h and consumed either 1.2 g CHO·g. kg -1·h-1 or a similar 
volume of flavoured water for the first 2 h.  They were provided with 500 ml of the 
appropriate beverage and instructed to consume it at regular intervals during the 2 h 
interval.  The CHO consisted of maltodextrin, fructose and dextrose (Kinetica Ltd., Carbery, 
Ireland).  Each participant also consumed a standardised low-CHO lunch consisting of 304 
kcal: 52% CHO, 39% fat, 9% protein during the first hour of the recovery period.  Water was 
ingested ad libitum during the 3 h recovery period.  Following the recovery period, 
participants undertook a second bout of HIIR that was identical to the first session.  Muscle 
and blood samples were obtained before and after exercise.   
High Intensity Interval Exercise 
Participants performed 3 sets of maximal sprints (Figure 3.3).  A set consisted of 3 x 
110 m with a 20 s passive recovery period between each run (1 set) and a 4 min passive 
recovery period between sets.  Following each set a blood sample was taken to determine 
blood lactate concentration.  Each sprint was timed using electronic timing gates.  
 
 
 
 
 
 
 
 Figure 3.3 High intensity interval running (HIIR) protocol 
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Anthropometrics 
Height and body mass were measured to the nearest 0.1 cm using a portable scale 
(Seca 707 Balance Scales, GmbH, Hamburg, Germany).  Participants removed their shoes 
and stood with their feet together on the base plate with their arms loosely by their side.  
Each participant was asked to take a deep breath and to stand with their back as straight as 
possible against the vertical measuring rods and to look straight ahead.  Body mass was 
measured to the nearest 0.1 kg.  Participants were instructed to wear a light top and shorts 
and to remove their shoes prior to the measurement.  
Maximal Aerobic Capacity 
Maximal aerobic capacity was determined on a treadmill (Woodway ELG 55, 
Waukesha, WI) using a ramp protocol.  Subjects ran at 8 km.h-1, 10 km.h-1 and 12 km.h-1 for 3 
min at 1% gradient.  For the remainder of the test, the speed remained constant and the 
gradient increased by 1% every min until the participant reached volitional fatigue.  Heart 
rate and RPE were recorded during the final 10 sec of each min.  
Cardiorespiratory and Metabolic Measures  
Respiratory metabolic responses were determined using standard open-circuit 
spirometry techniques (Sensormedics Vmax 229, SensorMedics Corp., CA).  Prior to testing, 
the gas analysers were calibrated with standard gases of known concentration.  A mass flow 
sensor (Sensormedics, Loma Linda, CA, USA) was used to collect breath-by-breath 
measurement of ventilation.  A 3 L volume syringe (Sensormedics, Loma Linda, CA, USA) was 
used to calibrate the mass flow sensor prior to each test.   
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Mass Flow Sensor Heated Wire Anemometer-Mode of Operation  
The mass flow sensor is a low resistance tube with a tapered internal diameter 
extending from both ends of a laminar flow throat.  A cold and hot stainless steel wire 
electrically heated to -180°C and -240°C respectively, are centered in the flow stream.  
These wires are elements in a servo-controller bridge circuit that maintain the resistance 
ratio of the two wires at a constant value.  If only the temperature of the inspired gases 
changes, then both wires lose heat at the same rate and no current change is required to 
keep the bridge balanced.  As air flows across the wires, the hot air loses heat more rapidly 
than the cold air and current must be added to keep the bridges balanced at a 3:4 ratio. The 
amount of current required is proportional to the mass flow of the gas.  This method 
ensures that the sensor measures only the heat loss from the molecular convection of the 
moving gas stream, and not the artifact due to cooling of the gas as it passes through a 
breathing assembly.   The mass flow meter responds to instantaneous flow rates between 0-
16 L.sec-1 and integrated flow between 0-350 L.min1- with flow resistance <1.5 cmH2O
.L-1.sec-
1.  The mass flow sensor was outputted to the analyser module of the Vmax 229 and was 
sampled at a rate of 125 Hz.  
Mass Flow Sensor Calibration  
A 3 L volume syringe (Sensormedics, Loma Linda, CA, USA) was connected to the 
mass flow sensor, and stroked four times in order to measure inspired and expired volumes.  
The volumes were calculated by expressing 3 L as a fraction of each measured inspired and 
expired volume achieved during calibration.  An average correction factor was calculated for 
inspired and expired volumes, and used to fine-tune the volume measurement.   
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A verification procedure was performed. This involved stroking the 3 L volume 
syringe four times.  Inspired and expired volumes were measured using the newly calculated 
correction factors.  In order to pass the calibration procedure, one of the four strokes had to 
have an average flow rate <0.5 L.sec-1, and at least one of the four strokes had to have an 
average flow >3.0 L.sec-1.  
Gas Analysers  
The Vmax 229 utilizes a rapid response infrared measurement technique.  An O2 and 
CO2 analyser is integrated with the Vmax 229.  A small sample of inspired air is drawn 
through a sample cell, and exposed to an infrared light through an optical that is passed 
through a band pass filter and the sample cell.  An infrared detector responds to the amount 
of infrared light that passes through the sample cell.  The amount of light that passes 
through the sample cell varies according to the concentration of CO2 in the sample cell.  
Based on measured levels of infrared light intensity, the analyser computes the PCO2 in the 
gas sample.  The CO2 analyser is linearly scaled across the 0-100% range with a resolution of 
0.01% CO2, and a response time of <130 ms (10-90%) at 500 ml
.min-1 flow.  The O2 analyser 
is based on the high paramagnetic susceptibility of O2.  A diamagnetic glass dumbbell 
suspended in a magnetic field rotates in proportion to the PO2.  The analyser is linearly 
scaled across the 0-100% range with a resolution of 0.01% O2 and a response time of <130 
ms (10-90%) at 500ml.min-1 flow.  
Calibration of CO2 and O2 Analysers  
The gas analysers were calibrated with standard gases of known concentration (BOC 
gases, Dublin, Ireland).  The first calibration gas contained 26.00 ± 0.02% oxygen and the 
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balance nitrogen (N2).  The second calibration gas contained 4.00 ± 0.02% carbon dioxide, 
16.00 ± 0.02% O2, and the balance N2.  A small bore drying tube connected to the CO2 and 
O2 analysers sampled the calibration gases.  The absorption and evaporative properties of 
the drying tube ensured that the relative humidity of the calibration gas was equilibrated to 
ambient conditions prior to sampling by the O2 and CO2 analysers.  The calibration gas was 
sampled at a rate of 125 Hz. The response time was similar between O2 and CO2 analyser.  
Ratings of Perceived Exertion  
RPE was obtained using the 16-point Borg category RPE scale.  Prior to the maximal 
exercise test participants read a standard set of perceptual scaling instructions.  These 
instructions followed an established format used in previous investigations.  Low and high 
“perceptual anchors” were established during the maximal exercise test.  This involved 
asking participants to assign a rating of 6 (low anchor) to the lowest exercise intensity, and 
20 (high anchor) to the highest exercise intensity.  Participants were instructed to make 
their subjective assessments of perceived exertion relative to these minimum and maximum 
standards (perceptual anchors). 
Lactate Measurements 
Blood samples were drawn from the earlobe.  Prior to each sample, the ear lobe was 
wiped with alcohol and allowed to dry thoroughly.  The base of ear lobe was jabbed with a 
lancet (Accu-Chek Softclix, UK) and the first drop of blood was wiped away.  Pressure was 
placed on the ear lobe with the thumb and forefinger in order to provide an appropriate 
sample.  A 5 L sample of whole blood was automatically aspirated into a single use, 
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enzyme-coated electrode test strip (Lactate Pro Akray, Japan).  The reagent strip fills by 
capillary action directly from the earlobe site.   
Blood samples were analysed using and a hand-held portable analyser (Lactate Pro 
Akray, Japan).  The measuring range is 0.8–23 mM.  Lactate in the sample reacts with 
potassium ferricyanide and lactate oxidase to form potassium ferrocyanide and pyruvate.  
Upon the application of a given voltage, ferrocyanide is oxidised, releasing electrons and 
creating a current. This current is measured amperometrically and is directly proportional to 
the lactate concentration of the blood sample.  The result is displayed after 60 s.  The 
Lactate Pro is supplied with a check strip and a calibration strip that provide a non-
quantitative indication of instrument accuracy. 
Performance Measurements 
Wireless electronic timing gates (Fusion Sport International) were used to measure 
the time for each 110 m interval sprint.  The timing gates were placed at the starting line.  
Participants were encouraged to complete each interval sprints in the shortest possible 
time.   
Muscle Biopsy 
Approximately 100-150 mg of muscle was obtained from the m. vastus lateralis 
midway between the upper pole of the patella and the anterior superior iliac spine at the 
anterior border of the iliotibial band using the percutaneous needle biopsy technique 
described by Bergstrom with the aid of suction 190.  Two biopsies were obtained from each 
leg during each trial.  Each biopsy was obtained from a separate incision site, with incision 
sites spaced 2–3 cm apart. 
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A small area of skin was shaved if necessary and 5.0 ml 1% w/v lidocaine HCl was 
infiltrated into the skin and subcutaneous tissues as far as the fascia but not into the muscle 
itself.  The biopsy area was further cleansed using povidine-iodine solution and a sterile 
drape placed around the incision site.  A 5 mm skin incision was made through the skin and 
the deep fascia with a number 11 blade scalpel.  
The obturator was removed from the 5 mm Bergstrom biopsy needle.  The needle 
was inserted with window closed (inner needle advanced to its furthest forward position). 
The needle was advanced, moving easily through skin until resistance was felt from the 
muscle sheath and then pushed through the sheath.  A sample of tissue was guillotined by 
opening the outer needle window (retracting inner needle) and then closing the window 
with forward thrust of the inner needle.  A 200 ml syringe attached to the proximal port of 
the needle permitted suction to be applied to draw the sample into the needle port.  
Closure of the port using a sharp trocar completed the acquisition of the sample.  This 
procedure was repeated approximately 3 times without removing the needle from the 
thigh.  The needle was then removed and the obturator used to evacuate the specimen.  
Samples were snap-frozen in liquid nitrogen and stored at -80° C until analysis. 
After the procedure, direct pressure was applied for approximately 5 min to 
minimise haematoma formation.  Once satisfied of haemostasis, several steristrips were 
applied to close the incision.  A waterproof dressing was placed over the wound.  An elastic 
stockinette was placed over the thigh for further compression for a few hours if required.   
 96 
Blood and Muscle Analysis 
Muscle Metabolites and Glycogen 
Two pieces of frozen wet muscle (10–15 mg) were removed from each of the first 
biopsy samples under liquid nitrogen for glycogen, metabolite and protein analysis.  The 
muscle from each biopsy was freeze dried, dissected free of visible blood and connective 
tissue, and powdered for metabolite and glycogen analyses.  An aliquot of freeze-dried 
muscle (10–12 mg) was extracted with 0.5 mol·L–1 perchloric acid (HClO4), containing 1 
mmol·L–1 EDTA, and neutralized with 2.2 mol·L–1 KHCO3. The supernatant was used to 
determine creatine, PCr and ATP contents with enzymatic spectrophotometric assays 211.  
Muscle glycogen content was determined from 2 aliquots of freeze-dried muscle (each 2–3 
mg) from all biopsies, as described elsewhere 211.  Muscle metabolites were corrected for 
total creatine, as described below. 
Muscle calculations 
Muscle ADP and free AMP (AMP) contents were calculated by assuming equilibrium 
of the creatine kinase and adenylate kinase reactions 212.  Specifically, ADP was calculated 
using the measured ATP, creatine, and PCr values, an estimated H+ concentration, and the 
creatine kinase constant of 1.66 x 109 213. AMP was calculated from the estimated ADP and 
measured ATP content, using the adenylate kinase equilibrium constant of 1.05.  Free 
inorganic phosphate (Pi) was calculated by adding the estimated resting free phosphate of 
10.8 mmol·kg–1 dry weight 212 to the difference in PCr content (D [PCr]) minus the 
accumulation of glucose 6-phosphate between rest and selected exercise time points.  
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Substrate level phosphorylation was calculated between rest and 5 min, using the following 
equation:  
ATP provision rate: 1.5 (∆[lactate])+ [∆PCr] 
Where ∆ is the difference between the rest and 5 min values and brackets indicate 
concentration 214. 
Western Blots Analysis 
Muscle Homogenization: Frozen muscle samples (30 mg) were added to ice-cold lysis 
buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM EGTA, 50mM NaF, 1% Triton X-100, 10 mM 
sodium β-glycerol phosphate, 5 mM sodium pyrophosphate, 2 mM DTT, 1 mM PMSF, 
0.004% protease inhibitor cocktail (Sigma Aldrich, Oakville, ON), and 1mM Na 
orthovanadate).  Samples were scissor minced and then centrifuged at 1500 g for 15 min at 
4°C, and the supernatant was obtained.  
Protein concentration of the homogenate was determined using a BCA assay.  
Muscle homogenate was solubilized in 4 x Laemmli's buffer, resolved by SDS-PAGE, and wet-
transferred to nitrocellulose membrane (2 h, 30   for all except ACCβ membranes which 
were left overnight at 30V).  The membranes were blocked for 1 h and then incubated 
overnight at 4°C with commercially available primary antibodies to measure, total and 
phosphorylated AMPK (1:1000), p38MAPK (1:1000) and ACCβ (1:1000) (Cell Signaling 
Technology, Inc).  Secondary antibodies were also purchased from Cell Signaling Technology 
and were diluted as follows; AMPK (1:1000), p38MAPK (1:1000) and ACCβ 
After incubation with appropriate secondary antibody for 1 h, the immune 
complexes were detected using the enhanced chemiluminescence method (Western 
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Lightning Plus-ECL; PerkinElmer, Waltham, MA), and quantified with densitometry (Gene 
Tools software, PerkinElmer).  All phospho-proteins were normalised to the corresponding 
proteins after stripping the phospho antibody for 30 min at 50°C in stripping buffer (65 mM 
Tris HCl, 2% SDS vol/vol, 0.8% mercaptoethanol vol/vol) and re-probing with the primary 
antibody for the corresponding total.  
Blood Measurements 
Venous whole blood was collected in 4 ml vacutainers.  The whole blood was 
analysed for lactate and glucose.  The supernatant was stored at –20 °C and analyzed for 
glycerol and  free fatty acids with a colorimetric assay 211 (Randox, UK.), and insulin with a 
magnetic bead panel (Millipore, Cork, Ireland).  
Statistical Analysis 
SPSS 19 for Windows statistical software will be used to perform the statistical 
analysis.  Normality and homogeneity of variance were assessed using the Kolmogorov-
Smirnov test and Levene’s test, respectively.  A paired sample T-test was used to compare 
the changes in muscle and blood parameters in all 18 participants in response to the AM 
HIIR session.  The performance times and blood lactate levels for the 3 HIIR’s within each set 
were averaged and compared to each other using a one way repeated measures ANOVA.  A 
time (pre and post) x group (CHO and P) 2-way repeated measure ANOVA was used to 
compare the changes in muscle and blood and performance parameters in response to the 
PM HIIR session.  The performance times for the 3 HIIR’s within each set were averaged and 
compared to each other using a two way (group (2) x time (3) 2-way repeated measures 
ANOVA.  Blood lactate levels for the 3 HIIR’s within each set were averaged and compared 
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to each other and baseline using a two way (group (2) x time (4) 2-way repeated measures 
ANOVA.  No significant interactions were found and all the main effects were probed using a 
Bonferroni for multiple comparisons.  Statistical significance will be accepted at the P < 0.05 
level of confidence. 
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Results 
The anthropometric characteristics of the participants in both the CHO and P group.are 
shown in table 3.1.   
 
Table 3.1 Anthropometric data 
 
 
 
Blood Lactate Levels  
Acute Exercise – AM (N=18) 
Blood lactate levels before and after the acute AM bout of ER and HIIR are illustrated 
in figure 3.4.  Circulating blood lactate levels were higher (p<0.001) at the end of the 20 min 
submaximal run than baseline-1.  The 20 min ER was followed by 4 min of passive recovery.  
Blood lactate was still significantly (p<0.001) elevated above baseline at the end of the 
recovery, immediately prior to HIIE.  Blood lactate levels were significantly higher than 
baseline-2 after each of the 3 sets of HIIE.  There was a significant difference (p<0.001) in 
blood lactate between each of the HIIR’s.   
 
 CHO Placebo 
Age 357.43 ± 115.68  288.24 ± 82.02Ɨ 
Weight 18.78 ± 4.86 18.39 ± 3.73 
Height 60.15 ± 17.73 60.16 ± 11.30 
  O2max (ml
.kg1.min1) 35.96 ± 10.37 43.07 ± 13.10 
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Acute Exercise – PM (N=9) 
There was no significance difference in blood lactate levels between the CHO and P 
condition during the ER or the sets of HIIE.   
Placebo Group (N=9) 
PM blood lactate levels in the placebo group before and after the acute bouts of ER 
and HIIR are illustrated in figure 3.5.  Blood lactate levels were higher (p<0.001) than 
baseline-1 following the 20 min submaximal run and remained significantly elevated above 
baseline following a further 4 min of passive recovery.  Blood lactate levels were 
significantly higher than baseline-2 after each sets of HIIE.  In addition, there was a 
significant difference in blood lactate between set 1 and 2 and between set 1 and 3 of HIIE.  
 
Figure 3.4 Lactate measures before and after the AM exercise session 
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Carbohydrate Group (N=9) 
PM blood lactate levels in the CHO group before and after the acute bouts of ER and 
HIIR are illustrated in figure 3.6.  At the end of the 20 min submaximal run blood lactate 
levels were higher (p<0.01) than baseline 1 and remained significantly elevated above 
baseline following the 4 min of passive recovery.  Blood lactate levels were significantly 
higher than baseline-2 after each set of HIIE.  In addition, there was a significant difference 
in blood lactate levels between each set of HIIE.  
 
 
 
 
 
Figure 3.5 PM blood lactate levels in the placebo group before and after the 
PM exercise bout. ‡p< vs BL1 
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Performance Times During HIIE 
Acute Exercise – AM (N=18) 
The performance times were averaged across the 3 high intensity exercise bouts 
within each set and are presented in Figure 3.7.  There was no difference in the 
performance time during the first and second set.  The average time was significantly slower 
during the third set than the second set.   
 
 
 
 
 
Figure 3.6 PM blood lactate levels in the CHO group before and after the 
PM exercise bout. †p<0.01 vs BL1 
Figure 3.7 Performance times during each set of HIIR during the AM session 
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Acute Exercise – PM (N=9) 
The performance times for the CHO and P group are illustrated in figure 3.8.  There 
was no significant difference in performance times between any of the 3 sets of HIIR within 
the CHO or P condition.  Performance time was significantly faster in the CHO than the P 
group during the first set of HIIR.  Although performance time was faster in the CHO than 
the P during set 2 and set 3 it did not reach statistical significance (p<0.08).  The average 
times in the CHO and P group over the 3 HIIR sets were 27 and 30 s in the AM exercise 
session and 26 and 31 s in the PM exercise session respectively.  These averages were 
compared using a t-test and the CHO group was statistically faster than the P group in the 
AM exercise session (p<0.03). The CHO group in the PM exercise session was almost 
statistically faster than the P group (p<0.056) 
 
 
 
 
 
 
 
Figure 3.8 The average time taken to complete each set in placebo and CHO 
group 
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Muscle Levels of Glycogen, ATP, PCr and Cr Before and After the AM Exercise Session 
Table 3.2 summarises the muscle levels of glycogen, ATP, PCr and Cr before and after 
the AM exercise session. Compared to baseline, muscle glycogen content decreased by 10% 
(p<0.01), and there was no significant change in ATP, PCr or Cr following the combined ER 
and HIIR session.   
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Table 3.2 Muscle levels of glycogen, ATP, PCr and Cr before and after the AM exercise 
session (n=18) 
 
 
 
 
Values are means   SD; †p < 0.01 vs. pre-training 
Blood Parameters Before and After the AM Exercise Session 
Table 3.3 summarises the measured blood parameters before and after the AM 
exercise session.  Compared to baseline, blood levels of glucose, lactate, NEFA and glycerol 
were decreased (p<0.001) following the combined ER and HIIR session.  There was no 
significant difference in plasma insulin levels before or after the AM exercise session.   
 
Table 3.3 Blood parameters before and after the AM exercise session 
 Baseline-1 Post Exercise 
Glucose (mmol/L) 3.92 ± 0.65  6.01 ± 1.13‡ 
Lactate (mmol/L) 0.99 ± 0.38 10.48 ± 2.77‡ 
Non-esterified fatty acids (mmol/L) 0.08 ± 0.04 0.26 ± 0.14‡ 
Glycerol (μmol/L) 16.85 ± 6.23 196.83 ± 29.82‡ 
Insulin (μIU/ml) 71.98 ± 94.03  56.53 ± 45.92 
Values are means  SD; ‡p < 0.001 vs. pre-training 
Muscle Levels of Glycogen, ATP, PCr and Cr Before and After the AM Exercise Session 
Table 3.4 summarises the muscle levels of glycogen, ATP, PCr and CR before and 
after the PM exercise session.  Compared to baseline, muscle glycogen content decreased 
significantly (p<0.001), in both CHO and P group (Figure 3.9).  Muscle PCr content were also 
significantly lower after than before exercise in both CHO (p<0.01) and P groups (p<0.05).  
 Pre Exercise Post Exercise 
Glycogen (mmol.kg-1.dw) 357.43 ± 115.68  288.24 ± 82.02Ɨ 
ATP (mmol.kg-1 dw 18.78 ± 4.86 18.39 ± 3.73 
PCr (mmol.kg-1 dw) 60.15 ± 17.73 60.16 ± 11.30 
Cr (mmol.kg-1.dw) 35.96 ± 10.37 43.07 ± 13.10 
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Compared to baseline, there was no significant change in muscle levels of ATP or Cr in CHO 
or P after the exercise session.  
Blood Parameters Before and After the PM Exercise Session 
Table 3.4 summarises the measured blood parameters before and after the PM 
exercise session.  Compared to baseline, blood levels of glucose, lactate, NEFA and glycerol 
were significantly decreased following the exercise session.  Plasma insulin was lower 
(p<0.05) in P than CHO before the exercise session, and did not change relative to baseline 
in either condition after exercise.   
 
 
 
 
 
 
 
 
 
 
Figure 3.9 Glycogen levels before and after the AM exercise session and 
before and after the PM exercise session in the placebo and 
CHO group 
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Table 3.4 Muscle levels of glycogen, ATP, PCr and Cr before and after the PM exercise session 
 
 
 
 
 
 
Values are means   SD; *p < 0.05 vs. pre-training; †p < 0.01 vs. pre-training; ‡p < 0.001 vs. pre-training 
 
  
 Group  
 Placebo (n=9)  CHO (n=9) 
 Pre Exercise Post Exercise  Pre Exercise Post Exercise 
Glycogen (mmol.kg-1.dw) 309.76 ± 43.73 212.26 ± 50.66‡  374.27 ± 92.36 257.37 ± 110.28‡ 
ATP (mmol.kg-1.dw 19.51 ± 3.67 20.58 ± 3.45  18.55 ± 2.43 18.23 ± 2.53 
PCr (mmol.kg-1.dw) 67.89 ± 8.48 52.49 ± 17.78*  68.47 ± 7.24 48.70 ± 18.90Ɨ 
Cr (mmol.kg-1.dw) 38.76 ± 6.55 50.77 ± 14.37  41.16 ± 9.45 53.40 ± 16.29 
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Table 3.5 Pre and post exercise blood data before and after PM exercise 
 Group   
 Placebo (n=9)  CHO (n=9) 
 Pre Exercise Post Exercise  Pre Exercise Post Exercise 
Glucose (mmol/L) 4.33 ± 0.33 5.33 ± 1.29*  3.71 ± 0.57 5.35 ± 1.08‡ 
Lactate (mmol/L) 0.96 ± 0.46 8.38 ± 2.70‡  1.37 ± 0.23 11.72 ± 3.32‡ 
Non-esterified fatty acids (mmol/L) 0.40 ± 0.18 0.75 ± 0.21‡  0.07 ± 0.04 0.36 ± 0.14‡ 
Glycerol (μmol/L) 42.81 ± 17.05 221.07 ± 55.92‡  17.12 ± 6.62 208.08 ± 43.75‡ 
Insulin (μIU/ml) 32.26 ± 18.26 a 26.68 ± 18.19  85.86 ± 102.80 63.56 ± 41.04 
Values are means   SD; *p < 0.05 vs. pre-training; ‡p < 0.001 vs. pre-training; a p < 0.05 vs. CHO 
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Muscle Signalling Proteins  
Tables 3.5 and 3.6 summarise the muscle signalling proteins levels before and after 
the AM and PM exercise session respectively.  Maximal activity of ACCβ at baseline and 
after the AM and PM exercise sessions is illustrated in figures 3.10.  Compared to baseline, 
phosphorylation and maximal activity of ACCβ increased significantly (p<0.001) after the 
first exercise bout.  Following the PM exercise session, there was also a significant increase 
(p<0.001) in ACCβ activity in CHO and P compared to baseline.   
 
 
 
 
 
 
 
 
 
Figure 3.10 Maximal activity of Acetyl-CoA carboxylase β 
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Maximal activity of AMPK and P38MAPK after the AM and PM exercise sessions are 
illustrated in figures 3.11 and 3.12.  There was no effect on either the AM or PM combined 
ER and HIIE session on total or phosphorylated AMPK or p38MAPK  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.11 Maximal activity of Activated monophosphate protein kinase (AMPK) 
Figure 3.12 Maximal activity of p38 Mitogen activated protein kinase 
(p38AMPK) 
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Table 3.6 Signalling proteins before and after AM exercise 
 
 
 
 
 
 
 
Values are means   SD; *p < 0.05 vs. pre-training; ‡p < 0.001 vs. pre-training 
 Pre  Exercise Post  Exercise 
Phospho AMPK (A.U.) 0.71± 0.41 0.61 ± 0.38 
Total AMPK (A.U.) 1.06 ± 0.54 1.11 ± 0.60 
Phospho/Total AMPK 0.69 ± 0.37 0.71 ± 0.51 
Phospho ACCβ (A.U.) 0.46 ± 0.43 1.23 ± 1.48* 
Total ACCβ (A.U.) 1.12 ± 1.28 1.12 ± 1.96 
Phospho/Total ACCβ (A.U.) 0.59 ± 0.72 1.83 ± 0.95‡ 
Phospho  MAPK (A.U.) 3.81 ± 2.90 3.42 ± 2.18 
Total MAPK (A.U.) 1.62 ± 0.63 1.41 ± 0.51 
Phospho/Total MAPK(A.U.) 2.43 ± 1.74 2.53 ± 1.77 
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Table 3.7 Signalling proteins before and after PM exercise 
 Group   
 Placebo (n=9)  CHO (n=9) 
 Pre Exercise Post Exercise  Pre Exercise Post Exercise 
Phospho AMPK (A.U.) 0.48 ± 0.22 0.64 ± 0.04  0.39 ± 0.22 0.63 ± 0.38 
Total AMPK (A.U.) 0.71 ± 0.32 1.03 ± 0.71  0.50 ±  0.30 0.67 ± 0.42 
Phospho/Total AMPK (A.U.) 
Phospho  ACCβ (A.U.) 
0.71 ± 0.37 
0.12 ± 0.08 
0.71 ± 0.34 
0.66 ± 0.62Ɨ 
 0.94 ± 0.61 
0.12 ± 0.12 
0.98 ± 0.43 
0.55 ± 0.49‡ 
Total ACCβ (A.U.) 0.48 ± 0.41 0.63 ± 0.99  0.30 ± 0.24 0.35 ± 0.48 
Phospho/Total ACCβ (A.U.) 0.32 ± 0.13 1.74 ± 1.17‡  0.49 ± 0.32 2.65 ± 1.34Ɨ 
Phospho  MAPK (A.U.) 3.26 ±2.40 2.88 ± 2.68  2.36 ± 1.13 3.18 ± 2.16 
Total MAPK (A.U.) 1.22 ± 0.29 1.36 ± 0.51  1.22 ± 0.29 1.36 ± 0.51 
Phospho/Total MAPK (A.U.) 2.85 ± 2.32 2.21 ± 1.92  2.61 ± 1.29 2.84 ± 1.85 
Values are means   SD; †p < 0.01 vs. pre-training; ‡ p < 0.001 vs. pre-training 
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Summary 
After the AM exercise session, ACCβ was the only signalling molecule to increase.  
There was no effect of the exercise session on AMPK or p38MAPK.  Although muscle 
glycogen was significantly decreased after the AM exercise session, the depletion rate was 
low.  In the PM exercise session CHO had no effect on signalling pathways and ACCβ was 
again up-regulated in both groups.  Muscle glycogen decrease significantly in both groups.  
Performance time was significantly faster in the CHO than the P group during the first set of 
HIIR during the PM exercise session.  Although performance time was faster in the CHO than 
the P during set 2 and set 3 it did not reach statistical significance (p<0.08) 
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Chapter 4  
              STUDY 2 
Introduction 
It is well established that ET induces numerous physiological and metabolic 
adaptations that improve submaximal endurance capacity 32,215.  Although this type of 
training offers significant training adaptations it requires a large time commitment.  Recent 
studies have shown that brief repeated sessions of maximal capacity HIIT induces changes 
in skeletal muscle energy metabolism that resemble endurance type training 12,13,23.  A study 
by Gibala et al., (2006) 22 found that 6 sessions of HIIT over 2 weeks, totaling approximately 
15 min of maximal cycling increases the maximal activity of mitochondrial enzymes and 
improves performance during tasks that rely heavily on aerobic energy provision.   
PGC-1α is a nuclear transcriptional co-activator that regulates several important 
metabolic processes, including mitochondrial biogenesis 137,171.  This transcriptional co-
activator has the ability to act as an energy sensor for the cell, exerting its effects through 
interactions with transcription factors bound to specific DNA elements in the promoter 
region of genes, translating changes in metabolism into alterations in gene expression.  PGC-
1α co-activates a number of transcription factors, such as NRF-1, NRF-2 and ERRα, that lead 
to the transcriptional activation of mitochondrial Tfam and a number of nuclear-encoded 
respiratory proteins (Figure 4.1).  Tfam directs both replication and transcription of the 
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mitochondrial genome which encodes fundamental respiratory proteins such as COX IV.  
Subunits comprising the ETC complexes (complex 1-V) are encoded by both nuclear and 
mitochondrial genome and therefore serve as markers of the co-ordinated expression of 
nuclear and mitochondrial gene transcription by PGC-1α. 
 
 
 
 
 
 
 
 
Transcription factors, such as NRF-1, NRF-2 and ERRα, which stimulate the transcriptional activation of 
mitochondrial Tfam and a number of nuclear-encoded respiratory proteins which induce mitochondrial 
biogenesis.  Peroxisome proliferator-activated receptor γ co-activator α, PGC-1α;NRF1 and 2, nuclear receptor 
factor 1 and 2; ERRα estrogen related receptor; mitochondrial transcription factor A 
Recent HIIT studies have found a significant relation between increases in both 
AMPK and p38MAPK activities and increases in PGC-1α mRNA and skeletal muscle oxidative 
capacity.  An increase in CS protein content 74, β-HAD maximal activity  11 and COX subunits 
of II and IV 74 was indicative of the enhanced oxidative capacity of the muscle.  This 
demonstrates the role PGC-1α plays in enhancing mitochondrial biogenesis after HIIT 11,12,23.  
Figure 4.1 PGC-1α co-activation of transcription factors in skeletal muscle 
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With the exception of Bartlett et al., (2012) 84 Serpiello et al.,(2011) 85 and Morton et 
al, (2009) 24 all other studies on HIIT have involved cycle exercise.  Bartlett and Morton used 
similar HIIR protocols (5 x 3 min at 90%   O2max separated by 3 min of active recovery 
between 25-50%   O2max) to determine the activation of mitochondrial biogenesis through 
p38MAPK and AMPK signalling pathways 84.  Serpiello et al.,(2011) 85 is the only study to 
date to demonstrated both the acute and chronic effects of sprint training on the molecular 
signalling pathways associated with mitochondrial biogenesis.  
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Study Aim  
 To compare the physiological and metabolic responses of two weeks of HIIR or ER 
and the subsequent effects on endurance exercise performance. 
Study Objectives 
1. To compare changes in p38MAPK, AMPK, PGC-1α, Tfam protein content, the 
enzymatic activity of CS and β-HAD and the protein content of oxidative enzymes, 
complex I-V, in skeletal muscle before and after 6 sessions of either HIIR and ER 
2. To compare resting muscle glycogen concentration before and after 6 sessions of 
either ER and HIIR 
3. To compare the physiological and metabolic responses in response to 6 sessions of 
ER and HIR training 
4. To compare the effect of 6 sessions of either ER and HIIR on endurance exercise 
performance   
Study Hypothesis  
1. There will be a similar increase in p38 MAPK, AMPK, PGC-1α, Tfam protein content, 
the enzymatic activity of CS and β-HAD and the protein content of oxidative 
enzymes, complex I-IV in the ER and HIIR groups after 6 exercise sessions. 
2. Resting muscle glycogen concentration will have increased to a similar extent in the 
HIIR and ER groups after 6 exercise sessions 
3.    O2 max will not increase in either the HIIR or ER group after 2 weeks of training.  
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4. There will be a greater performance enhancement in the HIIR group in comparison 
to the ER group after 6 sessions of training  
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Methods 
Subjects 
Fourteen club level Gaelic footballers (mean ± SD; age 21.71 ± 2.28 yr; BMI 24.25  ± 
1.25 kg.m2;   O2max 55.14 ± 4.90 ml·min
-1.kg-1) participated in the study.  Participants were 
fully informed of the experimental procedures and possible discomforts associated with the 
study before giving their written informed consent to participate.  The study was approved 
by the Ethics Committee at Dublin City University (DCUREC 148).  
Overview of Study Design 
Participants were randomly assigned to either an ER or a HIIR group. The study 
design is outlined in figure 4.2 and involved either 6 HIIR or ER sessions over a 2 week 
period.  The experimental procedure consisted of baseline testing, 2 weeks of HIIR or ER, 
and post-training measurements.  A muscle biopsy and blood sample was taken before and 
after the training period.  Participants were instructed to continue their normal dietary 
practices throughout the study but refrain from alcohol and caffeine 24 h prior to each 
laboratory visit.   
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Biopsy
Blood sample
0 h 
(8 am)
24 h 
(8 am)
28 h 
(12 pm)
Match
31.5-32 h   
(3 - 4 pm)
56 h  
(3 – 4 pm)
Controlled or uncontrolled  Diet
Controlled or uncontrolled  Diet
 
Baseline testing 
Participants made 3 separate visits to the Human Performance Laboratory at DCU.  
Each visit was separated by 24 h.  The first visit was used to assess anthropometric 
characteristics and measure maximal aerobic capacity (  O2max).  During the second visit 
participants performed an endurance run to exhaustion at 110% v  O2 max.  A resting needle 
muscle biopsy sample and a blood sample were taken during the final screening visit. The 
post-training muscle biopsy was taken 48 h after the last exercise session with additional 
post training measurements taken after a further 48 h.   
Figure 4.2 Study 2 Research design 
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Anthropometrics-  
(As described in the methods section of chapter 3) 
Maximal Aerobic Capacity Assessment/Lactate Threshold 
Maximal aerobic capacity was determined on a treadmill (Woodway ELG 55, 
Waukesha, WI) using a ramp protocol.  At baseline and at the end of each 3 min stage a 5 L 
blood sample was taken from the earlobe to determine whole blood lactate concentration. 
Subjects warmed-up at 8 km·h-1 for 3 min at 1% gradient.  Following the warm-up, the speed 
was increased by 1 km·h-1 every 3 min until blood lactate concentrations reached 4.0 
mmol·L-1.  Treadmill velocity was then kept constant and the gradient increased by 1% every 
60 s until the subject reached volitional fatigue.  Heart rate and RPE were recorded during 
the final 10 s of each exercise min.  
Performance Test 
 Participants warmed up for 5 min on a treadmill (Woodway ELG 55, Waukesha, WI) 
at 50% of their calculated v  O2 speed.  The speed was then increased to 110% of their 
calculated v  O2  speed and participants ran until volitional fatigue.  
Training Program  
Participants commenced the training protocol 48 h following the final baseline 
screening visit.  Training involved 3 sessions of HIIR or ER per week for 2 weeks.  Endurance 
training consisted of 50 min of continuous treadmill running at a velocity corresponding to 
75%   O2max.  Before and after each ET session a 5 L blood sample was taken from the 
earlobe to determine whole blood lactate concentration. The HIIT protocol involved 3 sets 
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of high intensity running interspersed with short recovery periods (Figure 4.3).  Each interval 
run was 110 m and involved forward and backward sprints over distances ranging from 10-
20 m.  A set consisted of 3 x 110 runs with a 20 s recovery period between each run, and a 5 
min recovery period between sets.  At the end of each run a 5 L blood sample was taken 
from the earlobe to determine whole blood lactate concentration.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Post-training measurements 
Approximately 48 h following the last training session, a resting muscle biopsy was 
obtained from the same leg as used for the first biopsy, separated by 2-3 cm from the 
original incision site. A blood sample was also obtained.  Subjects also performed the same 
pre-training tests after the training protocol, starting with the muscle biopsy,   O2 test and 
performance test (figure 4.2).  
Figure 4.3 High intensity interval running (HIIR) protocol 
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Cardiorespiratory and Metabolic Measures  
(As described in the methods section of chapter 3). 
Mass Flow Sensor Heated Wire Anemometer-Mode of Operation  
As described in the methods section of chapter 3. 
Mass Flow Sensor Calibration  
As described in the methods section of chapter 3. 
Gas Analysers  
As described in the methods section of chapter 3. 
Calibration of CO2 and O2 Analysers  
As described in the methods section of chapter 3. 
Ratings of Perceived Exertion  
As described in the methods section of chapter 3. 
Lactate Measurements 
Blood samples were drawn from the earlobe.  Prior to each sample, the ear lobe was 
wiped with alcohol and allowed to dry thoroughly.  The base of the ear lobe was jabbed with 
a lancet (Accu-Chek Softclix, UK) and the first drop of blood was wiped away.  Pressure was 
placed on ear lobe with the thumb and forefinger in order to provide an appropriate 
sample.  A 5 L sample of whole blood was automatically aspirated into a single use, 
enzyme-coated electrode test strip (Lactate Pro Akray, Japan).  The reagent strip fills by 
capillary action directly from the earlobe site.   
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Blood samples were analysed using and a hand-held portable analyser (Lactate Pro 
Akray, Japan).  The measuring range is 0.8–23 mM.  Lactate in the sample reacts with 
potassium ferricyanide and lactate oxidase to form potassium ferrocyanide and pyruvate.  
Upon the application of a given voltage, ferrocyanide is oxidised, releasing electrons and 
creating a current. This current is measured amperometrically and is directly proportional to 
the lactate concentration of the blood sample.  The result is displayed after 60 s.  The 
Lactate Pro is supplied with a check strip and a calibration strip that provide a non-
quantitative indication of instrument accuracy. 
Muscle Biopsy 
As described in the methods section of chapter 3. 
Muscle enzyme activity 
Two pieces of frozen wet muscle (10–15 mg) was removed from each of the first 
biopsy samples under liquid nitrogen for western blotting and for the spectrophotometric 
determination of mitochondrial CS and β-HAD,, maximal activities (37 °C), as described 
elsewhere 211,216.  An aliquot of each muscle enzyme homogenate (citrate synthase and β-
HAD) was then extracted with 0.5 mol·L–1 perchloric acid (HClO4), containing 1 mmol·L
–1 
EDTA, and neutralized with 2.2 mol·L–1 KHCO3.  The supernatant from the extracts was used 
for the enzymatic spectrophotometric determination of total creatine 211.  Enzyme 
measurements were normalized to the highest total creatine content measured from all 
biopsies from each subject.  
Muscle metabolites and glycogen 
As described in the methods section of chapter 3. 
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Muscle calculations 
As described in the methods section of chapter 3. 
Western Blots Analysis 
Muscle Homogenization: Frozen muscle samples (30 mg) were added to ice-cold lysis 
buffer (50 mM Tris-HCl, 1mM EDTA, 1 mM EGTA, 50mM NaF, 1% Triton X-100, 10 mM 
sodium β-glycerol phosphate, 5 mM sodium pyrophosphate, 2 mM DTT, 1mM PMSF, 0.004% 
protease inhibitor cocktail (Sigma Aldrich, Oakville, ON), and 1mM Na orthovanadate).  
Samples were homogenized by machine for 1 min using a FastPrep-24 Instrument (MP 
Biomedicals, Solon, OH), samples were then centrifuged at 1500 x g for 15 min at 4°C, and 
the supernatant was obtained.  Protein concentration of the homogenate was determined 
using a BCA assay.  Muscle homogenate was solubilized in 4 x Laemmli's buffer, boiled (95°C, 
5 minutes), resolved by SDS-PAGE, and wet-transferred to polyvinylidene difluoride 
membranes [1–1.5 hour, 100 V].  The membranes were blocked for 1 h and then incubated 
overnight at 4°C with commercially available primary antibodies to measure, AMPKα 
(1:1000), and p38MAPK (1:1000), (Cell Signaling technology, Danvers, MA), PGC-1α (1:1000),  
(Calbiochem, La Jolla, CA, USA), Tfam (1:200), (Santa Cruz Biotechnology, Santa Cruz, CA, 
USA) and complex I-IV (1:1000), (MitoProfile Human Total OXPHOS Human WB Antibody 
Cocktail,  Mitosciences, USA).  Secondary antibodies were purchased from Cell Signaling 
technology, except for those used for Tfam, which were supplied by Santa Cruz.  Dilutions 
for secondary antibodies were as follows: AMPKα (1:2000), and p38MAPK (1:2000), PGC-1α 
(1:1000), Tfam (1:1000) and complex I-IV (1:1000). 
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After incubation with appropriate secondary antibody for 1 h, the immune 
complexes were detected using the enhanced chemiluminescence method (Western 
Lightning Plus-ECL; PerkinElmer, Waltham, MA), and quantified with densitometry (Gene 
Tools software, PerkinElmer).  Equal loading was confirmed using alpha tubulin (Cell 
Signaling technology, Danvers, MA). 
Blood Measurements 
Venous whole blood was collected in 4 ml vacutainers.  The supernatant was stored 
at –20 °C and analyzed for glycerol 211 and non-esterified fatty acids (NEFA) (Randox, UK) 
with a colorimetric assay and insulin with a magnetic bead panel (Millipore, Cork, Ireland). 
Statistical Analysis 
SPSS 19 for Windows statistical software was used to perform the statistical analysis.  
The Kolmogorov-Smirnov test and the Levene’s test were used to asses for normality and 
homogeneity of variance, respectively.  Since both tests were significant a paired sample 
Wilcoxon sign tank test was used to compare within groups, and a Mann Whitney test was 
used to compare between groups.  Statistical significance will be accepted at the P < 0.05 
level of confidence. 
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Results 
Maximal Aerobic Capacity 
Table 4.1 summarises the physiological responses at maximal exercise in the HIIR 
and ER group before and after training. There was no difference in oxygen uptake, minute 
ventilation, RPE, or maximal heart rate at maximal exercise in the HIIR or ER group prior to 
training.  There was no significant change in   2max in either group in response to training.  
Compared to pre-training, maximal minute ventilation was higher (p< 0.05) in the HIIR group 
after training.  Maximal heart rate after training was significantly lower than pre training. 
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Table 4.1 Physiological responses at maximal exercise in the HIIR and ER group before and after training 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are means   SD; *p < 0.05 vs. pre-training 
 Group 
 HIIT (n=7)  ET (n=7) 
 Pre Training Post Training  Pre Training Post Training 
Age (yr) 21 -  22 - 
Height (cm) 177.11 -  174.82 - 
Weight (kg) 74.81 ± 7.88 74.91 ± 7.41  75.14 ± 6.82 75.26 ± 6.64 
  O2max (ml
.kg1.min1) 51.48 ± 4.55 55.37 ± 4.34*  51.27 ± 1.88 54.05 ± 4.50 
  O2max (L
.min1) 4.03 ± 0.45 4.33 ± 0.50  3.77 ± 0.46 3.98 0.48 
Maximal ventilation (L.min1) 97.54 ± 18.32 113.21 ± 16.13*  99.5 ± 17.33 105 ± 20.62 
RER 1.11 ± 0.08 1.10 ± 0.08  1.10 ± 0.06 1.07 ± 0.07 
Maximal heart rate (bpm) 184.24 ± 12.93 189.12 ± 9.62  200.4 ± 12.53 188.8 ± 10.51* 
RPE 19.00 ± 1.41 19.71 ± 0.49  19.29 ± 0.76 20.00 ± 0.00 
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Performance Test 
There was no difference between groups in time to exhaustion at v  2 max at 
baseline.  Time to exhaustion at v  2 max was increased in both the HIIR (p< 0.05) and ER 
group (p< 0.01) in response to training (Figure 4.4). 
 
 
 
 
 
 
 
 
*p< 0.05 vs. pre-exercise; ‡p < 0.001 vs. pre-exercise 
 
 
 
 
 
 
 
Figure 4.4  Performance increase (min) before and after training in the high   
intensity interval running (HIIR) and endurance running (ER) group 
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Blood Lactate Levels During HIIR and ER Training Sessions 
Preliminary analysis using a one-way repeated measures ANOVA, compared baseline 
blood lactate levels in the ER group prior to each session and at the end of each of the 6 
training sessions.  There was no significant difference in blood lactate levels before or 
immediately following any of the 6 training sessions.  Similarly there was no difference in 
baseline blood lactate levels or blood lactate levels following set 1, 2 and 3 during any of the 
6 training sessions in the HIIR group.  Baseline and post exercise blood lactate levels in the 
ER group were therefore averaged during each training session and compared using a paired 
sample t-test.  A significant difference was then observed between baseline and each set.  
Muscle Metabolites 
Resting muscle glycogen, PCr, and ATP content was similar in both groups prior to 
training (table 4.2).  Compared to pre-training, resting muscle glycogen content increased 
significantly after training in the HIIR group, only.  There was also a decrease in resting ATP 
(p<0.05) and an increase in PCr (p<0.05) content in the HIIR group after training.  
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Table 4.2 Muscle levels of glycogen, ATP, PCr and Cr in the HIIR and ER groups before and after exercise training 
 
 
 
 
 
 
 
Values are means   SD; *p < 0.05 vs. pre-training 
 Group 
 HIIT (n=7)  ET (n=7) 
 Pre Training Post Training  Pre Training Post Training 
Glycogen (mmol.kg-1.dw) 426.71 ± 120.62  575.42 ± 142.13*  426.34 ± 63.63 444.76 ± 97.53 
ATP (mmol.kg-1.dw) 24 ± 2 21.62 ± 1.52*  24.24 ± 3.74 22.47 ± 1.65 
PCr (mmol.kg-1.dw ) 79.62 ± 4.83 80.45 ± 4.64*  79.63 ± 4.34 77.36 ± 4.44 
Cr (mmol.kg-1.dw ) 38.57 ± 4.23 38.32 ± 3.93  39.22 ± 3.72 41.64 ± 4.93 
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Muscle Signalling Proteins 
Compared to baseline there was a significant increase in AMPK protein content 
(p<0.05) in the HIIR group (table 4.3) (Figure 4.5).  There was no significant difference in 
p38MAPK before or after training in groups (Figure 4.6).  
PCC-1α, ETC Complex Subunits and Tfam Protein  
There was no difference in pre-training levels of either complex PGC-1α or any of the 
subunits of the ETC complexes in the ER or HIIR group.  Complex I, II, III, IV, V and PGC-1α 
protein were significantly increased (p<0.05) following 6 sessions of HIIR training.  In 
contrast, ER training significantly increased complex V and PGC-1α (p< 0.05) only (table 4.3).  
There was no significant difference in Tfam in either group. The total level of each protein is 
illustrated in figure, 4.7- 4.13. 
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Table 4.3 Signalling and transcription proteins 
 Group 
 HIIT (n=7)  ET (n=7) 
 Pre Training Post Training  Pre Training Post Training 
AMPK (A.U) 737.3 ± 149.41  797 ± 162*  716.67 ± 176.18 879.28 ± 188.74 
MAPK (A.U.) 81.72 ± 17.31 89.23 ± 13.91  81.65 ± 16.42 82.23 ± 8.85 
Tfam (A.U.) 466.75 ± 148.27 546.45 ± 205.27  571.79 ± 165.12 662.69 ± 264.32 
Complex I (A.U.) 336.68 ± 92.77 486.56 ± 194.72*  429.33 ± 127.78 496.81 ± 164.72 
Complex II (A.U.) 371.41 ± 243.24 488.67 ± 273.09*  451.36 ± 158 555.09 ±287.81 
Complex III (A.U.) 246.74 ±125.32 293.1 ± 113.45*  243.08 ± 86.48 311.2 ±104.37 
Complex IV (A.U.) 850.63 ± 428.91 966.65 ± 474.92*  1089.85 ± 412.11 1172.285 ± 414.02 
Complex V (A.U.) 505.29 ± 131.28 572 ± 141.17*  472.25 ± 149.31 563.68 ± 166.78* 
PGC-1α (A.U.) 150 ± 29.69  182.74 ± 34.16*  123.45 ± 19.13 181.47 ± 47.23* 
Values are means   SD; *p < 0.05 vs. pre-training 
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Figure 4.5 Total adenosine monophosphate kinase (AMPK) pre and post training in 
the HIIR and ER group. *p < 0.05 vs. pre-exercise 
 
Figure 4.6 p38 mitogen activated protein kinase (p38MAPK) pre and post training in 
the HIIR and ER group 
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Figure 4.7 Peroxisome proliferator activated receptor γ co-activator 1-α (PGC-1α) 
pre and post training in the HIIR and ER group. *p < 0.05 vs. pre-
exercise 
Figure 4.8 Transcription factor A (Tfam) pre and post training in the HIIR and ER 
group 
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Figure 4.9 Complex I subunit pre and post training in the HIIR and ER group.  
     *p < 0.05 vs. pre-exercise 
Figure 4.10 Complex II subunit pre and post training in the HIIR and ER group.  
        *p < 0.05 vs.  pre-exercise 
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Figure 4.11 Complex III subunit pre and post training in the HIIR and ER group.  
       *p < 0.05 vs.  pre-exercise 
 
Figure 4.12 Complex IV subunit pre and post training in the HIIR and ER group.  
        *p < 0.05 vs.  pre-exercise 
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Figure 4.13 Complex V subunit pre and post training in the HIIR and ER group 
        *p < 0.05 vs.  pre-exercise 
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Skeletal Muscle Mitochondrial Enzymes 
There was no difference in the activity of CS or β-HAD in the HIIR or ER group before 
training.   The activity of CS and β-HAD were significant higher (p< 0.05) than baseline in the 
HIIT and ET groups respectively following the 6 training sessions.  (Figure 4.14-4.15).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14 Citrate synthase (CS) maximal activity pre and post training in the HIIR and ER 
group. *p < 0.05 vs.  pre-exercise 
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Figure 4.15 3 hydroylacyl-CoA dehydrogenase (β-HAD) maximal activity pre and post 
training in the HIIR and ER group. *p < 0.05 vs.  pre-exercise 
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Summary 
There was a significant increase in resting glycogen levels and AMPK protein levels in 
the HIIR group only, after training.  There was a significant increase in subunits of complex I-
V of the ETC in the HIIR group after training, whereas, there was only an increase in the 
subunit of complex V in the ER group after training.  There was no increase in Tfam in either 
group after training. PGC-1α was significantly elevated in both groups after training.  
Endurance performance also improved in both the HIIR and ER groups after training.  
Training also induced a significant increase in the activity of CS and β-HAD in the HIIR and ER 
groups respectively.  
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Chapter 5  
           Discussion 
Overview 
There is a growing body of evidence to indicate that HIIT has the potential to 
stimulate skeletal muscle remodeling similar to that associated with ET.  Contraction 
induced signal transduction pathways involved in the initiation of skeletal muscle 
mitochondrial biogenesis are activated after a single bout of high intensity exercise.  
Previous studies have found that as little as 6 sessions of maximal high intensity cycling, 
totaling 15 min of exercise, increases the maximal activity of mitochondrial enzymes and 
improves submaximal endurance exercise performance.  Other adaptations elicited by HIIT 
and ET include an increase in muscle content of mitochondrial proteins associated and 
alterations in substrate utilization at the same absolute workload.   
Considering that the majority of previous HIIT studies involved untrained individuals, 
it is perhaps not surprising that there were significant alterations in mitochondrial protein 
content and function.  The present series of studies examined whether acute and chronic 
exercise of sufficient stimulus would illicit similar alterations in signalling responses and 
subsequent mitochondrial biogenesis in trained individuals involved in Gaelic football, an 
invasive team based field sport.  The acute session of HIIR was not found to be sufficient to 
increase the phosphorylation of either AMPK or p38MAPK, although a downstream marker 
of AMPK activation, ACCβ was increased in response to HIIR, suggesting the possibility of a 
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transient increase in AMPK signalling.  Six sessions of HIIR over a two week period did 
however, induce a more pronounced increase in mitochondrial biogenesis compared to six 
sessions of ER.  
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Study 1 
It was hypothesized that a single bout of HIIR would activate specific signalling 
pathways that regulate gene expression and RNA translation, a key response in early 
training adaptations to HIIE57.  AMPK is a key energy sensing enzyme that is activated in 
skeletal muscle during exercise.  It promotes energy production to ensure cellular 
homeostasis.  Activation of AMPK may be related to relative work intensity, with higher 
workloads related to more pronounced changes in AMPK phosphorylation 88, 217.   
A number of recent studies found an enhanced activation of AMPK in response to an 
acute bout of HII cycling 23,25,82. Exercise induced phosphorylation of AMPK, a marker of 
AMPK’s activity is well documented in skeletal muscle following HIIE 13,23,25.  In the present 
study there was no increase in AMPK phosphorylation in response to an acute bout of HIIR.  
An increase in AMP concentration activates AMPK 57.  Since repeated high intensity sprints 
induce rapid changes in energy turnover and therefore alter the ATP to AMP ratio, it was 
expected that AMPK activation would significantly increase after the bout of HIIR.  In 
separate studies muscle ATP levels were found to decrease following 4 Wingate tests 
interspersed with 4 min recovery periods and after a single 30 s maximal cycle bout  82,218.  
Skeletal muscle content of ATP did not significantly change in response to the high intensity 
interval running session used in the present study, despite the fact that blood lactate levels 
ranged from 11-14 mmol.L.   
To date, only two studies have found an increase in AMPK phosphorylation following 
an acute bout of HIIR 84,85.  Bartlette et al., (2012) 84 had participants perform 6 x 3 min 
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bouts of HIIR at 90%   2max for a total of 18 min of high intensity activity.  In contrast, only 
2.5 min of HIIR was undertaken in the present study.  It is possible therefore, that a 
minimum duration of HIIR may be required to induce a significant increase in AMPK 
activation.  Serpiello et al., (2011) 85 examined AMPK activation 1 h following 3 sets of 5 x 4 s 
sprint runs in recreationally active men.  From the published data it is difficult to determine 
whether AMPK activity was statistically increased after exercise, but an effect size, which 
the author deemed to be moderate was reported.  Furthermore, the change in AMPK was 
found 1 h after the bout of HII running.  This finding contradicts other studies that have 
found an increase in AMPK immediately after exercise, with a decreased response within 3 h 
of recovery 23.   
The fitness characteristics of the participants may also help to explain the absence of 
an increase in AMPK activity after the acute bout of HIIR in the present study.  AMPK is 
attenuated in trained muscle compared to untrained at the same relative exercise intensity, 
but is still significantly elevated above basal levels 117,219.  An increase in skeletal muscle 
mitochondrial density allows trained individuals to attain the same cellular rate of 
mitochondrial oxidative phosphorylation with a lower rate per mitochondrion for any 
absolute workload 30.  ATP and PCr decrease to a smaller degree and free ADP 
concentrations increase to a lesser extent in cells with elevated mitochondrial contents at 
the same absolute workload. Better preservation of free ADP lowers the rate of AMP 
formation and therefore decreases AMPK activation and that of its upstream activators.  
However, in endurance trained men, cycling for 20 min at 80%   2peak been shown to 
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increase AMPK phosphorylation despite PCr and ADP concentrations and the AMP/ATP ratio 
being unchanged 79. 
A unique feature of the present investigation is the fact that the participants were 
trained Gaelic football players.  Gaelic football is one of the most popular sports in Ireland 
and can be described as a hybrid of soccer, rugby and basketball.  It involves single or 
repeated bouts of activity involving high running velocities and muscle power.  It is possible, 
that the capacity of the muscle to sense energy changes in Gaelic football players is 
therefore more sensitive to that of endurance trained athletes allowing the AMPK response 
to returned to baseline before the muscle biopsy was taken.   
ACCβ enzyme is considered a sensitive indicator of skeletal muscle AMPK activity in 
vivo 82.  Recent HIIT studies have found a large increase in ACCβ phosphorylation coinciding 
with an increase in AMPK phosphorylation in both running and cycling 23,85.  The fact that 
the phosphorylation of the downstream enzyme ACCβ increased 3 fold above resting values 
following the combined ER and HIIR session suggests that there may have been a transient 
activation of AMPK.  Muscle glycogen is also a regulator of AMPK activity 208.  In the present 
study muscle glycogen content decreased by 69 mmol-1.kg-1.ww.  Pilegaard et al., (2001)  
suggests that there is a threshold of glycogen depletion between 100-478 mmol-1.kg-1.ww 
Several exercise studies have found AMPK activity increased when glycogen content was 
decreased by ≥ 100 mmol-1.kg-1.ww 23–25.  It is therefore possible that the decrease in muscle 
glycogen levels did not meet the required threshold to enhance AMPK activation.  
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P38MAPK is a stress activated protein kinase that couples cellular disturbances to 
various adaptive and maladaptive responses in skeletal muscle 108.  The activation of 
p38MAPK in skeletal muscle is to some extent dependant on the nature of exercise 3 and/or 
training status 217.  A number of studies have found an enhanced activation of p38MAPK 
after an acute bout of HII exercise 13,23,25.  Exercise induced activation of p38MAPK may be 
mediated by the energetic status of the cell.  Similar to the activation of AMPK after HIIT, 
p38MAPK is also activated in response to an acute bout of HII cycling and lower intensity but 
higher volume running 23,84.  There was no activation of p38MAPK following the acute bout 
of combined ER and HII running in the present study, which is consistent with the study 
undertaken by Serpiello et al., (2011) 85 that involved  3 sets of 5 x 4 s sprint runs in 
recreationally active men.   
In the second part of this study it was hypothesized that compared to feeding a meal 
low in CHO, feeding a high dose of CHO would blunt the activation of signalling pathways 
involved in skeletal muscle mitochondrial biogenesis.  There was no significant effect of 
altering CHO feeding during recovery on subsequent exercise induced phosphorylation of 
AMPK or p38MAPK.   
CHO feeding during recovery had no effect on muscle glycogen levels or AMPK 
activity.  AMPK consists of a glycogen binding domain that is allosterically inhibited when 
bound to glycogen.  Previous studies have found that exercise increases AMPK activity when 
glycogen levels are significantly reduced 79.  In the present it was expected that feeding a 
large dose of CHO during the recovery period would enhance glycogen stores compared to 
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the placebo group prior to the PM exercise bout.  This increase in glycogen content was 
expected to reduce AMPK activity.  However, there was no significant difference in muscle 
glycogen levels between the CHO and placebo group after feeding.   There was also a similar 
decrease (32%) in glycogen content in both groups after exercise.  In a recent study Coffey 
et al., (2011) 220 found that feeding a CHO-whey supplement had no effect on AMPK activity 
following 10 x 6 sprint cycle exercises in healthy men .  
Phosphocreatine (PCr) is also a known activator of AMPK 19 and therefore changes in 
these levels must also be considered when interpreting the lack of AMPK phosphorylation 
observed after exercise.  Phosphocreatine is a high energy compound made up of the amino 
acid creatine linked to phosphate by a high energy anhydride bond.  The PCr concentration 
in resting muscle is 75-85 mmol.kg dm, which is five to six times greater than ATP 221.  The 
energy released from the breakdown of PCr is coupled to the synthesis of ATP in a reversible 
reaction catalyzed by creatine kinase; PCr + ADP + H+  ATP + Cr.  The forward reaction is 
favoured during muscle contraction.  PCr levels are directly related to power output and the 
intense nature of sprint running rapidly depletes these levels in order to maintain ATP 
concentrations.  The ability to resynthesis PCr depends on the trained state of the muscle, 
with trained individual replenishing PCr at a faster rate that untrained individuals and 
therefore maintaining a greater power output for longer during exercise.  It is presumed 
that the participants in this study were sprint trained from an early age and therefore have a 
greater ability to replenish PCr levels.  Therefore, the decrease in PCr levels observed after 
the PM exercise session suggests that the muscle was on the cusp of energetic stress.  The 
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addition of another run would have placed further stress on the exercising muscle, 
decreasing PCr levels further and perhaps activating the AMPK signalling pathway. 
Studies have also found that nuclear p38MAPK is phosphorylated in the presence of 
reduced intramuscular glycogen 222.  It has been speculated that AMPK may be an upstream 
activator of p38MAPK 223.  A high muscle glycogen content may reduce AMPK 
phosphorylation and in turn the activation of p38MAPK.  However, a recent study found a 
significant increase in p38MAPK phosphorylation after exercise in the fasted compared to 
the CHO fed condition despite a similar level of glycogen depletion in both groups 25.  It is 
possible therefore, that activation of p38MAPK is more sensitive to CHO feeding than 
glycogen concentration.  The effect of the low CHO meal on blood glucose levels must be 
considered in the present study.  Feeding the low CHO meal (50g) to the placebo group 
could have increased blood glucose levels, preventing a reduced signalling response.  
However, insulin levels were significantly different between CHO and P, and FFA and 
glycerol were significantly higher in the P than CHO.  This suggests that the low CHO meal 
did not have a significant impact on blood glucose levels.   
It is surprising that feeding 1.2g CHO.kg-1.h-1 for 2 h did not result in a measurable 
increase in glycogen resynthesis between exercise sessions.  This is in contrast to studies 
that have fed 1.0-1.4g CHO.kg-1.h-1 post exercise and found glycogen resynthesis rates of 25-
45 mmol.kg-1 dry wet-1.h-1 during recovery 224,225.  In contrast to the present study, these 
studies performed glycogen depleting exercise protocols before CHO feeding.  It is well 
established that glycogen resynthesis rates are inversely related to pre-feeding glycogen 
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levels.  High muscle glycogen content levels prior to feeding can decrease the activity of 
glycogen synthase 226.  It is reasonable to speculate that the glycogen levels in the present 
study which remained high after the AM exercise session may have prevented and/or 
slowed the rate of glycogen resynthesis during the recovery period.  The reduced glycogen 
resynthesis is consistent with a recent study involving HII cycling 25.  
ACCβ plays a role in fatty acid oxidation and is considered a sensitive indicator of 
skeletal muscle AMPK activity in vivo 82.  The 5 fold increase in ACCβ in both groups was not 
expected.  ACCβ catalyses the reaction that converts acetyl-CoA to malonly-CoA.  Insulin and 
glucose stimulate an increase in ACCβ resulting in an accumulation of malonyl-CoA, which 
inhibits CATT-1.  CAT-I is a major rate limiting step for the transport of LCFA into the 
mitochondria and is very sensitive to changes in malonyl-CoA concentrations.  In fasted 
mice, ACCβ is inactivated which causes a decrease in malonyl-CoA concentration and an 
increase in β-oxidation.  After re-feeding an increase in malonyl-CoA levels and a decrease in 
β-oxidation was observed in the rats 227.  Therefore, in the present study it was expected 
that ACCβ phosphorylation would be reduced in the placebo group, facilitating FFA 
oxidation. 
Performance time was significantly faster in the CHO than the placebo group during 
the first set of HIIE and the difference almost reached statistical significance (p<0.08) when 
intergroup comparison were made during the second and third set.  It is easy to conclude 
that feeding CHO during the recovery period enhanced HIIR performance, but both muscle 
glycogen and glucose were similar in both groups after exercise.  
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 Study 2 
Skeletal muscle oxidative phenotype in response to HIIT and ET is regulated by PGC-
1α, a transcriptional co-activator that serves to coordinate mitochondrial biogenesis.  
Several signalling pathways have been linked to exercise induced activation of PGC-1α, 
including AMPK and p38MAPK.  Recent acute HIIT studies have found an increase in AMPK 
phosphorylation which promotes the expression of genes encoding mitochondrial and 
metabolic proteins 13,23,84,85.  P38MAPK also phosphorylates a variety of substrates including 
transcription factors and co-activators localised in the cytoplasm or nucleus, and is 
therefore implicated in the regulation of gene transcription 23,25,84. 
In the present study, there was a significant increase in AMPK protein content after 
HIIR.  However, an increase in protein content may not signify an increase in AMPK activity, 
which would indicate a training induced up-regulation of the pathway.  It is interesting to 
note that in study 1, AMPK and p38MAPK were not activated by an acute bout of high 
intensity exercise, yet mitochondrial biogenesis was more evident in the HIIR group than the 
ER group.  It is possible that pathways other than those measured may have been activated 
in response to HIIT which subsequently induced an increased expression of metabolic 
proteins.  Due to the observed increase in the enzymatic activity of ACCβ it may also be that 
AMPK signalling pathways were increased but the antibody used to detect its activity lacked 
sensitivity 
Numerous studies have found an increase in PGC-1α protein content after 4-6 weeks 
of HIIT training (Burgomaster, Howarth, & Gibala, 2008; Serpiello et al., 2011).  This study is 
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the first to find a significant increase in PGC-1α protein after 6 sessions of both HIIR and ER.  
A recent study found an increase in the abundance of nuclear PGC-1α protein, but failed to 
find any change in total protein content suggesting that the total amount of protein may not 
be affected by acute or chronic exercise 13,188.  It has been assumed that an increase in PGC-
1α protein expression mediates the increase in mitochondrial biogenesis.  However, the 
evidence is equivocal regarding the time course of this adaptive process.  Accumulating 
evidence suggests that PGC-1α’s subcellular localisation from the cytosol to the nucleus 
could allow for its activation and subsequent mitochondrial biogenesis, without the need for 
an increase in total protein content 13,122,188.  In contrast, Perry et al, (2010) 15 found an 
increase in PGC-1α protein content 24 h after a single high intensity interval cycle session.  
In this study 10 untrained men participated in 10 x 4 min HII cycle at 90%   2max.  The 
levels of PGC-1α protein content continued to increase and plateaued between the 4th and 
7th training session.   
Each of the ETC complexes (I-IV) are comprised of multiple subunits.  For example, 
complex IV is made up of 13 subunits, three of which are encoded by mtDNA.   The HIIR 
program in the present study resulted in an increase in protein content of specific subunits 
of complex I (NADH:ubiquinone oxidoreductase/NADH dehydrogenase), II (succinate 
dehydrogenase complex); III ((cytochrome bc1 complex), IV (cytochrome c oxidase (COX)) 
and complex V (ATP Synthase).  Complex I, III and IV of the ETC serve to transfer electrons to 
a series of carriers of increasing redox potential resulting in an electrochemical gradient 
across the inner membrane.  Complex V is comprised of an ATPase coupled to an inner 
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membrane protein channel.  It couples the proton pumping to ATP hydrolysis.  The increase 
in protein abundance of ETC subunits in response to 2 weeks of HIIR indicated that this 
mode of training is appropriate for enhancing the capacity for electron flux through the ETC.  
The increase in the ATP synthase subunit also indicates a greater capacity for ADP 
phosphorylation.  Complex II transfers electrons from FADH2 to ubiquinone.  However, 
unlike complex I, III and IV this complex is not coupled to the pumping of H+ into the 
intermembrane space.  Previous studies have also found an increase in subunits of complex 
II, III, IV and V of the ETC after HIIR 13,15,22,25. 
An increase in COX maximal activity and ETC complex subunits are well known to 
increase after endurance training and are commonly used as a representative marker of 
mitochondrial biogenesis  13,18.  In a recent study, 2 weeks of HIIR was found to increase 
maximal COX activity with a concomitant increase in the protein content of COX II and COX 
IV subunits 13.  The subunits of complex I (NDUA8), complex III (UQCRC2) and complex IV 
(COXII) are mitochondrial encoded 228 (Figure 5.1).   
PGC-1α-dependent regulation of the expression of each of these subunits is likely to 
be mediated by Tfam.  Tfam induces the expression of mtDNA that encodes fundamental 
respiratory proteins 18,136.  PGC-1α has been shown to influence the transcriptional activity 
of Tfam through NRF activation 18.  It is surprising that Tfam did not increase after HIIR, since 
there was a significant increase in protein content of subunits of complex, I, III and IV and 
PGC-1α protein.  Although, there is evidence that an increase in mtDNA with no further 
change in Tfam may indicate that the existing Tfam is sufficient to induce mitochondrial 
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biogenesis 15,136.  It is also possible that the level of Tfam which is imported from the cytosol 
to the mitochondria was increased to induce the mitochondrial biogenesis observed after 
HIIR sessions.  This could not be measured with the Bergstrom muscle biopsy technique.  
 
 
 
 
 
 
*Proteins in blue are up regulated by both HIIT and ET. Those in red are up-regulated by HIIT only.  
The subunits of complex II (SDHB), complex V (ATP5A) are nuclear encoded 229 
(Figure 5.1).  PGC-1α-dependent regulation of the expression of each of these subunits is 
likely to be mediated by co-activation of NRF-1, by virtue of the presence of an NRF-1 and -2 
binding site on each of the promoter regions of the genes that regulate the transcription of 
complex II and complex V subunits 229.  In contrast, the subunit in complex V was the only 
ETC protein that was significantly up-regulated following 6 sessions of ER.  This finding 
suggests that only nuclear encoded mitochondrial proteins are up-regulated after 6 sessions 
of ET.  However, Gibala et al., (2006) 22 found an increase in COX subunits II and IV after 6 HII 
and endurance cycle sessions.  
Figure 5.1 Schematic of protein subunits upregulated in complexes of the electron 
transport chain after high intensity exercise and endurance exercise* 
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In addition to the increase in skeletal muscle oxidative respiratory markers in 
response to exercise, there was also significant alterations in both CHO and fat metabolism 
in response to 2 weeks of HIIR and ER.  Previous HIIR studies have consistently found an 
increase in mitochondrial enzymes 11–13,15.  CS catalyses the condensation of 2 molecules of 
acetyl CoA and 1 molecule of oxaloacetate to form citrate, and is a key regulatory enzyme in 
the TCA cycle.  It is a common marker of muscle oxidative potential as it exists in constant 
proportion with other mitochondrial enzymes 230.  Interestingly, CS was increased in the HIIR 
group only in the present study.  
There was no increase in β-HAD activity after HIIR.  This is consistent with findings of 
Burgomaster et al., (2005) 12 in which untrained men participated in 6 HIIR sessions over a 2 
week period.  In contrast, 7 bouts of HIIR over a 2 week period resulted in a significant 
increase in the maximal activity of β-HAD and the protein content of the plasma membrane 
associated fatty acid binding protein (FABPm) 231.  The total training time commitment was 
30 times greater (5 h) than the protocol used in the Burgomaster et al. (2005) 12 study (10 
min).  In another study, Burgomaster et al.,. (2008) 11 found a significant increase in β-HAD 
following 6 week HIIR and ER.  These findings indicate that an increase in maximal activity of 
β-HAD requires a minimal volume of intense, interval based exercise training.  Resting 
muscle glycogen was significantly increased in the HIIT only.  This is consistent with previous 
studies that have found an increase in glycogen content after 14 days of sprint training 
12,232,233.  
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Aerobic endurance performance increased by 34% and 21% in HIIR and ER 
respectively, after training.  Numerous studies 12,22 have also found an increase in endurance 
performance without an increase in   2 max in response to 2 weeks of HIIT.  The potential 
mechanism(s) responsible for the improved performance in endurance running capacity in 
the HIIR is likely to be related to improvement in respiratory control during exercise as 
evident by a significant increase in CS activity.  There was no increase in CS in the ER group.  
Although substrate utilization was not measured in the current study it is possible that the 
increase in endurance performance in the ER group may be related to the changes in β-HAD 
activity.  In addition to changes in the activity of key regulatory enzymes involved in CHO 
and fat metabolism, other potential mediators of the change in endurance performance 
may include an increase in skeletal muscle blood flow 234, lactate transport capacity 235, ionic 
regulation and sarcoplasmic recticulum function 236. 
Conclusion 
In summary this study found that in trained Gaelic football players an acute bout of 
HIIR does not activate AMPK or p38MAPK signalling cascades.  Although, the significant 
increase in ACCβ phosphorylation, which was evident in both groups may indirectly indicate 
an increase in AMPK signalling.  The lack of response may be associated with the trained 
state of the participants whose daily/weekly training sessions involve numerous bouts of 
HIIR.  This could sensitize the muscle to energy changes allowing the signalling responses to 
return to normal before the muscle biopsy was taken.  The intensity and duration of the HIIR 
session also needs to be considered.  The intensity of each session was assessed using blood 
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lactate measurements which reached between 11-14 mmol.L after each HIIR set.  It is 
therefore likely that the short duration of the HIIE session may also have contributed to the 
lack of signalling response found after exercise.  The decrease in PCr found after the PM 
exercise session certainly suggests that another HIIR may have induced the activation of 
signalling pathways.  It is difficult to interpret whether CHO feeding had any effect on the 
signalling pathways without initial activation in the AM exercise session. It may be assumed 
that CHO feeding had no affect on the AMPK signalling pathways as ACCβ phosphorylation 
was not affected by CHO consumption.  The enhanced performance found in the CHO group 
during the first set of the PM exercise session should be interpreted with caution as both, 
muscle glycogen and blood glucose levels were similar in both groups after exercise.  
The lack of signalling may also be related to an individual’s adaptability which is 
driven by genotypic variation within a relatively small cluster of genes.  Timmons et al.,237 
recently discovered an underlying genetic link to an individual’s adaptability for a complex 
and multifactorial physiological trait (aerobic capacity).  However, moderately trained Gaelic 
games players are a relatively homogenetic cohort, with similar height, weight and 
endurance capacity.  Gaelic games players are also trained from a young age and this 
conditioning may play a role in epigenetics, inducing a similar genetic make-up and reducing 
the variability in exercise adaptations.  
Despite the lack of signalling after an acute bout of HIIR in the first study, 6 sessions 
of HIIR coincided with an increase in several classical markers of mitochondrial biogenesis.  
This increase in both nuclear and mitochondrial gene transcription is clearly due to the 
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cumulative effect of multiple exercise sessions.  The ER training protocol also induced 
mitochondrial biogenesis signified by an increase in PGC-1α protein content.  However, the 
only other markers of mitochondrial biogenesis upregulated were those encoded by nuclear 
genome such as the subunit of complex V of the ETC.  The increase in activity of β-HAD also 
links PGC-1α to an enhanced expression of nuclear proteins.  
An increase in mitochondrial protein expression occurs following repeated training 
which induces an increase in mRNA expression of selected gene 5,44,134.  It is suggested that 
repeated burst of mRNA expression are fundamental to the intracellular adaptive response 
to exercise training. . Perry et al.,(2010) 15 found a 10 fold increase in PGC-1α mRNA, a 53% 
increase in Tfam mRNA and a 50% increase in PPARβ/δ mRNA 4 h after a HIIE session.  An 
increase in CS and β-HAD 4 and 24 h after the HIIE session was also found.  Furthermore, 
exercise is also suggested to alter the methylation of certain genes in a dose responsive 
manner, enhancing gene expression 238.  The inclusion of multiple biopsies at more than one 
time point after the PM exercise session, allowing us to measure mRNA and/or DNA 
methylation would have allowed for a greater understanding of whether mitochondrial 
biogenesis was initiated by HIIR.  This would help to explain the adaptive increases in 
protein expression found after HIIR training in the second study. 
Interestingly, although HIIR induced a greater increase in mitochondrial biogenesis 
compared to 6 session of ER, this did not translate into a more enhanced increase in 
endurance performance.  
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In conclusion HIIR is a more sufficient stimulus that ER to induced mitochondrial 
biogenesis in moderately trained Gaelic games players.  
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Future Directions 
1. To compare the effects of HIIT on team sports athletes, endurance athletes and 
untrained individuals 
2. Examine whether there is a threshold of HIIR needed to activate signalling pathways 
involved in mitochondrial biogenesis  
3. Compare the effect of training duration (2, 4 and 6 weeks) on mitochondrial 
biogenesis  
4. To examine the effect of HIIT on mitochondrial biogenesis in sedentary, moderately 
trained and highly trained women 
5. Examine the effect of HIIT of transcription proteins such as NRF-1 and 2, ERRα, MEF2  
6. Evaluate  the changes in substrate utilisation after 2, 4 and 6 weeks of HIIT 
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Appendix A 
Study 1 
 
 
 
Dublin City University 
RESEARCH ETHICS COMMITTEE 
 
APPLICATION FOR APPROVAL OF A PROJECT INVOLVING HUMAN 
PARTICIPANTS 
 
Application No. (office use only)  DCUREC/2008/   
 
Period of Approval (office use only) ....../....../...... to
 ....../....../.... 
 
This application form is to be used by researchers seeking ethics approval for individual projects and 
studies. The signed original and an electronic copy of your completed application must be 
submitted to the DCU Research Ethics Committee.   
 
NB - The hard copy must be signed by the PI.  The electronic copy should consist of one file only, 
which incorporates all supplementary documentation.  The completed application must be 
proofread and spellchecked before submission to the REC.  All sections of the application form 
should be completed.  Applications which do not adhere to these requirements will not be 
accepted for review and will be returned directly to the applicant. 
 
Applications must be completed on the form; answers in the form of attachments will not be 
accepted, except where indicated.  No handwritten applications will be accepted.  Research must 
not commence until written approval has been received from the Research Ethics Committee. 
 
 
PROJECT TITLE Effect of nutrients on skeletal muscle signalling pathways in response to 
high intensity interval training. 
 
PRINCIPAL 
INVESTIGATOR(S) 
Prof. Niall Moyna 
 
 
Please confirm that all supplementary information is included in your application (in both signed 
original and electronic copy). If questionnaire or interview questions are submitted in draft form, a 
copy of the final documentation must be submitted for final approval when available. 
 
 INCLUDED NOT 
APPLICABLE 
Bibliography    
Recruitment advertisement    
Plain language statement/Information Statement    
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Informed Consent form    
Evidence of external approvals related to the research    
Questionnaire  
draft 
 
final 
 
Interview Schedule  
draft 
 
final 
 
Debriefing material     
Other    
 
Please note: 
 
1. Any amendments to the original approved proposal must receive prior REC approval. 
 
2. As a condition of approval investigators are required to document and report immediately 
to the Secretary of the Research Ethics Committee any adverse events, any issues which 
might negatively impact on the conduct of the research and/or any complaint from a 
participant relating to their participation in the study 
 
 
Please submit the signed original, plus the electronic copy of your completed application to:  
Ms. Fiona Brennan, Research Officer, Office of the Vice-President for Research  
(fiona.brennan@dcu.ie, Ph. 01-7007816) 
 
 
Guidelines to Applicants 
 
1.1 PRINCIPAL INVESTIGATOR(S):  The named Principal Investigator is the person with primary 
responsibility for the research project. Doctoral researchers and Research Masters or their 
supervisors may be listed as Principal Investigators, depending on the conventions of the discipline 
and on the individual case. It should be made clear, in subsequent sections of this application, who is 
carrying out the research procedures. In the case of Taught Masters and undergraduate student 
projects the supervisors are Principal Investigators. 
 
2.0 PROJECT OUTLINE:  Provide a brief outline of the project, aims, methods, duration, funding, 
profile of participants and proposed interaction with them. This description must be in everyday 
language that is free from jargon.  Please explain any technical terms or discipline-specific phrases.  
 
2.1 LAY DESCRIPTION:  Provide a brief outline of the project, including what participants will be 
required to do.  This description must be in everyday language which is free from jargon.  Please 
explain any technical terms or discipline-specific phrases. (No more than 300 words). 
 
2.2 AIMS OF AND JUSTIFICATION FOR THE RESEARCH:  State the aims and significance of the project 
(approx. 400 words). Where relevant, state the specific hypothesis to be tested. Also please provide a 
brief description of current research, a justification as to why this research should proceed and an 
explanation of any expected benefits to the community. NB – all references cited should be listed in 
an attached bibliography. 
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2.3 PROPOSED METHOD:  Provide an outline of the proposed method, including details of data 
collection techniques, tasks participants will be asked to do, the estimated time commitment 
involved, and how data will be analysed. If the project includes any procedure which is beyond 
already established and accepted techniques please include a description of it.  (No more than 400 
words.) 
 
2.4 PARTICIPANT PROFILE:  Provide number, age range and source of participants.  Please provide a 
justification of your proposed sample size.  Please provide a justification for selecting a specific 
gender. 
 
2.5 MEANS BY WHICH PARTICIPANTS ARE TO BE RECRUITED:  Please provide specific details as to 
how you will be recruiting participants. How will people be told you are doing this research? How will 
they be approached and asked if they are willing to participate? If you are mailing to or phoning 
people, please explain how you have obtained their names and contact details. This information will 
need to be included in the plain language statement. If a recruitment advertisement is to be used, 
please ensure you attach a copy to this application. 
 
3.3 POTENTIAL RISKS TO PARTICIPANTS AND RISK MANAGEMENT PROCEDURES:  Identify, as far as 
possible, all potential risks to participants (physical, psychological, social, legal or economic etc.), 
associated with the proposed research. Please explain what risk management procedures will be put 
in place. 
 
3.6 ADVERSE/UNEXPECTED OUTCOMES:  Please describe what measures you have in place in the 
event that there are any unexpected outcomes or adverse effects to participants arising from 
involvement in the project. 
 
3.7 MONITORING:  Please explain how you propose to monitor the conduct of the project (especially 
where several people are involved in recruiting or interviewing, administering procedures) to ensure 
that it conforms with the procedures set out in this application.  In the case of student projects please 
give details of how the supervisor(s) will monitor the conduct of the project. 
 
3.8 SUPPORT FOR PARTICIPANTS:  Depending on risks to participants you may need to consider 
having additional support for participants during/after the study.  Consider whether your project 
would require additional support, e.g., external counselling available to participants.  Please advise 
what support will be available. 
 
4.0 INVESTIGATORS’ QUALIFICATIONS, EXPERIENCE AND SKILLS:  List the academic qualifications 
and outline the experience and skills relevant to this project that the researchers and any supporting 
staff have in carrying out the research and in dealing with any emergencies, unexpected outcomes, 
or contingencies that may arise. 
 
5.2 HOW WILL THE ANONYMITY OF THE PARTICIPANTS BE RESPECTED?  Please bear in mind that 
where the sample size is very small, it may be impossible to guarantee anonymity/confidentiality of 
participant identity.  Participants involved in such projects need to be advised of this limitation. 
 
5.3 LEGAL LIMITATIONS TO DATA CONFIDENTIALITY:  Participants need to be aware that 
confidentiality of information provided can only be protected within the limitations of the law - i.e., it 
is possible for data to be subject to subpoena, freedom of information claim or mandated reporting 
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by some professions. Depending on the research proposal you may need to specifically state these 
limitations.   
 
6.0 DATA/SAMPLE STORAGE, SECURITY AND DISPOSAL: For the purpose of this section, “Data” 
includes that in a raw or processed state (e.g. interview audiotape, transcript or analysis).  “Samples” 
include body fluids or tissue samples. 
 
8.0 PLAIN LANGUAGE STATEMENT:  Written information in plain language that you will be providing 
to participants, outlining the phases and nature of their involvement in the project and inviting their 
participation.  Please note that the language used must reflect the participant age group and 
corresponding comprehension level. 
 
9.0 INFORMED CONSENT FORM:  This is a very important document that should be addressed by 
participants to researchers, requiring participants to indicate their consent to specific statements, 
and give their signature. 
 
FOR FURTHER INFORMATION AND NOTES ON THE DEVELOPMENT OF PLAIN LANGUAGE 
STATEMENTS AND INFORMED CONSENT FORMS, PLEASE CONSULT THE DCU REC WEBSITE: 
WWW.DCU.IE/RESEARCH/ETHICS 
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1. ADMINISTRATIVE DETAILS 
 
THIS PROJECT IS:  Research Project  Funded Consultancy 
(tick as many as 
apply) 
 Practical Class  Clinical Trial 
  Student Research Project  
(please give details) 
 Other  - Please Describe:       
  Research
Masters 
 Taught Masters 
  PhD  Undergraduate 
 
Project Start 
Date: 
June 2011 Project End 
date: 
May 2012 
 
1.1 INVESTIGATOR CONTACT DETAILS  
 
PRINCIPAL INVESTIGATOR(S):  
TITLE SURNAME FIRST NAME PHONE FAX EMAIL 
Prof Moyna Niall 7008802 7008888 niall.moyna@dcu.ie 
 
OTHER INVESTIGATORS:  
TITLE SURNAME FIRST NAME PHONE FAX EMAIL 
Dr. McCaffrey Noel 0872797597 7008888 noel.mccaffrey@dcu.ie 
Dr. Susta Davide  7008888 davide.susta@dcu.ie 
Ms Tobin Crionna 0860705130 7008888 crionna.tobin9@mail.dcu.ie  
 
FACULTY/DEPARTMENT/SCHOOL/ CENTRE: School of Health and Human Performance 
1.2 WILL THE RESEARCH BE UNDERTAKEN ON-SITE AT DUBLIN CITY UNIVERSITY? 
 YES  NO  
1.3 IS THIS PROTOCOL BEING SUBMITTED TO ANOTHER ETHICS COMMITTEE, OR HAS IT BEEN 
PREVIOUSLY SUBMITTED TO AN ETHICS COMMITTEE?) 
 YES  NO  
 
DECLARATION BY INVESTIGATORS 
The information contained herein is, to the best of my knowledge and belief, accurate.  I have read 
the University’s current research ethics guidelines, and accept responsibility for the conduct of the 
procedures set out in the attached application in accordance with the guidelines, the University’s 
policy on Conflict of Interest and any other condition laid down by the Dublin City University Research 
Ethics Committee or its Sub-Committees.  I have attempted to identify all risks related to the research 
that may arise in conducting this research and acknowledge my obligations and the rights of the 
participants. 
 
If there any affiliation or financial interest for researcher(s) in this research or its outcomes or any 
other circumstances which might represent a perceived, potential or actual conflict of interest this 
should be declared in accordance with Dublin City University policy on Conflicts of Interest.  
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I and my co-investigators or supporting staff have the appropriate qualifications, experience and 
facilities to conduct the research set out in the attached application and to deal with any 
emergencies and contingencies related to the research that may arise. 
Signature(s): 
 
Principal investigator(s):    
 
Print name(s) in block letters: Niall Moyna 
 
Date:      14/4/2011 
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2. PROJECT OUTLINE  
2.1 LAY DESCRIPTION 
 
Carbohydrate (CHO) is an important fuel source for skeletal muscle during exercise. Athletes 
are generally advised to ingest a daily diet that is moderate to high in carbohydrate to meet 
the energy demands of training (1;2). However, recent evidence has suggested however that 
periodic restriction of carbohydrate before exercise can increase training induced gains in 
skeletal muscle metabolism and performance (3;4).  
  
Changes in skeletal muscle metabolism in response to training are thought to be the result of 
the cumulative effects of transient changes in gene activation in response to each exercise 
bout (5).  Acute exercise activates several signaling cascades in muscle which, in turn, 
stimulate transcription of mitochondrial and metabolic genes to initiate the changes in 
skeletal muscle metabolism.  AMP activated protein kinase (AMPK) and p38 mitogen-
activated protein kinase (p38) have been implicated as potential mediators of this process.  
Both AMPK and P38 have been shown to activate peroxisome proliferator-activated receptor 
γ coactivator-α (PGC-1α), the master regulator of mitochondrial gene expression (6;7).  
Interestingly, the exercise-induced increase in AMPK activity  and p38 phosphorylation are 
augmented when pre-exercise muscle glycogen content is reduced (8, 9). Thus, restricting 
CHO intake could augment AMPK and p38 activation and subsequently increase the 
mitochondrial response to training via an increase in PGC-1α activation. Since the restriction 
of nutrients after exercise is unrealistic in the real world setting we propose that feeding a 
whey based solution with minimal amounts of carbohydrate will induce similar benefits in 
muscle metabolism and performance as restricting CHO.  
2.2 AIMS OF AND JUSTIFICATION FOR THE RESEARCH  
Aims of the Research: 
To compare the effect of feeding a whey based solution, a carbohydrate based solution or an 
isocaloric placebo based solution during recovery on the skeletal muscle metabolic 
responses after high intensity interval training. 
 Justification: 
Restricting the intake of carbohydrate before exercise training has recently been shown to 
result in larger improvements in skeletal muscle metabolism compared to training with 
repleted CHO stores (3.4).  Previous studies (3,4) have found a greater increase in the activity 
of metabolic enzymes; citrate synthase (CS) HAD, cytochrome oxidase IV (COXIV) and whole 
body fat oxidation in response to 3 weeks of training while restricting CHO intake compared 
to a non CHO restriction protocol.  The frequency and volume of training were equal in both 
groups.  However, since the restricted groups trained 2 times/day while the non-restricted 
trained once per day it was not possible to determine if the greater metabolic adaptations in 
response to CHO restriction resulted from the fact that the subjects undertook multiple daily 
exercise sessions or the CHO restriction per se.  To answer this question, Morton et al., (10) 
had 2 groups of endurance trained men perform 6 weeks of high intensity intermittent 
running on 2 d/week.  Group 1 consumed a 6.4% glucose solution and group 2 consumed a 
placebo solution immediately before every second training session.  In addition group 1 and 
group 2 consumed 3ml/kg CHO solution or placebo respectively during the active recovery 
periods.  There was a training-induced increase in muscle oxidative capacity in the CHO-
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restricted condition only.  In a more recent study (11) 10 subjects performed two exercise 
trials in random order separated by > 1 week.  Each trial consisted of a morning and 
afternoon session (5 x 4 min cycling at 90-95% of heart rate reserve) separated by 3 h of 
recovery during which subjects ingested either a high CHO drink or an isocaloric placebo 
before the afternoon session.  Following the afternoon exercise sessions p38 MAPK 
phosphorylation was higher in the CHO restricted group.  The author concluded that p38 
MAPK is a nutrient sensitive signaling molecule which may alter the skeletal muscle adaptive 
response under CHO-restricted conditions.  While the restriction of CHO before an exercise 
session enhances skeletal muscle oxidative adaptations it is unknown whether feeding a 
whey protein supplement, which is a non-carbohydrate solution immediately after exercise 
would convey similar metabolic and signaling responses to a subsequent bout of exercise. 
  1.  Burke LM (2007) Nutrition strategies for the marathon :fuel for training and racing.  Sports 
Medicine 37: 344-347 
  2.  Hawley JA, Gibala MJ (2007) Innovations in athletic performance: role of substrate availability 
to modify training adaptation and performance.  Journal of Sports Science S 1: S115-S124 
  3.  Hansen AK, Fischer CP (2005) Skeletal muscle adaptation: training twice every second day vs. 
training once daily.  J Appl.Physiol. 93-99 
  4.  Yeo WK, Paton CD (2008) Skeletal muscle adaptation and performance responses to once a day 
verses twice every second day endurance training regimens.  J Appl.Physiol. 1462-1470 
  5.  Joesph AM, Pilegaard H (2006) Control of gene expression and mitochondrial biogenesis in 
muscular adaptation to endurance exercise.  Essays Biochem 13-29 
  6.  Akimoto T, Pohnert SC (2005) Exercise stimulates PGC-1 alpha transcription in skeletal muscle 
through actiavtion of the p38 MAPK pathway.  J Biol.Chem. 19587-19593 
  7.  Jager S, Handschin C (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via 
direct phosphorylation of PGC1-alpha.  Proc Natl Acad Sci USA 12017-12022 
  8.  Wojtaszewski JF, MacDonald C (2003) Regulation of 5'-AMP-activated protein kinase activity 
and substrate utilisation in exercising human skeletal muscle.  J Physiol Endocrinol Metab E813-
E822 
  9.  Chan MH, McGree SL (2004) Altering nutrient intake that reduces glycogen content leads to 
phosphorylation of nuclear p38 MAP kinase in human skeletal muscle: association with IL-6 
gene transcription during contraction.  FASEB J 1785-1787 
  10.  Morton JP, Croft L (2009) Reduced carbohydrate availability does not modulate training-
induced heat shock protein adaptations but does upregulate oxidative enzymes activity in 
human skeletal muscle.  J Appl.Physiol. 1513-1521 
  11.  Cochran AJR, Little PJ (2010) Carbohydrate feeding during recovery alters the skeletal muscle 
metabolic response to repeated sessions of high-intensity interval exercise in humans.  J 
Appl.Physiol. 628-636 
2.3  PROPOSED METHOD 
 STUDY OVERVIEW 
Subjects will make 2 visits to the Human Performance Laboratory in the School of Health and 
Performance at DCU.  The first visit will be used to assess their maximal aerobic capacity 
(VO2max).  During the second visit they will undertake 2 high intensity interval trials (HIIT) 
separated by 4 h.  Prior to this visit they will be randomly assigned to a whey (W), 
carbohydrate (C) or placebo (P) group.  A muscle biopsy will be taken immediately before 
and immediately after the first and second HIIT. 
STUDY VISITS 
Visit 1- This visit will last approximately 1 h, during which subjects will perform an exercise 
test to assess their maximal aerobic capacity.   
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Visit 2 – Subjects will complete 2 HIIT on a treadmill, separated by a recovery period of 4 h.  
Muscle biopsies and blood samples will be taken immediately before and after the first and 
second high HIIT and 3 h after the second HIIT.  
Nutritional Protocol: Prior to visit 2 subjects will be given a standardised breakfast (63% 
CHO, 25% Fat & 12% protein) to ingest prior to arriving at the laboratory.  Following the HIIT, 
group C will ingest 1.2g/kg-1 every hour throughout the recovery period, group W will ingest 
0.25g.kg-1 of protein every hour throughout the recovery period, and group P will ingest an 
isocaloric solution every hour throughout the recovery period. 
High Intensity Interval Trial (HIIT): This will involve two set of 6 x 2 min runs on a treadmill 
at 80-90% VO2max with alternating 2-3 recovery periods.  The recovery period between each 
set will be 4 h.  
 
 
LABORATORY PROCEDURES 
Maximal Aerobic Capacity Assessment: Maximal aerobic capacity will be determined on a 
treadmill (Woodway ELG 55, Waukesha, WI) using a ramp protocol.  The test will be 
performed ≥ 48 h prior to the first HIIT.  Subjects will warm-up at 3.6 mph for 2 min.  
Following the warm-up, the gradient will be increased at a rate of 0.2% every 12 sec until the 
subject reaches volitional exhaustion.  The test will be deemed to be maximal if it satisfies at 
least 3 of the following criteria; levelling of oxygen consumption, volitional exhaustion, RER > 
1.1 and heart rate within ± 10 beats of the age predicted max.  HR will be recorded 
continuously, and blood lactate will be assessed each minute.  
Respiratory Metabolic Measures: Expired oxygen, carbon dioxide, ventilatory volume and 
respiratory exchange ratios (RER) will be determined using a Sensormedics Vmax 229 
metabolic system (SensorMedics Corp., Yorba Linda CA).  Prior to testing, the gas analysers 
will be calibrated with standard gases of known concentration. 
Muscle Biopsy: Rationale for muscle biopsy samples 
Taken from the vastus lateralis using a sterile 5mm diameter biopsy needle under local 
anaesthesia.  
1. Little JP. A practical model of low-volume high-intensity interval training induces 
mitochondrial biogenesis in human skeletal muscle: potential mechanism. J Physiol 588.6: 
1011-1022, 2010 
2. Burgomaster KA. Similar metabolic adaptations during exercise after low volume sprint 
interval and traditional endurance training in humans. J Physiol 586: 151-160, 2008 
3. Burgomaster KA. Effect of short-term sprint interval training on human skeletal muscle 
carbohydrate metabolism during exercise and time-trial performance. J Appl Physiol 100: 
2041-2047, 2006 
Statistical Analysis: 
SPSS for Windows statistical software will be used to perform the statistical analysis.  A 3 x 3 
RM ANOVA will be used to compare and within group differences.  Statistical significance 
will be accepted at the P < 0.05 level of confidence  
2.4 PARTICIPANT PROFILE 
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Inclusion criteria:  Apparently healthy men, currently playing at junior club level or higher 
level, and between the ages of 18 – 35 years.   
Exclusion criteria:  Volunteers will be excluded if they smoke, have diabetes, cardiovascular 
disease or have any other medical conditions that contraindicate exercise participation. 
2.5 MEANS BY WHICH PARTICIPANTS ARE TO BE RECRUITED  
A recruitment advertisement will be emailed to members of the Dublin City University Gaelic 
games club and all Dublin city Gaelic games clubs.  Permission will be sought from each club 
prior to posting the advertisement.  The aim of the study, the rationale for the study, the 
tests involved, the time commitment and the potential benefits will be explained to the 
players.  Players will be provided with an opportunity to ask questions.  If they wish to 
participate in the study they will have to provide a written informed consent, which will be 
witnessed on their visit to the School of Health and Human Performance.   
2.6 PLEASE EXPLAIN WHEN, HOW, WHERE, AND TO WHOM RESULTS WILL BE DISSEMINATED, 
INCLUDING WHETHER PARTICIPANTS WILL BE PROVIDED WITH ANY INFORMATION AS TO 
THE FINDINGS OR OUTCOMES OF THE PROJECT? 
The study findings will be presented at scientific meetings and published in scientific 
journals.  Subjects will be provided with a report, which will summarise the relevant results 
from their participation in the research project.  
2.7 OTHER APPROVALS REQUIRED Has permission to gain access to another location, 
organisation etc. been obtained?  Copies of letters of approval to be provided when 
available.  
 YES  NO  NOT APPLICABLE 
2.8 HAS A SIMILAR PROPOSAL BEEN PREVIOUSLY APPROVED BY THE REC? 
 YES  NO 
 
(If YES, please state both the REC Application Number and Project Title) 
 
3. RISK AND RISK MANAGEMENT 
3.1 ARE THE RISKS TO SUBJECTS AND/OR RESEARCHERS ASSOCIATED WITH YOUR PROJECT 
GREATER THAN THOSE ENCOUNTERED IN EVERYDAY LIFE? 
 
 YES  NO If YES, this proposal will be subject to full REC review 
If NO, this proposal may be processed by expedited 
administrative review 
 
 
3.2         WHAT DOES THE RESEARCH INVOLVE: 
 YES NO 
 Use of a questionnaire? (attach copy)?   
 interviews (attach interview questions)?   
 observation of participants without their knowledge?   
210 
 
 participant observation (provide details in section 2)?   
 audio- or video-taping interviewees or events?   
 access to personal and/or confidential data (including student, patient 
or client data) without the participant’s specific consent? 
  
 administration of any stimuli, tasks, investigations or procedures 
which may be experienced by participants as physically or mentally 
painful, stressful or unpleasant during or after the research process? 
  
 performance of any acts which might diminish the self-esteem of 
participants or cause them to experience embarrassment, regret or 
depression? 
  
 investigation of participants involved in illegal activities?   
 procedures that involve deception of participants?   
 administration of any substance or agent?   
 use of non-treatment of placebo control conditions?   
 collection of body tissues or fluid samples?   
 collection and/or testing of DNA samples?   
 participation in a clinical trial?   
 administration of ionising radiation to participants?   
3.3 POTENTIAL RISKS TO PARTICIPANTS AND RISK MANAGEMENT PROCEDURES (see 
Guidelines) 
The nature and risks involved in the study will be explained prior to starting the study, and a 
contact number will be provided.  
Subjects may experience some muscle soreness in their legs or nausea following the 
maximal exercise test.  Exercise testing carries with it a very small risk of abnormal heart 
rhythms, heart attack, or death in less than one in 30,000 patients.  The pre-test likelihood 
of these risks in asymptomatic men < 55 years of age is very low.  There may be discomfort 
during the muscle biopsy with some pain and delayed soreness afterward.  There is a risk of 
bleeding, bruising, infection and scaring of the skin.  Temporary numbness of the skin near 
the biopsy site may occur.  There may be discomfort when taking blood and the 
development of a small bruise at the site of puncture.   
High intensity may increase the risk for muscle strains and tears.  A 5 min warm-up will 
precede each training session to help reduce the risk of injury.  
3.4 ARE THERE LIKELY TO BE ANY BENEFITS (DIRECT OR INDIRECT) TO PARTICIPANTS FROM 
THIS RESEARCH? 
 
 YES  NO  
3.5 ARE THERE ANY SPECIFIC RISKS TO RESEARCHERS? (e.g. risk of infection or where research is 
undertaken at an off-campus location) 
  
 YES  NO There is a small risk of infection from needle and blood 
samples.  Standard safety procedures will be strictly adhered 
to. 
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3.6 ADVERSE/UNEXPECTED OUTCOMES 
The School of Health and Human Performance has the facilities to deal with all aspects of 
this study and an emergency plan is in place for adverse events.  All minor injuries will be 
addressed by an individual trained in first aid (either a member of the research team or the 
staff).  The laboratory is equipped with an emergency crash cart and defibrillator.  An 
individual trained in first aid (or Advanced Cardiac Life Support) will be present during each 
test.  In the unlikely event of a serious adverse outcome, the subject will be brought to the 
VHI clinic in Airside Retail Park, Swords. 
3.7 MONITORING  
Weekly meetings will take place between Prof. Niall Moyna (principal investigator) and the 
other researchers.  These meetings will provide opportunities to access progress, give 
feedback, and monitor development of the research.  The School of Health and Human 
Performance has a detailed list of Standard Operating Procedures for each of the protocols 
in this study.  All researchers will be familiar with the procedures and the Safety Statement 
before beginning data collection.  
3.8 SUPPORT FOR PARTICIPANTS  
 It is anticipated that no additional support will be required.  
3.9 DO YOU PROPOSE TO OFFER PAYMENTS OR INCENTIVES TO PARTICIPANTS? 
 
 YES  NO (If YES, please provide further details.)      
 
4. INVESTIGATORS’ QUALIFICATIONS, EXPERIENCE AND SKILLS (Approx. 200 words – see 
Guidelines) 
Prof. Moyna is an exercise physiologist and has extensive experience with exercise testing 
Dr. Noel McCaffrey and Dr. Davide Susta are physicians with extensive experience in the 
muscle biopsy technique 
Crionna Tobin is a PhD student in the School of Health and Human Performance.  She has a 
BSc, a Higher Diploma in Human Nutrition and a Higher Diploma in Sports Nutrition.  
 
5. CONFIDENTIALITY/ANONYMITY 
5.1 WILL THE IDENTITY OF THE PARTICIPANTS BE PROTECTED? 
 
 YES  NO (If NO, please explain) 
 
IF YOU ANSWERED YES TO 5.1, PLEASE ANSWER THE FOLLOWING QUESTIONS: 
5.2 HOW WILL THE ANONYMITY OF THE PARTICIPANTS BE RESPECTED?  
Confidentiality is an important issue during data collection.  Participant’s identity, or other 
personal information, will not be revealed or published.  Subjects will be assigned an ID 
number under which all personal information will be stored in a secure file and saved in 
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password protected file in a computer at DCU.  The investigators alone will have access to 
the data. 
5.3 LEGAL LIMITATIONS TO DATA CONFIDENTIALITY: (Have you included appropriate 
information in the plain language statement and consent form?  See Guidelines) 
 
 YES  NO (If NO, please advise how participants will be advised.)  
The following statement should be included in the plain language statement. 
‘Confidentiality of information provided can only be protected within the limitations of the 
law.  It is possible for data to be subject to subpoena, freedom of information claim or 
mandated reporting by some professions. 
6 DATA/SAMPLE STORAGE, SECURITY AND DISPOSAL (see Guidelines) 
6.1 HOW WILL THE DATA/SAMPLES BE STORED? (The REC recommends that all data be stored 
on campus) 
Stored at DCU       
Stored at another site      
6.2 WHO WILL HAVE ACCESS TO DATA/SAMPLES? 
Access by named researchers only     
Access by people other than named researcher(s)   
Other  :      
6.3 IF DATA/SAMPLES ARE TO BE DISPOSED OF, PLEASE EXPLAIN HOW, WHEN AND BY WHOM 
THIS WILL BE DONE? 
The principal investigator will be responsible for security of the collected data.  The data will 
be kept in locked facilities in the department through which the project is being conducted.  
Access to the data will only be attainable by the main researchers.  Data will be kept for a 
minimum of five years from the date of publication of the research.  Aside from the main 
researchers, no others will have access to the raw data. Data will be shredded after five 
years and Prof. Moyna will carry this out.  
 
7. FUNDING 
7.1 HOW IS THIS WORK BEING FUNDED? 
 The Gaelic Athletic Association  
7.2 PROJECT GRANT NUMBER (If relevant and/or known) 
7.3 DOES THE PROJECT REQUIRE APPROVAL BEFORE CONSIDERATION FOR FUNDING BY A 
GRANTING BODY?  
 
 YES  NO  
 
HOW WILL PARTICIPANTS BE INFORMED OF THE SOURCE OF THE FUNDING? 
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In the plain language statement 
 
 
 
 
7.5      DO ANY OF THE RESEARCHERS, SUPERVISORS OR FUNDERS OF THIS PROJECT HAVE A 
PERSONAL,   FINANCIAL OR COMMERCIAL INTEREST IN ITS OUTCOME THAT MIGHT 
COMPROMISE THE INDEPENDENCE AND INTEGRITY OF THE RESEARCH, OR BIAS THE 
CONDUCT OR RESULTS OF THE RESEARCH, OR UNDULY DELAY OR OTHERWISE AFFECT THEIR 
PUBLICATION? 
  
 NO  
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8. PLAIN LANGUAGE STATEMENT  
Plain Language Statement 
Dublin City University 
Project Title: Effect of nutrients on skeletal muscle signalling pathways in response to high 
intensity interval training. 
 
The Research Study will take place in the School for Human Health and Human Performance DCU 
and the DCU Sports Grounds 
The research study is being funded by the Gaelic Athletic Association.   
The principal investigator is: Prof. Niall M. Moyna, (Tel: 7008802 Fax 7008888) EMAIL 
niall.moyna@dcu.ie 
 
1. Carbohydrate is an important fuel source for skeletal muscle during exercise and athletes 
are advised to eat a daily diet that is high to moderate in carbohydrate to meet the energy 
demands of training.  There is now evidence that restricting carbohydrate before exercise 
can increase the fat burning capability of the muscle and improve exercise performance. 
This study will examine whether a protein, a carbohydrate or a flavoured drink will 
influence how muscles adapt high intensity exercise. 
2. You will make 2 visits to the Human Performance Laboratory in DCU.  The first visit to the 
laboratory will last approximately 1 hour, during which you will undertake a treadmill 
exercise test to determine your fitness level.   
3. The second visit will be 6 hours in duration.  You will undertake two high intensity interval 
trials (HIIT) separated by 4 hours.  Each trial will be preceded by a 5 minute warm-up.  You 
will run for 2 min at a high intensity on a treadmill.  This will be repeated 5 more times for 
a total of 6 runs.  You will have a 2-3 min recovery between each run.  You will then take a 
4 hour break and after which you will repeat the 6 high intensity runs.  During the 4 hour 
recovery period you will be fed either; a carbohydrate, protein or flavoured drink every 
hour.  A blood sample and muscle biopsy will be taken immediately before and after the 
first and second HIIT. 
4. Your identity and other personal information will not be revealed, published or used in 
further studies.  You will be assigned an ID number under which all personal information 
will be stored in a secure file and saved in a password protected file in a computer at DCU.  
The principal investigator, and collaborators listed on this ethics application will have 
access to the data.  You need to be aware that confidentiality of information provided can 
only be protected within the limitations of the law.  It is possible for data to be subject to 
subpoena, freedom of information claim or mandated reporting by some professions.  
5. The original documentation will be stored for a maximum of 5 years.  Thereafter the 
documentation will be shredded. 
6. Your participation in this research project is voluntary and you may withdraw your consent 
at any time. 
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If participants have concerns about this study and wish to contact an independent person, please 
contact: 
The Secretary, Dublin City University Research Ethics Committee, c/o Office of the Vice-
President for Research, Dublin City University, Dublin 9.  Tel 01-7008000 
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9. INFORMED CONSENT FORM  
INFORMED CONSENT 
 
Title:  Does feeding a nonenergetic placebo solution induce similar muscle 
signalling responses when compared to a carbohydrate solution after high 
intensity training 
Principal investigator: Prof Niall M. Moyna 
Other investigators:  Ms Crionna Tobin, Dr. Noel McCaffrey, Dr. Davide Susta 
Purpose:  This study will examine whether a carbohydrate solution or an isocaloric 
placebo solution will influence different pathways in the muscle related to 
metabolism after high intensity interval exercise. 
 
Participant Requirements 
1. I will have the purpose of the study, each of the steps involved and the risks of participating 
in the study explained to me.  I will have the opportunity to ask any questions and if I am 
happy with the answers I will provide written informed consent for participation in the 
research project.  I will then complete a medical history form, which will ask questions about 
my general health, personal and family health history, smoking, exercise, and dietary habits. 
I will talk with a medical doctor about the information I have provided and I understand, 
based on the information provided, the medical doctor may exclude me from participating in 
the research project.  If I agree to participate in the study I will make 2 visits to the Human 
Performance Laboratory in DCU. 
2. For the first visit, I will arrive in the morning to the Human Performance Laboratory in DCU 
following my normal breakfast.  I will take part in a fitness test to measure my fitness level.  
This will involve me exercising with a mouthpiece (similar to a snorkel) in my mouth to 
measure the amount of air I breathe in and out. 
3. On my second visit to the Human Performance Laboratory I will take part in two high 
intensity interval trials.  Each trial will be separated by 4 hours during which I will ingest 
either; a protein, carbohydrate or a flavoured drink.  I will have a blood sample and muscle 
biopsy sample taken immediately before and after the first and second high intensity 
interval trial.  The muscle biopsy sample will involve taking a small piece of muscle, about 
the size of a pea from my thigh with a special biopsy needle.  A small area of the leg will be 
injected with a local anesthetic, then a small incision will be made in the skin and a needle 
inserted briefly into the muscle.  The incision will be closed with sterile strip bandaids, and 
my leg will be wrapped snugly with an elastic bandage to maintain pressure. Before I leave I 
will be given supplies to change the dressing around the biopsy sites. 
4. I will not drink alcohol or caffeine, or participate in any type of exercise 24 h before my first 
visit to DCU. 
Sometimes there are side effects from performing exercise tests. These side effects are often 
called risks, and for this project, the risks are: 
1. Exercise testing carries with it a very small risk of exercise induced asthma, abnormal heart 
rhythms, heart attack, or death in less than one in 30,000 patients.  The risk of sudden death 
during exercise for healthy men is 1:15000-18000.  Because I will be asked to give a 
maximum effort, I may experience some muscle soreness in my arms and legs or nausea 
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following the maximal exercise test.  It should be noted that if the experimental protocol is 
adhered to, the likelihood of these risks occurring is minimal. 
 
2. I understand that there may be discomfort during the muscle biopsy with some pain and 
delayed soreness afterward.  There is a risk of bleeding, bruising, infection and scaring of the 
skin.  After the biopsy, my leg may feel stiff and sore.  Temporary numbness of the skin near 
the biopsy may also occur. 
3. High intensity may increase the risk for muscle strains and tears.  A 5 min warm-up will 
precede each training session to help reduce the risk of injury.  
 
There may be benefits from my participation in this study.  These are: 
1. I will receive a copy of my personal results, body fat and fitness measurements  
2. I understand that no other benefits have been promised me. 
Participant – please complete the following (Circle Yes or No for each question) 
I have read the Plain Language Statement     Yes/No 
I understand the information provided      Yes/No 
I have had an opportunity to ask questions and discuss this study   Yes/No 
I have received satisfactory answers to all my questions     Yes/No 
My confidentiality will be guarded: 
Dublin City University will protect all the information about me, and my part in this study, within the 
limitations of the law.  My identity or personal information will not be revealed or published. All 
records associated with my participation in the study will be subject to the usual confidentiality 
standards applicable to medical records.  In addition, the study findings may be presented at 
scientific meetings and published in a scientific journal and/or as part of a postgraduate thesis, but 
my identity will not be divulged and only presented as part of a group.   
If I have questions about the research project, I am free to call Prof Niall Moyna at 01-7008802.   
Taking part in this study is my decision.   
I understand that my participation in this study is voluntary and that I may withdraw my consent at 
any time by notifying any of the investigators.  I may also request that my data and samples be 
removed from the database or storage and destroyed.  My withdrawal from this study, or my refusal 
to participate, will in no way affect my relationship with Dublin City University or my entitlements as 
a student or staff member.  I understand that my participation in this research may be terminated by 
the investigator without regard to my consent if I am unable or unwilling to comply with the 
guidelines and procedures explained to me.  
Signature: 
I have read and understood the information in this form.  My questions and concerns have been 
answered by the researchers, and I have a copy of this consent form.  Therefore, I consent to take 
part in this research project 
Participants Signature:         
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Name in Block Capitals:         
Witness:             
Date:                
 
Email to participants: 
The school of Health and Human Performance is conducting a study to examine whether feeding 
either a protein solution, a carbohydrate solution or a placebo solution will influence different 
pathways in the muscle related to exercise after high intensity exercise. You will make 2 visits to 
the Human Performance Laboratory in DCU.  The first visit will last approximately 1 hour during 
which you will perform an endurance exercise test.  The second visit will be 6 hours in duration, 
during which you will take part in 2 high intensity exercise trials.  Each trial will be separated by 4 
hours during which you will ingest either; a protein, carbohydrate or a flavoured drink.  A blood 
sample and muscle biopsy sample will be taken immediately before and after the first and second 
high intensity interval trial.   
We are looking for healthy men between the ages of 18 – 35 years who are currently playing 
Gaelic football at college or club level.  
If you would like to hear more about this study or would consider participating, please contact 
one of the following; 
Crionna Tobin 
Email: Crionna.tobin9@mail.dcu.ie 
Mobile number: 086-0705130 
 
Thank you, 
 
Niall M. Moyna, PhD  
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Dublin City University 
RESEARCH ETHICS COMMITTEE 
 
APPLICATION FOR APPROVAL OF A PROJECT INVOLVING HUMAN 
PARTICIPANTS 
 
Application No. (office use only)  DCUREC/2008/   
 
Period of Approval (office use only) ....../....../...... to
 ....../....../.... 
 
This application form is to be used by researchers seeking ethics approval for individual projects and 
studies. The signed original and an electronic copy of your completed application must be 
submitted to the DCU Research Ethics Committee.   
 
NB - The hard copy must be signed by the PI.  The electronic copy should consist of one file only, 
which incorporates all supplementary documentation.  The completed application must be 
proofread and spellchecked before submission to the REC.  All sections of the application form 
should be completed.  Applications which do not adhere to these requirements will not be 
accepted for review and will be returned directly to the applicant. 
 
Applications must be completed on the form; answers in the form of attachments will not be 
accepted, except where indicated.  No handwritten applications will be accepted.  Research must 
not commence until written approval has been received from the Research Ethics Committee. 
 
 
PROJECT TITLE Muscle adaptations in response to low volume high intensity interval 
training and endurance training in Gaelic games players 
 
PRINCIPAL 
INVESTIGATOR(S) 
Prof. Niall Moyna 
 
 
Please confirm that all supplementary information is included in your application (in both signed 
original and electronic copy). If questionnaire or interview questions are submitted in draft form, a 
copy of the final documentation must be submitted for final approval when available. 
 
 INCLUDED NOT 
APPLICABLE 
Bibliography    
Recruitment advertisement    
Plain language statement/Information Statement    
Informed Consent form    
Evidence of external approvals related to the research    
Questionnaire  
draft 
 
final 
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Interview Schedule  
draft 
 
final 
 
Debriefing material     
Other    
 
Please note: 
 
3. Any amendments to the original approved proposal must receive prior REC approval. 
 
4. As a condition of approval investigators are required to document and report immediately 
to the Secretary of the Research Ethics Committee any adverse events, any issues which 
might negatively impact on the conduct of the research and/or any complaint from a 
participant relating to their participation in the study 
 
 
Please submit the signed original, plus the electronic copy of your completed application to:  
Ms. Fiona Brennan, Research Officer, Office of the Vice-President for Research  
(fiona.brennan@dcu.ie, Ph. 01-7007816) 
 
 
Guidelines to Applicants 
 
1.1 PRINCIPAL INVESTIGATOR(S):  The named Principal Investigator is the person with primary 
responsibility for the research project. Doctoral researchers and Research Masters or their 
supervisors may be listed as Principal Investigators, depending on the conventions of the discipline 
and on the individual case. It should be made clear, in subsequent sections of this application, who is 
carrying out the research procedures. In the case of Taught Masters and undergraduate student 
projects the supervisors are Principal Investigators. 
 
2.0 PROJECT OUTLINE:  Provide a brief outline of the project, aims, methods, duration, funding, 
profile of participants and proposed interaction with them. This description must be in everyday 
language that is free from jargon.  Please explain any technical terms or discipline-specific phrases.  
 
2.1 LAY DESCRIPTION:  Provide a brief outline of the project, including what participants will be 
required to do.  This description must be in everyday language which is free from jargon.  Please 
explain any technical terms or discipline-specific phrases. (No more than 300 words). 
 
2.2 AIMS OF AND JUSTIFICATION FOR THE RESEARCH:  State the aims and significance of the project 
(approx. 400 words). Where relevant, state the specific hypothesis to be tested. Also please provide a 
brief description of current research, a justification as to why this research should proceed and an 
explanation of any expected benefits to the community. NB – all references cited should be listed in 
an attached bibliography. 
 
2.3 PROPOSED METHOD:  Provide an outline of the proposed method, including details of data 
collection techniques, tasks participants will be asked to do, the estimated time commitment 
involved, and how data will be analysed. If the project includes any procedure which is beyond 
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already established and accepted techniques please include a description of it.  (No more than 400 
words.) 
 
2.4 PARTICIPANT PROFILE:  Provide number, age range and source of participants.  Please provide a 
justification of your proposed sample size.  Please provide a justification for selecting a specific 
gender. 
 
2.5 MEANS BY WHICH PARTICIPANTS ARE TO BE RECRUITED:  Please provide specific details as to 
how you will be recruiting participants. How will people be told you are doing this research? How will 
they be approached and asked if they are willing to participate? If you are mailing to or phoning 
people, please explain how you have obtained their names and contact details. This information will 
need to be included in the plain language statement. If a recruitment advertisement is to be used, 
please ensure you attach a copy to this application. 
 
3.3 POTENTIAL RISKS TO PARTICIPANTS AND RISK MANAGEMENT PROCEDURES:  Identify, as far as 
possible, all potential risks to participants (physical, psychological, social, legal or economic etc.), 
associated with the proposed research. Please explain what risk management procedures will be put 
in place. 
 
3.6 ADVERSE/UNEXPECTED OUTCOMES:  Please describe what measures you have in place in the 
event that there are any unexpected outcomes or adverse effects to participants arising from 
involvement in the project. 
 
3.7 MONITORING:  Please explain how you propose to monitor the conduct of the project (especially 
where several people are involved in recruiting or interviewing, administering procedures) to ensure 
that it conforms with the procedures set out in this application.  In the case of student projects please 
give details of how the supervisor(s) will monitor the conduct of the project. 
 
3.8 SUPPORT FOR PARTICIPANTS:  Depending on risks to participants you may need to consider 
having additional support for participants during/after the study.  Consider whether your project 
would require additional support, e.g., external counselling available to participants.  Please advise 
what support will be available. 
 
4.0 INVESTIGATORS’ QUALIFICATIONS, EXPERIENCE AND SKILLS:  List the academic qualifications 
and outline the experience and skills relevant to this project that the researchers and any supporting 
staff have in carrying out the research and in dealing with any emergencies, unexpected outcomes, 
or contingencies that may arise. 
 
5.2 HOW WILL THE ANONYMITY OF THE PARTICIPANTS BE RESPECTED?  Please bear in mind that 
where the sample size is very small, it may be impossible to guarantee anonymity/confidentiality of 
participant identity.  Participants involved in such projects need to be advised of this limitation. 
 
5.3 LEGAL LIMITATIONS TO DATA CONFIDENTIALITY:  Participants need to be aware that 
confidentiality of information provided can only be protected within the limitations of the law - i.e., it 
is possible for data to be subject to subpoena, freedom of information claim or mandated reporting 
by some professions. Depending on the research proposal you may need to specifically state these 
limitations.   
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6.0 DATA/SAMPLE STORAGE, SECURITY AND DISPOSAL: For the purpose of this section, “Data” 
includes that in a raw or processed state (e.g. interview audiotape, transcript or analysis).  “Samples” 
include body fluids or tissue samples. 
 
8.0 PLAIN LANGUAGE STATEMENT:  Written information in plain language that you will be providing 
to participants, outlining the phases and nature of their involvement in the project and inviting their 
participation.  Please note that the language used must reflect the participant age group and 
corresponding comprehension level. 
 
9.0 INFORMED CONSENT FORM:  This is a very important document that should be addressed by 
participants to researchers, requiring participants to indicate their consent to specific statements, 
and give their signature. 
 
FOR FURTHER INFORMATION AND NOTES ON THE DEVELOPMENT OF PLAIN LANGUAGE 
STATEMENTS AND INFORMED CONSENT FORMS, PLEASE CONSULT THE DCU REC WEBSITE: 
WWW.DCU.IE/RESEARCH/ETHICS 
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1. ADMINISTRATIVE DETAILS 
 
THIS PROJECT IS:  Research Project  Funded Consultancy 
(tick as many as 
apply) 
 Practical Class  Clinical Trial 
  Student Research Project  
(please give details) 
 Other  - Please Describe:       
  Research
Masters 
 Taught Masters 
  PhD  Undergraduate 
 
Project Start 
Date: 
September 2010 Project End 
date: 
December 2011 
 
1.1 INVESTIGATOR CONTACT DETAILS  
 
PRINCIPAL INVESTIGATOR(S):  
TITLE SURNAME FIRST NAME PHONE FAX EMAIL 
Prof Moyna Niall 7008802 7008888 niall.moyna@dcu.ie 
 
OTHER INVESTIGATORS:  
TITLE SURNAME FIRST NAME PHONE FAX EMAIL 
Dr. McCaffrey Noel 087279759
7 
7008888 noel.mccaffrey@dcu.ie 
Dr. Susta Davide  7008888 davide.susta@dcu.ie 
Ms Tobin Crionna 086070513
0 
7008888 crionna.tobin9@mail.dcu.ie  
Mr. Cregg Cathal 087763302
1 
7008888 cathal.cregg2@mail.dcu.ie 
Mr. Kelly David 085161820
7 
7008888 david.kelly59@mail.dcu.ie 
 
FACULTY/DEPARTMENT/SCHOOL/ CENTRE: School of Health and Human Performance 
1.2 WILL THE RESEARCH BE UNDERTAKEN ON-SITE AT DUBLIN CITY UNIVERSITY? 
 YES  NO  
1.3 IS THIS PROTOCOL BEING SUBMITTED TO ANOTHER ETHICS COMMITTEE, OR HAS IT BEEN 
PREVIOUSLY SUBMITTED TO AN ETHICS COMMITTEE?) 
 YES  NO  
 
DECLARATION BY INVESTIGATORS 
The information contained herein is, to the best of my knowledge and belief, accurate.  I have read 
the University’s current research ethics guidelines, and accept responsibility for the conduct of the 
procedures set out in the attached application in accordance with the guidelines, the University’s 
policy on Conflict of Interest and any other condition laid down by the Dublin City University Research 
Ethics Committee or its Sub-Committees.  I have attempted to identify all risks related to the research 
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that may arise in conducting this research and acknowledge my obligations and the rights of the 
participants. 
 
If there any affiliation or financial interest for researcher(s) in this research or its outcomes or any 
other circumstances which might represent a perceived, potential or actual conflict of interest this 
should be declared in accordance with Dublin City University policy on Conflicts of Interest.  
 
I and my co-investigators or supporting staff have the appropriate qualifications, experience and 
facilities to conduct the research set out in the attached application and to deal with any 
emergencies and contingencies related to the research that may arise. 
Signature(s): 
 
Principal investigator(s):    
 
Print name(s) in block letters: Niall Moyna 
 
Date:      3/9/2010 
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2. PROJECT OUTLINE  
2.1 LAY DESCRIPTION 
Endurance training predominates in intermittent type sports such as Gaelic games in which 
aerobic fitness is essential (1). Recent studies have shown that brief repeated sessions of 
‘all-out’ high intensity or sprint type interval training (SIT) induce changes in skeletal muscle 
metabolism that resemble endurance type (ET) training (3;4).  Most of the studies which 
confirm these findings are based on untrained subjects who trained on a stationary bike in a 
laboratory (4, 5).  The purpose of this study is to compare the effect of 6 weeks (3 d/week) 
of SIT with 6 weeks (3 d/week) of ET on measures of fitness and performance in trained and 
untrained Gaelic football players.  The total training time will be approximately 11 h 33 min 
and 13.4 min for the ET and SIT respectively.  A total of 20 trained (T) and 20 untrained (U) 
subjects will be randomly assigned to an endurance training group (ET) or a high intensity 
interval training group (HIT).  Before and after the 6 week training program the subjects will 
have a muscle biopsy and blood sample taken and will undergo a number of tests to 
measure body composition, speed, power, agility, lactate threshold, aerobic capacity, 
anaerobic capacity, and endurance performance.  Blood lactate levels will be measured 
before and immediately after the third weekly training session. The results of the study may 
have significant implications for training guidelines for Gaelic football.  
2.2 AIMS OF AND JUSTIFICATION FOR THE RESEARCH  
Aims of the Research: 
To compare the effect of 6 weeks of SIT and ET on speed, power, agility, maximal aerobic 
capacity, anaerobic capacity, intermittent endurance capacity, muscle oxidative capacity and 
selected measures of whole body and skeletal muscle substrate metabolism in trained and 
untrained Gaelic football players.  The total training will be 11 h 33 min and 13.4 min for the 
SIT and ET group respectively.   
Justification: 
Endurance training induces numerous physiological and metabolic adaptations that improve 
endurance capacity (2).  Although this type of training offers significant training adaptations 
it requires a large time commitment.  Recent studies have shown that brief repeated 
sessions of ‘all-out’ high intensity or sprint type interval training (SIT) induces changes in 
skeletal muscle energy metabolism that resemble endurance type training (3;4).  Gibala et al 
(4) found similar molecular and cellular adaptations in skeletal muscle following 6 sessions 
of SIT or endurance training (ET) performed over 2 weeks despite the fact that the total 
training time commitment and exercise volume were significantly lower in SIT groups.   
In a more recent study (5), active but untrained subjects performed a constant-load cycling 
challenge (1 h at 65% of VO2max) before and after 6 weeks of SIT or ET.  The SIT group 
trained 3 d/week and each session consisted of four to six repeats of a 30 s ‘all out’ Wingate 
Test (mean power output~500W) with 4.5 min recovery between repeats, 3 days per week.  
The ET group trained 5 d/week and each session consisted of 40 -60 min of continuous 
cycling at a workload that elicited 65% ˙  2max (mean power output 150W). Despite the 
large time commitment differences, both protocols induced similar increases (p<0.05) in 
mitochondrial markers for skeletal muscle CH  (pyruvate dehydrogenase E1α protein 
content) and lipid oxidation (3-hydroxyacyl CoA dehydrogenase activity) and protein content 
of peroxisome proliferator-activated receptor-γ coactivator-1α. Glycogen and 
phosphocreatine utilization during exercise were reduced after training, and calculated rates 
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of whole-body CHO and lipid oxidation were decreased and increased, respectively, with no 
differences between groups (all main effects, P <0.05).  Given the markedly lower training 
volume in the SIT group, these data suggest that high-intensity interval training is a time-
efficient strategy to increase skeletal muscle oxidative capacity and induce specific 
metabolic adaptations during exercise that are comparable to traditional ET.  The majority of 
training studies (4-7) have used relatively untrained individuals and involved cycling as the 
mode of exercise.   
1. Keane S, Reilly T (1993) Analysis of work rates in Gaelic football.  Australian Journal of 
Sports Science 100-102 
2. Gollnick PD AR (1973) Effect of training on enzyme activity and fiber type composition of 
human skeletal muscle.  J.   Appl.Physiol. 107-111 
3. Henriksson J, Reitman JS (1976) Qualitative measures of enzyme activities in type I and 
type II muscle fibers of man after training.  Acta Physiologica Scandinavica 97: 392-397 
4. Gibala MJ, Little PJ (2006) Short-term sprint interval versus traditional endurance 
training: similar initial adaptations in human skeletal muscle and exercise performance.  
Journal of Physiology 901-911 
5. Burgomaster KA, Howarth KR, Gibala MJ (2008) Similar metabolic adaptations during 
exercise after low volume sprint interval and traditional endurance training in humans.  
Journal of Physiology 586: 151-160 
6. Burgomaster KA, Heigenhauser G J F, Gibala MJ (2006) Effect of short-term sprint interval 
training on human skeletal muscle carbohydrate metabolism during exercise and time-
trial performance.  J Appl.Physiol. 2041-2047 
7. Burgomaster KA, Hughes SC, Heigenhauser G J F, Gibala MJ (2005) Six sessions of sprint 
interval training increases muscle oxidative potential and cycle endurance capacity in 
humans.  J Appl.Physiol. 1985-1990 
2.3  PROPOSED METHOD 
 Study Overview 
The study will take place in the School of Health and Human Performance at DCU and the 
DCU Sports Grounds.  Subjects will undertake 2 weeks (3d/week) of endurance training 
(ET) or high intensity interval training (HIT).  Subjects will visit DCU on 3 separate 
occasions (1 screening and 2 study visits) before the study and on 2 separate occasions at 
the end of the study.  They will have a muscle biopsy and blood sample taken and will 
undergo a number of tests to measure body composition, speed, power, agility, lactate 
threshold, aerobic capacity, anaerobic capacity, and endurance performance.  Heart rate 
will be recorded during each training session and blood lactate levels will be measured 
before and immediately after the third weekly training session.  Each visit will be 
separated by at least 24 h. 
Screening Visit 
The screening visit will last approximately 1 h.  Subjects will undergo a brief medical 
examination and perform a Bangsbo Yo Yo Intermittent Recovery test.   
Study Visits 
Visit 1 - The visit will last approximately 2 h and will be used to measure body 
composition, muscle power, speed, agility, lactate threshold and maximal aerobic 
capacity (VO2max). 
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Visit 2 -    Subjects will run on the treadmill at 110% v VO2max until volitional fatigue.  
Visit 3 – A blood and a muscle biopsy sample will be taken from each subject  
Endurance Training Program  
Subjects will run on a treadmill at 70-80% VO2max.  Subjects will run for 50 min during 
the training sessions.  
Sprint-Interval Training Protocol 
Subjects will sprint 110 m followed by a 50 metre recovery run.  The sprint and recovery 
run must be completed in 20 sec.  This will be repeated 3 more times followed by a 5 min 
recovery period (1 set).   
Figure : Training protocol 
 Laboratory Procedures: 
Maximal Aerobic Capacity Assessment/ Lactate Threshold: Maximal aerobic capacity will be 
determined on a treadmill (Woodway ELG 55, Waukesha, WI) using a ramp protocol.  
Subjects will warm-up at 8 km/h for 3 min at 1% gradient.  Following the warm-up, the 
speed will be increased 1 km/h every 3 min.  At baseline and at the end of each 3 min stage 
a blood sample will be taken to determine blood lactate concentration. When lactate 
concentrations reach 4 mmol the speed will remain constant and the gradient will be 
increased by 1% every 30 sec until the subject reaches volitional exhaustion.  The test will be 
deemed to be maximal if it satisfies at least 3 of the following criteria; levelling of oxygen 
consumption, volitional exhaustion, RER > 1.1 and heart rate within ± 10 beats of the age 
predicted max.  HR will be recorded continuously, will be assessed each minute.  
Respiratory Metabolic Measures: Expired oxygen, carbon dioxide, ventilatory volume and 
respiratory exchange ratios (RER) will be determined using a Sensormedics Vmax 229 
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metabolic system (SensorMedics Corp., Yorba Linda CA).  Prior to testing, the gas analysers 
will be calibrated with standard gases of known concentration. 
Percent Body Fat:  Lange skinfold calliper (Cambridge Scientific Industries, MD) will be used 
to measure double thickness subcutaneous adipose tissue on the right side of the body.  The 
following anatomical sites will be used: suprailiac, triceps and thigh.  A minimum of 2 
measurements will be taken at each site. If the measurements vary by more than 1 mm a 
third measurement will be taken.   
Blood Sampling at Rest: A standard venous puncture will be used to collect blood samples at 
rest before and after the training study.  A total volume of 30 ml will be taken. 
Blood Sampling During Exercise:  Blood samples (5-10 μl) will be taken from the earlobe 
using capillary tubes. The earlobe will be sterilized with a sterile wipe and then pricked with 
a lancet (AccuCheck Softclix Pro Lancet, Accu Check, Australia) to promote blood flow.   
Lactate Analysis:  Whole blood lactate concentration will be measured using a YSI 1500 
Sport Lactate Analyzer (YSI UK limited).   
Muscle Biopsy: Rationale for muscle biopsy samples 
Skeletal muscle biopsies are necessary before and after the training intervention to 
determine the molecular and cellular adaptations induced by the training intervention in 
skeletal muscle.  
4. Little JP. A practical model of low-volume high-intensity interval training induces 
mitochondrial biogenesis in human skeletal muscle: potential mechanism. J Physiol 
588.6: 1011-1022, 2010 
5. Burgomaster KA. Similar metabolic adaptations during exercise after low volume 
sprint interval and traditional endurance training in humans. J Physiol 586: 151-160, 
2008 
6. Burgomaster KA. Effect of short-term sprint interval training on human skeletal 
muscle carbohydrate metabolism during exercise and time-trial performance. J Appl 
Physiol 100: 2041-2047, 2006 
Statistical Analysis: 
A group (Trained or Untrained) x condition (ET or SIT) x time repeated measures ANOVA will 
be used to compare the mean differences within and between group.  SPSS for Windows 
statistical software will be used to perform the statistical analysis.  Statistical significance will 
be accepted at the P < 0.05 level of confidence  
2.4 PARTICIPANT PROFILE 
Inclusion criteria:  Apparently healthy men, currently playing at junior club level or higher 
level, and between the ages of 18 – 35 years.   
Fitness classification will be based on performance in the Bangsbo Yo-Yo Intermittent 
Recovery test.  Subjects who achieve a level ≤ 16.8 will be classified as untrained.  Subjects 
who achieve a level ≥ 16.8 will be classified as trained   
Exclusion criteria:  Volunteers will be excluded if they smoke or have any other medical 
conditions that contraindicate exercise participation. 
 
230 
 
 
2.5 MEANS BY WHICH PARTICIPANTS ARE TO BE RECRUITED  
A recruitment advertisement will be emailed to members of the Dublin City University Gaelic 
games club and all Dublin city Gaelic games clubs.  Permission will be sought from each club 
prior to posting the advertisement.  The aim of the study, the rationale for the study, the 
tests involved, the time commitment and the potential benefits will be explained to the 
players.  Players will be provided with an opportunity to ask questions.  If they wish to 
participate in the study they will have to provide a written informed consent, which will be 
witnessed on their visit to the School of Health and Human Performance.   
2.6 PLEASE EXPLAIN WHEN, HOW, WHERE, AND TO WHOM RESULTS WILL BE DISSEMINATED, 
INCLUDING WHETHER PARTICIPANTS WILL BE PROVIDED WITH ANY INFORMATION AS TO 
THE FINDINGS OR OUTCOMES OF THE PROJECT? 
The study findings will be presented at scientific meetings and published in scientific 
journals.  Subjects will be provided with a report, which will summarise the relevant results 
from their participation in the research project.  
2.7 OTHER APPROVALS REQUIRED Has permission to gain access to another location, 
organisation etc. been obtained?  Copies of letters of approval to be provided when 
available.  
 YES  NO  NOT APPLICABLE 
2.8 HAS A SIMILAR PROPOSAL BEEN PREVIOUSLY APPROVED BY THE REC? 
 YES  NO 
 
(If YES, please state both the REC Application Number and Project Title) 
 
3. RISK AND RISK MANAGEMENT 
3.1 ARE THE RISKS TO SUBJECTS AND/OR RESEARCHERS ASSOCIATED WITH YOUR PROJECT 
GREATER THAN THOSE ENCOUNTERED IN EVERYDAY LIFE? 
 
 YES  NO If YES, this proposal will be subject to full REC review 
If NO, this proposal may be processed by expedited 
administrative review 
 
3.2 WHAT DOES THE RESEARCH INVOLVE: 
 YES NO 
 Use of a questionnaire? (attach copy)?   
 interviews (attach interview questions)?   
 observation of participants without their knowledge?   
 participant observation (provide details in section 2)?   
 audio- or video-taping interviewees or events?   
 access to personal and/or confidential data (including student, patient 
or client data) without the participant’s specific consent? 
  
 administration of any stimuli, tasks, investigations or procedures   
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which may be experienced by participants as physically or mentally 
painful, stressful or unpleasant during or after the research process? 
 performance of any acts which might diminish the self-esteem of 
participants or cause them to experience embarrassment, regret or 
depression? 
  
 investigation of participants involved in illegal activities?   
 procedures that involve deception of participants?   
 administration of any substance or agent?   
 use of non-treatment of placebo control conditions?   
 collection of body tissues or fluid samples?   
 collection and/or testing of DNA samples?   
 participation in a clinical trial?   
 administration of ionising radiation to participants?   
3.3 POTENTIAL RISKS TO PARTICIPANTS AND RISK MANAGEMENT PROCEDURES (see 
Guidelines) 
The nature and risks involved in the study will be explained prior to starting the study, and a 
contact number will be provided.  
Subjects may experience some muscle soreness in their legs or nausea following the 
maximal exercise test.  Exercise testing carries with it a very small risk of abnormal heart 
rhythms, heart attack, or death in less than one in 30,000 patients.  The pre-test likelihood 
of these risks in asymptomatic men < 55 years of age is very low.  There may be discomfort 
during the muscle biopsy with some pain and delayed soreness afterward.  There is a risk of 
bleeding, bruising, infection and scaring of the skin.  Temporary numbness of the skin near 
the biopsy site may occur.  There may be discomfort when taking blood and the 
development of a small bruise at the site of puncture.   
3.4 ARE THERE LIKELY TO BE ANY BENEFITS (DIRECT OR INDIRECT) TO PARTICIPANTS FROM 
THIS RESEARCH? 
 
 YES  NO The study will provide information than can be used to 
develop training programs for Gaelic football. 
3.5 ARE THERE ANY SPECIFIC RISKS TO RESEARCHERS? (e.g. risk of infection or where research is 
undertaken at an off-campus location) 
  
 YES  NO There is a small risk of infection from needle and blood 
samples.  Standard safety procedures will be strictly adhered 
to. 
3.6 ADVERSE/UNEXPECTED OUTCOMES 
The School of Health and Human Performance has the facilities to deal with all aspects of 
this study and an emergency plan is in place for adverse events.  All minor injuries will be 
addressed by an individual trained in first aid (either a member of the research team or the 
staff).  The laboratory is equipped with an emergency crash cart and defibrillator.  An 
individual trained in first aid (or Advanced Cardiac Life Support) will be present during each 
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test.  In the unlikely event of a serious adverse outcome, the subject will be brought to the 
VHI clinic on campus. 
3.7 MONITORING  
Weekly meetings will take place between Prof. N. Moyna (principal investigator) and the 
other researchers.  These meetings will provide opportunities to access progress, give 
feedback, and monitor development of the research.  The School of Health and Human 
Performance has a detailed list of Standard Operating Procedures for each of the protocols 
in this study.  All researchers will be familiar with the procedures and the Safety Statement 
before beginning data collection.  
 
3.8 SUPPORT FOR PARTICIPANTS  
 It is anticipated that no additional support will be required.  
3.9 DO YOU PROPOSE TO OFFER PAYMENTS OR INCENTIVES TO PARTICIPANTS? 
 
 YES  NO (If YES, please provide further details.)      
 
4. INVESTIGATORS’ QUALIFICATIONS, EXPERIENCE AND SKILLS (Approx. 200 words – see 
Guidelines) 
Prof. Moyna is an exercise physiologist and has extensive experience with exercise testing 
Dr. Noel McCaffrey and Dr. Davide Susta are physicians with extensive experience in the 
muscle biopsy technique 
Crionna Tobin is a PhD student at the School of Health and Human Performance.  She has a 
Bsc, a Higher Diploma in Human Nutrition and a Higher Diploma in Sports Nutrition.  
Mr. David Kelly and Cathal Cregg are postgraduate students and have extensive experience 
in laboratory and field based exercise testing. 
5. CONFIDENTIALITY/ANONYMITY 
5.1 WILL THE IDENTITY OF THE PARTICIPANTS BE PROTECTED? 
 
 YES  NO (If NO, please explain) 
 
IF YOU ANSWERED YES TO 5.1, PLEASE ANSWER THE FOLLOWING QUESTIONS: 
5.2 HOW WILL THE ANONYMITY OF THE PARTICIPANTS BE RESPECTED?  
Confidentiality is an important issue during data collection.  Participant’s identity, or other 
personal information, will not be revealed or published.  Subjects will be assigned an ID 
number under which all personal information will be stored in a secure file and saved in 
password protected file in a computer at DCU.  The investigators alone will have access to 
the data. 
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5.3 LEGAL LIMITATIONS TO DATA CONFIDENTIALITY: (Have you included appropriate 
information in the plain language statement and consent form?  See Guidelines) 
 
 YES  NO (If NO, please advise how participants will be advised.)  
The following statement should be included in the plain language statement. 
‘Confidentiality of information provided can only be protected within the limitations of the 
law.  It is possible for data to be subject to subpoena, freedom of information claim or 
mandated reporting by some professions. 
6 DATA/SAMPLE STORAGE, SECURITY AND DISPOSAL (see Guidelines) 
6.1 HOW WILL THE DATA/SAMPLES BE STORED? (The REC recommends that all data be stored 
on campus) 
Stored at DCU      
Stored at another site     (Please explain where and for what 
purpose) 
6.2 WHO WILL HAVE ACCESS TO DATA/SAMPLES? 
Access by named researchers only         
Access by people other than named researcher(s)   (Please explain who and for 
what purpose)  
Other  :     (Please explain) 
 
6.3 IF DATA/SAMPLES ARE TO BE DISPOSED OF, PLEASE EXPLAIN HOW, WHEN AND BY WHOM 
THIS WILL BE DONE? 
The principal investigator will be responsible for security of the collected data.  The data will 
be kept in locked facilities in the department through which the project is being conducted.  
Access to the data will only be attainable by the main researchers.  Data will be kept for a 
minimum of five years from the date of publication of the research.  Aside from the main 
researchers, no others will have access to the raw data. Data will be shredded after five 
years and Prof. Moyna will carry this out.  
 
7. FUNDING 
7.1 HOW IS THIS WORK BEING FUNDED? 
 The Gaelic Athletic Association  
7.2 PROJECT GRANT NUMBER (If relevant and/or known) 
7.3 DOES THE PROJECT REQUIRE APPROVAL BEFORE CONSIDERATION FOR FUNDING BY A 
GRANTING BODY?  
 
 YES  NO  
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7.4 HOW WILL PARTICIPANTS BE INFORMED OF THE SOURCE OF THE FUNDING? 
In the plain language statement 
 
 
 
 
7.5      DO ANY OF THE RESEARCHERS, SUPERVISORS OR FUNDERS OF THIS PROJECT HAVE A 
PERSONAL,   FINANCIAL OR COMMERCIAL INTEREST IN ITS OUTCOME THAT MIGHT 
COMPROMISE THE INDEPENDENCE AND INTEGRITY OF THE RESEARCH, OR BIAS THE 
CONDUCT OR RESULTS OF THE RESEARCH, OR UNDULY DELAY OR OTHERWISE AFFECT THEIR 
PUBLICATION? 
  
 NO  
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8. PLAIN LANGUAGE STATEMENT  
Plain Language Statement 
Dublin City University 
Project Title: Muscle adaptations in response to low volume high intensity interval training and 
endurance training in Gaelic games 
The Research Study will take place in the School for Human Health and Human Performance DCU 
and the DCU Sports Grounds 
The research study is being funded by the Gaelic Athletic Association.   
The principal investigator is: Prof. Niall M. Moyna, (Tel: 7008802 Fax 7008888) EMAIL 
niall.moyna@dcu.ie 
7. A good level of endurance is important for Gaelic football players.  Many players spend 
considerable time running long distances to improve their endurance.  Research studies 
have shown that training involving short sprints with short recovery periods (sprint interval 
training) can also improve endurance.  The amount of time required to improve endurance 
is considerable less when sprint interval training is undertaken compared to distance 
running.  No studies have compared the effect of endurance training and sprint interval 
training on endurance performance in Gaelic football players.  The purpose of this study is 
to compare the effect of a 6 week endurance training and sprint interval training program 
on endurance performance in Gaelic football players.   
You will make 3 visits to the Human Performance Laboratory in DCU before and 2 visits 
after taking part in the training program.  The first visit before the study will last 
approximately 1 hour and will involve you undergoing a brief medical examination and 
performing an endurance exercise test.  The second visit will be 2 hours in duration and 
will be used to your aerobic fitness.  During the third visit you will have a blood and a 
muscle biopsy and blood sample taken. You will then be assigned, by chance, to one of two 
groups.  One group will take part in sprint-interval training and the other group will take 
part in endurance training 3 times per week for 2 weeks. Subjects randomised to the 
endurance training group will run on a treadmill at 70-80% VO2max.  Subjects will run for 
50 min during the training sessions. Subjects randomised to the sprint-interval training will 
sprint 100 m followed by a 50 metre recovery run.  The sprint and recovery run must be 
completed in 40 sec.  This will be repeated 3 more times followed by a 4 min recovery 
period (1 set).  Subjects will complete 3 sets during the training session.  Training sessions 
will be carried out on the sprint track in DCU or in the DCU gym depending on which 
training program you are undertaking. Each training session will be monitored by graduate 
students to ensure compliance. During the last training session you repeat the same 
endurance test that you undertook before the study. You will repeat the elements of the 
previous second and third visits in the human performance lab in DCU 24-48 hrs after the 
last training session. During the first of the post-training visits to the human performance 
lab in DCU you will have a blood and a muscle biopsy sample taken.  For the duration of 
the study you will not be able to participate in any other type of exercise during this 6 
week period. 
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8. You will receive a report summarizing the results from your tests undertaken during the 
study.  No other benefits have been promised.  
9. Your identity and other personal information will not be revealed, published or used in 
further studies.  You will be assigned an ID number under which all personal information 
will be stored in a secure file and saved in a password protected file in a computer at DCU.  
The principal investigator, and collaborators listed on this ethics application will have 
access to the data.  You need to be aware that confidentiality of information provided can 
only be protected within the limitations of the law.  It is possible for data to be subject to 
subpoena, freedom of information claim or mandated reporting by some professions.  
10. The original documentation will be stored for a maximum of 5 years.  Thereafter the 
documentation will be shredded. 
11. Your participation in this research project is voluntary and you may withdraw your consent 
at any time. 
If participants have concerns about this study and wish to contact an independent person, please 
contact: 
The Secretary, Dublin City University Research Ethics Committee, c/o Office of the Vice-
President for Research, Dublin City University, Dublin 9.  Tel 01-7008000 
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9. INFORMED CONSENT FORM  
INFORMED CONSENT 
Title:  Muscle adaptations in response to low volume high intensity interval 
training and endurance training in Gaelic games 
Principal investigator: Prof Niall M. Moyna 
Other investigators:  Ms Crionna Tobin, Mr Cathal Cregg, Mr David Kelly, Dr. Noel McCaffrey, Dr. 
Davide Susta 
Purpose:  The purpose of this study is to compare the effect of a 6 week endurance 
training and sprint interval training program on endurance performance in 
Gaelic football players.   
Participant Requirements 
5. I will have the purpose of the study, each of the steps involved and the risks of participating 
in the study explained to me.  I will have the opportunity to ask any questions and if I am 
happy with the answers I will provide written informed consent for participation in the 
research project.  I will then complete a medical history form, which will ask questions about 
my general health, personal and family health history, smoking, exercise, and dietary habits. 
I will talk with a medical doctor about the information I have provided and I understand, 
based on the information provided, the medical doctor may exclude me from participating in 
the research project.  If I agree to participate in the study I will make 3 visits to the Human 
Performance Laboratory in DCU before and 2 visits after taking part in the training program.   
6. For the first visit, I will arrive in the morning to the Human Performance Laboratory in DCU 
following my normal breakfast.  I will undergo a brief medical screening to evaluate my 
current physical condition.  I will undergo an exercise test on a treadmill to measure my 
aerobic fitness and lactate threshold. To assess my fitness I will have a mouthpiece similar to 
a snorkel in my mouth to measure the amount of air I breathe in and out. To assess my 
lactate threshold I will have my ear pricked to collect a small blood sample.  
7. On my second visit to the Human Performance Laboratory.  I will take part in an endurance 
fitness test to measure my endurance capacity. This will involve running on a tredmill until I 
fatigue. 
8. During the third visit I will have a blood and a muscle biopsy sample taken.  The muscle 
biopsy sample will involve taking a small piece of muscle, about the size of a pea taken from 
my thigh with a special biopsy needle.  A small area of the leg will be injected with a local 
anaesthetic, then a small incision will be made in the skin and a needle inserted briefly into 
the muscle.  The incision will be closed with sterile strip bandaids, and my leg will be 
wrapped snugly with an elastic bandage to maintain pressure. Before I leave I will be given 
supplies to change the dressing around the biopsy sites.  
9. After the third visit to the laboratory I will be assigned, by chance, to one of two groups. I 
will take part in sprint-interval training or endurance training 3 times per week for 2 weeks. 
At the end of the third weekly training session I will have my ear pricked to collect a small 
blood sample to measure my blood lactate levels. This test will assess how well I am 
responding to each training session.  
10. During the last training session I will repeat the same endurance test that I undertook before 
the study.  I will repeat the elements of the previous second and third visits in the Human 
Performance Laboratory in DCU 24-48 hrs after the last training session. 
11. I will not participate in any other type of exercise during this 6 week period. 
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Sometimes there are side effects from performing exercise tests. These side effects are often 
called risks, and for this project, the risks are: 
4. Exercise testing carries with it a very small risk of exercise induced asthma, abnormal heart 
rhythms, heart attack, or death in less than one in 30,000 patients.  The risk of sudden death 
during exercise for healthy men is 1:15000-18000.  Because I will be asked to give a 
maximum effort, I may experience some muscle soreness in my arms and legs or nausea 
following the maximal exercise test.  It should be noted that if the experimental protocol is 
adhered to, the likelihood of these risks occurring is minimal. 
5. I understand that the insertion and placement of a cannula (to take blood samples) should 
be minimally painful but a slight ache may be felt and a small bruise may appear on my arm.  
There is also a small risk of infection, but by using the appropriate techniques this risk is 
minimal. 
6. I understand that there may be discomfort during the muscle biopsy with some pain and 
delayed soreness afterward.  There is a risk of bleeding, bruising, infection and scaring of the 
skin.  After the biopsy, my leg may feel stiff and sore.  Temporary numbness of the skin near 
the biopsy may also occur. 
There may be benefits from my participation in this study.  These are: 
3. I will receive a copy of my personal results, body fat and fitness measurements  
4. I understand that no other benefits have been promised me. 
Participant – please complete the following (Circle Yes or No for each question) 
I have read the Plain Language Statement     Yes/No 
I understand the information provided      Yes/No 
I have had an opportunity to ask questions and discuss this study   Yes/No 
I have received satisfactory answers to all my questions     Yes/No 
My confidentiality will be guarded: 
Dublin City University will protect all the information about me, and my part in this study, within the 
limitations of the law.  My identity or personal information will not be revealed or published. All 
records associated with my participation in the study will be subject to the usual confidentiality 
standards applicable to medical records.  In addition, the study findings may be presented at 
scientific meetings and published in a scientific journal and/or as part of a postgraduate thesis, but 
my identity will not be divulged and only presented as part of a group.   
If I have questions about the research project, I am free to call Prof Niall Moyna at 01-7008802.   
Taking part in this study is my decision.   
I understand that my participation in this study is voluntary and that I may withdraw my consent at 
any time by notifying any of the investigators.  I may also request that my data and samples be 
removed from the database or storage and destroyed.  My withdrawal from this study, or my refusal 
to participate, will in no way affect my relationship with Dublin City University or my entitlements as 
a student or staff member.  I understand that my participation in this research may be terminated by 
the investigator without regard to my consent if I am unable or unwilling to comply with the 
guidelines and procedures explained to me.  
Signature: 
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I have read and understood the information in this form.  My questions and concerns have been 
answered by the researchers, and I have a copy of this consent form.  Therefore, I consent to take 
part in this research project 
Participants Signature:         
Name in Block Capitals:         
Witness:             
Date:                
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Email to participants: 
The school of Health and Human Performance is conducting a study to compare the effect of a 6 
week endurance training and sprint interval training program on speed, agility, power and 
endurance performance in Gaelic football players.  You will make 3 visits to the Human 
Performance Laboratory in DCU before and 2 visits after taking part in the training program.  The 
first visit before the study will last approximately 1 hour and will involve you undergoing a brief 
medical examination and lactate threshold and your aerobic fitness.  The second visit will you will 
perform an endurance exercise test.  During the third visit you will have a blood and a muscle 
biopsy sample taken. You will then be assigned, by chance, to one of two groups.  One group will 
take part in sprint-interval training and the other group will take part in endurance training 3 
times per week for 2 weeks. During the last training session you will take part in an endurance 
test. You will repeat the elements of the previous second and third visits in the Human 
Performance Laboratory in DCU 24-48 hrs after the last training session. We are looking for 40 
healthy men, currently playing Gaelic football at any level, and between the ages of 18 – 35 years.   
If you would like to hear more about this study or would consider participating, please contact 
one of the following; 
Crionna Tobin 
Email: Crionna.tobin9@mail.dcu.ie 
Mobile number: 086-0705130 
 
David Kelly 
Email: david.kelly59@mail.dcu.ie 
Mobile number: 085-1618207 
 
Cathal Cregg 
Email: cathal.cregg2@mail.dcu.ie 
Mobile number: 087- 7633021 
 
Thank you, 
 
Niall M. Moyna, PhD  
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Standard template for ethical justification for blood sampling associated with human studies 
conducted within DCU. 
Completion instructions: 
This document is intended to prompt responses to a number of standard questions which generally 
need to be answered to justify the sampling of blood associated with human studies. 
The document is not meant to be an exhaustive exploration of the justification for such sampling 
and in specific situations.   Additional information may be required/ requested.   
Answers are expected to be brief but should also be informative.  See a sample completed form at 
the end.   
Queries should be directed to the Secretary of the Research Ethics Committee in the OVPR office.  
 
 
1) Briefly explain why blood sampling is required 
 
 
 
 
2) Outline the analyses, components or general applications to be investigated in subject 
blood  (now and any future studies) 
 
 
 
 
 
 
 
3) Are any alternatives available to substitute the venous sampling of blood?  yes/no.   
  
 
 
 
4) Will sampling require cannulation or direct vein puncture?   
 
 
 
 
 
5) Outline the minimum volume of original subject blood (i.e. not serum or plasma) required 
to measure the required components.   
  
 
 
 
To monitor circulating levels of glucose, lactate, free fatty acids and insulin, this will be 
used to determine adaptations in the subjects following the research intervention 
 
Blood lactate will be determined using a YSI 1500 Sport Lactate Analyzer (YSI UK 
limited).  Glucose will be analysed using a YSI 2300 Analyzer (YSI UK limited). Free fatty acids 
and insulin will be investigated using an automated clinical chemistry analyzer, Randox 
Daytona (Randox UK limited) 
 
No 
4.0 ml for circulating levels of glucose, free fatty acids and insulin. 
100µl for circulating levels of lactate 
Direct vein puncture and ear prick with lancet 
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6) Are steps being taken in the protocol to minimise the volume of blood samples being 
taken?   Yes 
  
 
  
 
 
 
 
 
 
7) Are steps included to minimise the number of blood samples/vein puncture being taken? 
 Yes 
 
 
 
 
 
8) Anticipated sampling methodology 
Volume of blood to be taken per sample 
 
4.0 ml for glucose, insulin and free fatty 
acids 
100µl for lactate 
Maximum number of samples to be taken per 
“sitting” 
 
6 for lactate 
6 for glucose, insulin and free fatty acids 
Maximum number of samples taken per day 
 
Screening Visit- 0 samples 
Visit 1 – 6 samples 
Visit 2 – 6 samples 
During training – 2 samples 
Visit 3 (post training program) – 6 
samples 
Visit 4 (post training program) – 6 
samples 
 
Maximum number of samples to be taken over 
the course of the full study (if long duration 
study indicate the amount taken in an active 1 
month period) 
 
12 blood samples and 14 lactate samples 
Maximum anticipate number of vein puncture 
episodes 
2 
Total volume of blood that will be taken from 
subject.  
 
50 ml 
 
9) I certify that:-  
 all persons sampling blood in this study are certified to do so through the school/unit where 
this work is being conducted  
Yes.  We have taken the minimum volume of blood that will allow us to examine 
circulating levels of glucose, lactate, free fatty acids and insulin. 
 
Yes.  We have taken the minimum number of blood samples that will allow us to 
examine circulating levels of glucose, lactate, free fatty acids and insulin. 
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 that all those manipulating the resultant samples are fully trained in the safe practice of 
handling blood  
 all persons handling this blood have received appropriate information according to current 
vaccination policy. 
 
 
Signature of Study PI   Date: 06 September 2010 
 
 
An original signed copy must accompany electronic submissions.  Alternatively, a PDF or other 
scanned version with a signature may be submitted 
 
 
 
 
 
 
 
 
 
 
 
